registry_id,year,age,age_group,sex,cancer_type,morphology,grade,basis_of_diagnosis,behavior,residence,treatment_status,vital_status,survival_months,scenario
KE-NRB-2010-00001,2010,45,45-54,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,34.1,high_burden
KE-NRB-2018-00002,2018,24,15-24,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,25.8,high_burden
KE-NRB-2013-00003,2013,42,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2015-00004,2015,71,65-74,Male,Colorectum,Sarcoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,19.0,high_burden
KE-NRB-2012-00005,2012,54,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-00006,2014,81,75+,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.3,high_burden
KE-NRB-2012-00007,2012,17,15-24,Male,Bladder,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.8,high_burden
KE-NRB-2017-00008,2017,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,54.2,high_burden
KE-NRB-2016-00009,2016,36,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.6,high_burden
KE-NRB-2015-00010,2015,52,45-54,Female,Corpus uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.1,high_burden
KE-NRB-2012-00011,2012,67,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,38.1,high_burden
KE-NRB-2016-00012,2016,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,34.1,high_burden
KE-NRB-2013-00013,2013,78,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.4,high_burden
KE-NRB-2009-00014,2009,48,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-00015,2017,61,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,22.4,high_burden
KE-NRB-2016-00016,2016,67,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,24.1,high_burden
KE-NRB-2013-00017,2013,47,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,57.0,high_burden
KE-NRB-2017-00018,2017,56,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.6,high_burden
KE-NRB-2017-00019,2017,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.0,high_burden
KE-NRB-2010-00020,2010,41,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.8,high_burden
KE-NRB-2015-00021,2015,29,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-00022,2015,35,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-00023,2013,50,45-54,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery + Radiotherapy,Dead,9.2,high_burden
KE-NRB-2015-00024,2015,57,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.6,high_burden
KE-NRB-2016-00025,2016,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.8,high_burden
KE-NRB-2012-00026,2012,56,55-64,Female,Ovary,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-00027,2012,74,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-00028,2014,35,35-44,Male,Bladder,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-00029,2009,39,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,23.3,high_burden
KE-NRB-2014-00030,2014,39,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.0,high_burden
KE-NRB-2014-00031,2014,35,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,14.5,high_burden
KE-NRB-2018-00032,2018,90,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,6.0,high_burden
KE-NRB-2014-00033,2014,52,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,32.4,high_burden
KE-NRB-2012-00034,2012,74,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,35.1,high_burden
KE-NRB-2015-00035,2015,29,25-34,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.0,high_burden
KE-NRB-2016-00036,2016,54,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,25.3,high_burden
KE-NRB-2011-00037,2011,73,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,17.6,high_burden
KE-NRB-2017-00038,2017,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,19.0,high_burden
KE-NRB-2014-00039,2014,67,65-74,Male,Colorectum,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,47.9,high_burden
KE-NRB-2009-00040,2009,2,0-14,Female,Breast,Lymphoma,Unknown,Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,1.1,high_burden
KE-NRB-2011-00041,2011,67,65-74,Male,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,46.8,high_burden
KE-NRB-2013-00042,2013,23,15-24,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2018-00043,2018,56,55-64,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.0,high_burden
KE-NRB-2017-00044,2017,39,35-44,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.2,high_burden
KE-NRB-2018-00045,2018,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,4.0,high_burden
KE-NRB-2018-00046,2018,32,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.1,high_burden
KE-NRB-2016-00047,2016,49,45-54,Female,Ovary,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,3.9,high_burden
KE-NRB-2009-00048,2009,19,15-24,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,11.0,high_burden
KE-NRB-2013-00049,2013,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.3,high_burden
KE-NRB-2018-00050,2018,35,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,12.4,high_burden
KE-NRB-2014-00051,2014,66,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.0,high_burden
KE-NRB-2014-00052,2014,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.3,high_burden
KE-NRB-2016-00053,2016,78,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.7,high_burden
KE-NRB-2009-00054,2009,60,55-64,Male,Stomach,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,43.1,high_burden
KE-NRB-2018-00055,2018,39,35-44,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-00056,2010,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,21.9,high_burden
KE-NRB-2009-00057,2009,36,35-44,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-00058,2018,36,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.2,high_burden
KE-NRB-2013-00059,2013,33,25-34,Male,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,5.7,high_burden
KE-NRB-2013-00060,2013,50,45-54,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-00061,2018,52,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-00062,2018,28,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,24.9,high_burden
KE-NRB-2018-00063,2018,64,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.4,high_burden
KE-NRB-2015-00064,2015,52,45-54,Male,Pancreas,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,16.5,high_burden
KE-NRB-2013-00065,2013,18,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,40.0,high_burden
KE-NRB-2016-00066,2016,58,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.5,high_burden
KE-NRB-2015-00067,2015,64,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,58.1,high_burden
KE-NRB-2017-00068,2017,34,25-34,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,27.4,high_burden
KE-NRB-2017-00069,2017,92,75+,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2014-00070,2014,78,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.0,high_burden
KE-NRB-2016-00071,2016,20,15-24,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.1,high_burden
KE-NRB-2014-00072,2014,81,75+,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,36.5,high_burden
KE-NRB-2014-00073,2014,77,75+,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,58.4,high_burden
KE-NRB-2016-00074,2016,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-00075,2012,87,75+,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.3,high_burden
KE-NRB-2013-00076,2013,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,1.8,high_burden
KE-NRB-2010-00077,2010,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.3,high_burden
KE-NRB-2015-00078,2015,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,11.1,high_burden
KE-NRB-2012-00079,2012,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-00080,2013,16,15-24,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.6,high_burden
KE-NRB-2009-00081,2009,64,55-64,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.0,high_burden
KE-NRB-2010-00082,2010,61,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-00083,2009,55,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,15.9,high_burden
KE-NRB-2017-00084,2017,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,36.5,high_burden
KE-NRB-2013-00085,2013,86,75+,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,19.3,high_burden
KE-NRB-2015-00086,2015,12,0-14,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.2,high_burden
KE-NRB-2016-00087,2016,44,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,55.9,high_burden
KE-NRB-2016-00088,2016,58,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,11.2,high_burden
KE-NRB-2017-00089,2017,63,55-64,Female,Corpus uteri,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,No treatment,Lost to follow-up,60.0,high_burden
KE-NRB-2013-00090,2013,36,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-00091,2012,40,35-44,Female,Other,Adenocarcinoma,Unknown,Other,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2011-00092,2011,31,25-34,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,38.1,high_burden
KE-NRB-2018-00093,2018,60,55-64,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,6.5,high_burden
KE-NRB-2014-00094,2014,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.1,high_burden
KE-NRB-2010-00095,2010,52,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-00096,2016,26,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-00097,2015,67,65-74,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-00098,2010,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Peri-urban,N/A,Dead,39.3,high_burden
KE-NRB-2015-00099,2015,61,55-64,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Alive,25.5,high_burden
KE-NRB-2014-00100,2014,63,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2015-00101,2015,71,65-74,Female,Thyroid,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,56.1,high_burden
KE-NRB-2018-00102,2018,35,35-44,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,10.9,high_burden
KE-NRB-2009-00103,2009,60,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,20.2,high_burden
KE-NRB-2015-00104,2015,48,45-54,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-00105,2009,56,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,58.3,high_burden
KE-NRB-2011-00106,2011,63,55-64,Female,Thyroid,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,22.4,high_burden
KE-NRB-2015-00107,2015,71,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,36.2,high_burden
KE-NRB-2012-00108,2012,60,55-64,Male,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,56.3,high_burden
KE-NRB-2018-00109,2018,87,75+,Male,Lung,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,10.4,high_burden
KE-NRB-2017-00110,2017,72,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,53.1,high_burden
KE-NRB-2009-00111,2009,63,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,14.4,high_burden
KE-NRB-2015-00112,2015,80,75+,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,1.0,high_burden
KE-NRB-2014-00113,2014,72,65-74,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,17.5,high_burden
KE-NRB-2017-00114,2017,53,45-54,Male,Multiple myeloma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,1.7,high_burden
KE-NRB-2013-00115,2013,63,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,No treatment,Dead,11.0,high_burden
KE-NRB-2011-00116,2011,68,65-74,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-00117,2010,55,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-00118,2010,42,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,22.4,high_burden
KE-NRB-2016-00119,2016,56,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.6,high_burden
KE-NRB-2014-00120,2014,35,35-44,Male,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,11.0,high_burden
KE-NRB-2013-00121,2013,82,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.5,high_burden
KE-NRB-2015-00122,2015,44,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-00123,2015,35,35-44,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.3,high_burden
KE-NRB-2010-00124,2010,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,24.7,high_burden
KE-NRB-2014-00125,2014,54,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Lost to follow-up,54.3,high_burden
KE-NRB-2014-00126,2014,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,21.9,high_burden
KE-NRB-2018-00127,2018,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,12.7,high_burden
KE-NRB-2012-00128,2012,33,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,2.3,high_burden
KE-NRB-2014-00129,2014,91,75+,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.9,high_burden
KE-NRB-2011-00130,2011,72,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,28.9,high_burden
KE-NRB-2013-00131,2013,73,65-74,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-00132,2010,43,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,17.6,high_burden
KE-NRB-2011-00133,2011,56,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2015-00134,2015,46,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.1,high_burden
KE-NRB-2015-00135,2015,77,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,7.9,high_burden
KE-NRB-2018-00136,2018,37,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,18.1,high_burden
KE-NRB-2018-00137,2018,66,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.7,high_burden
KE-NRB-2016-00138,2016,70,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,3.5,high_burden
KE-NRB-2012-00139,2012,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,15.0,high_burden
KE-NRB-2015-00140,2015,71,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.4,high_burden
KE-NRB-2015-00141,2015,51,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,41.5,high_burden
KE-NRB-2018-00142,2018,58,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,15.7,high_burden
KE-NRB-2011-00143,2011,36,35-44,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.1,high_burden
KE-NRB-2013-00144,2013,25,25-34,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,18.5,high_burden
KE-NRB-2010-00145,2010,27,25-34,Male,Colorectum,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2011-00146,2011,39,35-44,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,34.4,high_burden
KE-NRB-2017-00147,2017,91,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,3.0,high_burden
KE-NRB-2011-00148,2011,24,15-24,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,44.6,high_burden
KE-NRB-2018-00149,2018,35,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Dead,12.7,high_burden
KE-NRB-2012-00150,2012,57,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-00151,2013,62,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.0,high_burden
KE-NRB-2016-00152,2016,75,75+,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,7.1,high_burden
KE-NRB-2016-00153,2016,69,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,6.4,high_burden
KE-NRB-2010-00154,2010,35,35-44,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.6,high_burden
KE-NRB-2012-00155,2012,74,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemo + Radiotherapy,Dead,11.1,high_burden
KE-NRB-2017-00156,2017,51,45-54,Male,Colorectum,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,14.1,high_burden
KE-NRB-2015-00157,2015,58,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-00158,2014,62,55-64,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-00159,2018,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,49.9,high_burden
KE-NRB-2018-00160,2018,61,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-00161,2014,46,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2010-00162,2010,63,55-64,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,33.3,high_burden
KE-NRB-2013-00163,2013,58,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,19.8,high_burden
KE-NRB-2011-00164,2011,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,2.4,high_burden
KE-NRB-2015-00165,2015,95,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.9,high_burden
KE-NRB-2016-00166,2016,38,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.7,high_burden
KE-NRB-2015-00167,2015,73,65-74,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,34.4,high_burden
KE-NRB-2018-00168,2018,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.1,high_burden
KE-NRB-2012-00169,2012,81,75+,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.6,high_burden
KE-NRB-2016-00170,2016,81,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.1,high_burden
KE-NRB-2013-00171,2013,73,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,9.4,high_burden
KE-NRB-2016-00172,2016,49,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,32.5,high_burden
KE-NRB-2018-00173,2018,56,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.1,high_burden
KE-NRB-2010-00174,2010,38,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,6.9,high_burden
KE-NRB-2010-00175,2010,46,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,35.5,high_burden
KE-NRB-2015-00176,2015,38,35-44,Male,Oesophagus,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,19.4,high_burden
KE-NRB-2011-00177,2011,74,65-74,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.4,high_burden
KE-NRB-2016-00178,2016,2,0-14,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,11.0,high_burden
KE-NRB-2016-00179,2016,48,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,14.4,high_burden
KE-NRB-2012-00180,2012,50,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.6,high_burden
KE-NRB-2018-00181,2018,43,35-44,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.5,high_burden
KE-NRB-2016-00182,2016,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,57.9,high_burden
KE-NRB-2013-00183,2013,34,25-34,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.5,high_burden
KE-NRB-2010-00184,2010,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,23.0,high_burden
KE-NRB-2010-00185,2010,46,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,15.8,high_burden
KE-NRB-2018-00186,2018,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,21.5,high_burden
KE-NRB-2012-00187,2012,48,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,43.9,high_burden
KE-NRB-2010-00188,2010,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,46.6,high_burden
KE-NRB-2018-00189,2018,73,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.0,high_burden
KE-NRB-2014-00190,2014,85,75+,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.9,high_burden
KE-NRB-2018-00191,2018,44,35-44,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Dead,7.1,high_burden
KE-NRB-2010-00192,2010,38,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,7.9,high_burden
KE-NRB-2011-00193,2011,48,45-54,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,17.2,high_burden
KE-NRB-2012-00194,2012,32,25-34,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2017-00195,2017,56,55-64,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,55.6,high_burden
KE-NRB-2016-00196,2016,71,65-74,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.0,high_burden
KE-NRB-2016-00197,2016,40,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,30.1,high_burden
KE-NRB-2009-00198,2009,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,3.8,high_burden
KE-NRB-2012-00199,2012,48,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.2,high_burden
KE-NRB-2016-00200,2016,38,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,15.2,high_burden
KE-NRB-2015-00201,2015,63,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.1,high_burden
KE-NRB-2016-00202,2016,38,35-44,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.4,high_burden
KE-NRB-2011-00203,2011,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,45.7,high_burden
KE-NRB-2017-00204,2017,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.0,high_burden
KE-NRB-2015-00205,2015,56,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-00206,2010,61,55-64,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.1,high_burden
KE-NRB-2014-00207,2014,65,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,20.3,high_burden
KE-NRB-2011-00208,2011,32,25-34,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-00209,2015,74,65-74,Male,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,42.0,high_burden
KE-NRB-2010-00210,2010,46,45-54,Female,Thyroid,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-00211,2012,44,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.4,high_burden
KE-NRB-2009-00212,2009,45,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,35.0,high_burden
KE-NRB-2014-00213,2014,73,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,35.4,high_burden
KE-NRB-2011-00214,2011,46,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,29.1,high_burden
KE-NRB-2009-00215,2009,34,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,0.5,high_burden
KE-NRB-2016-00216,2016,53,45-54,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,48.2,high_burden
KE-NRB-2018-00217,2018,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,32.2,high_burden
KE-NRB-2011-00218,2011,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.6,high_burden
KE-NRB-2014-00219,2014,89,75+,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,33.5,high_burden
KE-NRB-2013-00220,2013,74,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,33.5,high_burden
KE-NRB-2018-00221,2018,70,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,36.6,high_burden
KE-NRB-2016-00222,2016,47,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,57.2,high_burden
KE-NRB-2009-00223,2009,38,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,31.6,high_burden
KE-NRB-2014-00224,2014,72,65-74,Female,Other,Leukemia,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,9.1,high_burden
KE-NRB-2015-00225,2015,61,55-64,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.9,high_burden
KE-NRB-2014-00226,2014,31,25-34,Male,Stomach,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-00227,2011,67,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.1,high_burden
KE-NRB-2010-00228,2010,42,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,14.4,high_burden
KE-NRB-2016-00229,2016,49,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,25.6,high_burden
KE-NRB-2018-00230,2018,49,45-54,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.7,high_burden
KE-NRB-2016-00231,2016,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.2,high_burden
KE-NRB-2015-00232,2015,37,35-44,Male,Colorectum,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,1.0,high_burden
KE-NRB-2014-00233,2014,57,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,6.0,high_burden
KE-NRB-2018-00234,2018,82,75+,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,23.9,high_burden
KE-NRB-2012-00235,2012,59,55-64,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.8,high_burden
KE-NRB-2018-00236,2018,47,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,20.6,high_burden
KE-NRB-2012-00237,2012,52,45-54,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,32.8,high_burden
KE-NRB-2013-00238,2013,47,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,17.3,high_burden
KE-NRB-2017-00239,2017,7,0-14,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,46.2,high_burden
KE-NRB-2016-00240,2016,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2013-00241,2013,76,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,15.8,high_burden
KE-NRB-2011-00242,2011,72,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.3,high_burden
KE-NRB-2017-00243,2017,54,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-00244,2016,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,53.1,high_burden
KE-NRB-2011-00245,2011,49,45-54,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.1,high_burden
KE-NRB-2013-00246,2013,24,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,17.4,high_burden
KE-NRB-2016-00247,2016,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,41.6,high_burden
KE-NRB-2018-00248,2018,67,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,21.1,high_burden
KE-NRB-2013-00249,2013,35,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,35.7,high_burden
KE-NRB-2018-00250,2018,74,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,16.4,high_burden
KE-NRB-2017-00251,2017,87,75+,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,11.5,high_burden
KE-NRB-2011-00252,2011,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-00253,2010,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2014-00254,2014,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,10.2,high_burden
KE-NRB-2014-00255,2014,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,31.1,high_burden
KE-NRB-2015-00256,2015,69,65-74,Female,Corpus uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,21.3,high_burden
KE-NRB-2018-00257,2018,64,55-64,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-00258,2013,50,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,3.3,high_burden
KE-NRB-2014-00259,2014,89,75+,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,3.5,high_burden
KE-NRB-2013-00260,2013,72,65-74,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.0,high_burden
KE-NRB-2017-00261,2017,52,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-00262,2018,63,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.6,high_burden
KE-NRB-2015-00263,2015,44,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-00264,2012,64,55-64,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,10.1,high_burden
KE-NRB-2017-00265,2017,61,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,25.9,high_burden
KE-NRB-2017-00266,2017,46,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,57.0,high_burden
KE-NRB-2011-00267,2011,80,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-00268,2017,71,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,13.9,high_burden
KE-NRB-2010-00269,2010,29,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.1,high_burden
KE-NRB-2018-00270,2018,60,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.3,high_burden
KE-NRB-2016-00271,2016,60,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-00272,2017,49,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.0,high_burden
KE-NRB-2018-00273,2018,29,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,12.1,high_burden
KE-NRB-2015-00274,2015,50,45-54,Male,Leukemia,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Lost to follow-up,9.1,high_burden
KE-NRB-2015-00275,2015,43,35-44,Female,Cervix uteri,Lymphoma,Unknown,Other,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-00276,2017,20,15-24,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2013-00277,2013,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,0.7,high_burden
KE-NRB-2010-00278,2010,38,35-44,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.1,high_burden
KE-NRB-2017-00279,2017,52,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-00280,2018,56,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.1,high_burden
KE-NRB-2017-00281,2017,58,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,49.2,high_burden
KE-NRB-2015-00282,2015,53,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,11.0,high_burden
KE-NRB-2015-00283,2015,66,65-74,Male,Kidney,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.4,high_burden
KE-NRB-2014-00284,2014,80,75+,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.5,high_burden
KE-NRB-2014-00285,2014,15,15-24,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,6.1,high_burden
KE-NRB-2018-00286,2018,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.6,high_burden
KE-NRB-2018-00287,2018,63,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,57.9,high_burden
KE-NRB-2014-00288,2014,48,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,14.3,high_burden
KE-NRB-2013-00289,2013,27,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,3.6,high_burden
KE-NRB-2016-00290,2016,61,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.6,high_burden
KE-NRB-2012-00291,2012,49,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.0,high_burden
KE-NRB-2011-00292,2011,67,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,29.8,high_burden
KE-NRB-2010-00293,2010,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,51.8,high_burden
KE-NRB-2015-00294,2015,95,75+,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,21.3,high_burden
KE-NRB-2013-00295,2013,48,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,No treatment,Dead,3.0,high_burden
KE-NRB-2015-00296,2015,69,65-74,Male,Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.2,high_burden
KE-NRB-2015-00297,2015,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,56.2,high_burden
KE-NRB-2014-00298,2014,57,55-64,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.1,high_burden
KE-NRB-2009-00299,2009,78,75+,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,19.2,high_burden
KE-NRB-2014-00300,2014,58,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,33.4,high_burden
KE-NRB-2011-00301,2011,17,15-24,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.7,high_burden
KE-NRB-2014-00302,2014,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,18.0,high_burden
KE-NRB-2016-00303,2016,28,25-34,Male,Kidney,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2012-00304,2012,61,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.2,high_burden
KE-NRB-2013-00305,2013,42,35-44,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,44.5,high_burden
KE-NRB-2012-00306,2012,47,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,7.3,high_burden
KE-NRB-2009-00307,2009,31,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,21.8,high_burden
KE-NRB-2018-00308,2018,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2017-00309,2017,44,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.6,high_burden
KE-NRB-2012-00310,2012,95,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.2,high_burden
KE-NRB-2015-00311,2015,66,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,1.6,high_burden
KE-NRB-2015-00312,2015,46,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,13.5,high_burden
KE-NRB-2017-00313,2017,74,65-74,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.3,high_burden
KE-NRB-2011-00314,2011,72,65-74,Male,Liver,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.8,high_burden
KE-NRB-2018-00315,2018,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-00316,2018,51,45-54,Female,Other,Adenocarcinoma,Unknown,Death certificate only,In situ,Peri-urban,N/A,Dead,15.6,high_burden
KE-NRB-2009-00317,2009,62,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-00318,2013,74,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,53.7,high_burden
KE-NRB-2013-00319,2013,46,45-54,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,55.0,high_burden
KE-NRB-2016-00320,2016,41,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,43.4,high_burden
KE-NRB-2016-00321,2016,53,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,25.3,high_burden
KE-NRB-2016-00322,2016,56,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,6.9,high_burden
KE-NRB-2011-00323,2011,44,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-00324,2015,65,65-74,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,52.8,high_burden
KE-NRB-2014-00325,2014,52,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,1.3,high_burden
KE-NRB-2009-00326,2009,37,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,48.5,high_burden
KE-NRB-2012-00327,2012,56,55-64,Female,Breast,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,17.6,high_burden
KE-NRB-2014-00328,2014,21,15-24,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,14.6,high_burden
KE-NRB-2012-00329,2012,40,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-00330,2018,17,15-24,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,16.0,high_burden
KE-NRB-2011-00331,2011,60,55-64,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-00332,2014,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,21.9,high_burden
KE-NRB-2016-00333,2016,54,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.1,high_burden
KE-NRB-2009-00334,2009,52,45-54,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,3.3,high_burden
KE-NRB-2014-00335,2014,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,11.5,high_burden
KE-NRB-2017-00336,2017,59,55-64,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2011-00337,2011,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Peri-urban,N/A,Alive,33.1,high_burden
KE-NRB-2017-00338,2017,46,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.4,high_burden
KE-NRB-2016-00339,2016,73,65-74,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,23.3,high_burden
KE-NRB-2014-00340,2014,70,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,3.5,high_burden
KE-NRB-2011-00341,2011,53,45-54,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,8.2,high_burden
KE-NRB-2015-00342,2015,70,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,17.7,high_burden
KE-NRB-2018-00343,2018,38,35-44,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.4,high_burden
KE-NRB-2011-00344,2011,38,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,11.8,high_burden
KE-NRB-2018-00345,2018,5,0-14,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,5.4,high_burden
KE-NRB-2017-00346,2017,55,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,10.0,high_burden
KE-NRB-2018-00347,2018,56,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,41.8,high_burden
KE-NRB-2014-00348,2014,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.3,high_burden
KE-NRB-2011-00349,2011,72,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,46.4,high_burden
KE-NRB-2016-00350,2016,6,0-14,Male,Pancreas,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,14.8,high_burden
KE-NRB-2015-00351,2015,62,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,34.7,high_burden
KE-NRB-2011-00352,2011,43,35-44,Female,Other,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,21.5,high_burden
KE-NRB-2015-00353,2015,65,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-00354,2015,86,75+,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-00355,2012,87,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-00356,2014,64,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.5,high_burden
KE-NRB-2014-00357,2014,56,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-00358,2015,67,65-74,Male,Pancreas,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,13.1,high_burden
KE-NRB-2015-00359,2015,70,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-00360,2018,48,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,14.9,high_burden
KE-NRB-2011-00361,2011,68,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.9,high_burden
KE-NRB-2016-00362,2016,42,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,0.7,high_burden
KE-NRB-2016-00363,2016,45,45-54,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.2,high_burden
KE-NRB-2009-00364,2009,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,0.6,high_burden
KE-NRB-2014-00365,2014,37,35-44,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.7,high_burden
KE-NRB-2017-00366,2017,61,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,53.5,high_burden
KE-NRB-2014-00367,2014,53,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,3.5,high_burden
KE-NRB-2014-00368,2014,54,45-54,Male,Multiple myeloma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,21.8,high_burden
KE-NRB-2013-00369,2013,54,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,23.9,high_burden
KE-NRB-2016-00370,2016,38,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2014-00371,2014,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,0.3,high_burden
KE-NRB-2017-00372,2017,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,35.2,high_burden
KE-NRB-2018-00373,2018,51,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-00374,2015,30,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,58.3,high_burden
KE-NRB-2010-00375,2010,89,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-00376,2016,80,75+,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.5,high_burden
KE-NRB-2017-00377,2017,62,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-00378,2015,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,16.6,high_burden
KE-NRB-2014-00379,2014,48,45-54,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.4,high_burden
KE-NRB-2014-00380,2014,40,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,21.7,high_burden
KE-NRB-2011-00381,2011,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-00382,2014,82,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,13.9,high_burden
KE-NRB-2013-00383,2013,61,55-64,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.8,high_burden
KE-NRB-2011-00384,2011,57,55-64,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Palliative care only,Alive,7.0,high_burden
KE-NRB-2018-00385,2018,89,75+,Female,Breast,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-00386,2013,36,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2018-00387,2018,73,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,22.4,high_burden
KE-NRB-2018-00388,2018,30,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.6,high_burden
KE-NRB-2015-00389,2015,56,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.6,high_burden
KE-NRB-2011-00390,2011,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,12.4,high_burden
KE-NRB-2015-00391,2015,51,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.2,high_burden
KE-NRB-2012-00392,2012,64,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,19.3,high_burden
KE-NRB-2018-00393,2018,67,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,40.6,high_burden
KE-NRB-2016-00394,2016,58,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.5,high_burden
KE-NRB-2013-00395,2013,50,45-54,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-00396,2012,21,15-24,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,48.9,high_burden
KE-NRB-2016-00397,2016,61,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-00398,2012,28,25-34,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2010-00399,2010,55,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-00400,2015,87,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.4,high_burden
KE-NRB-2015-00401,2015,36,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,24.4,high_burden
KE-NRB-2009-00402,2009,86,75+,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,11.7,high_burden
KE-NRB-2018-00403,2018,32,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.5,high_burden
KE-NRB-2016-00404,2016,71,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.3,high_burden
KE-NRB-2012-00405,2012,80,75+,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-00406,2013,39,35-44,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,45.3,high_burden
KE-NRB-2015-00407,2015,44,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,3.3,high_burden
KE-NRB-2017-00408,2017,37,35-44,Male,Pancreas,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,4.4,high_burden
KE-NRB-2009-00409,2009,80,75+,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,4.3,high_burden
KE-NRB-2018-00410,2018,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,0.2,high_burden
KE-NRB-2014-00411,2014,61,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,23.0,high_burden
KE-NRB-2013-00412,2013,19,15-24,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-00413,2017,38,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-00414,2015,41,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Lost to follow-up,25.4,high_burden
KE-NRB-2018-00415,2018,35,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-00416,2012,70,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,1.5,high_burden
KE-NRB-2010-00417,2010,62,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.5,high_burden
KE-NRB-2013-00418,2013,71,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,46.1,high_burden
KE-NRB-2010-00419,2010,87,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,6.6,high_burden
KE-NRB-2015-00420,2015,72,65-74,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2016-00421,2016,56,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-00422,2018,87,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.8,high_burden
KE-NRB-2015-00423,2015,65,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2009-00424,2009,91,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,0.9,high_burden
KE-NRB-2017-00425,2017,48,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,19.5,high_burden
KE-NRB-2018-00426,2018,60,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,41.3,high_burden
KE-NRB-2016-00427,2016,88,75+,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-00428,2016,61,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,18.7,high_burden
KE-NRB-2013-00429,2013,71,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,6.5,high_burden
KE-NRB-2013-00430,2013,72,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,29.3,high_burden
KE-NRB-2018-00431,2018,35,35-44,Male,Stomach,Unspecified,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,59.0,high_burden
KE-NRB-2010-00432,2010,34,25-34,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-00433,2018,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,10.8,high_burden
KE-NRB-2010-00434,2010,65,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.3,high_burden
KE-NRB-2017-00435,2017,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-00436,2013,39,35-44,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.2,high_burden
KE-NRB-2011-00437,2011,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,17.9,high_burden
KE-NRB-2018-00438,2018,44,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-00439,2018,52,45-54,Male,Pancreas,Unspecified,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Lost to follow-up,35.3,high_burden
KE-NRB-2010-00440,2010,63,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,14.4,high_burden
KE-NRB-2010-00441,2010,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.3,high_burden
KE-NRB-2018-00442,2018,69,65-74,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,42.8,high_burden
KE-NRB-2018-00443,2018,33,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,33.3,high_burden
KE-NRB-2014-00444,2014,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,2.0,high_burden
KE-NRB-2017-00445,2017,51,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Dead,57.2,high_burden
KE-NRB-2016-00446,2016,93,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,0.7,high_burden
KE-NRB-2014-00447,2014,80,75+,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-00448,2012,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.2,high_burden
KE-NRB-2016-00449,2016,47,45-54,Male,Kidney,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,23.1,high_burden
KE-NRB-2012-00450,2012,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2011-00451,2011,56,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,23.2,high_burden
KE-NRB-2016-00452,2016,57,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.2,high_burden
KE-NRB-2018-00453,2018,83,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,46.5,high_burden
KE-NRB-2012-00454,2012,45,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.0,high_burden
KE-NRB-2013-00455,2013,39,35-44,Male,Stomach,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,46.4,high_burden
KE-NRB-2009-00456,2009,69,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,31.8,high_burden
KE-NRB-2017-00457,2017,63,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Rural,Palliative care only,Dead,18.6,high_burden
KE-NRB-2015-00458,2015,69,65-74,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,4.0,high_burden
KE-NRB-2011-00459,2011,59,55-64,Male,Multiple myeloma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-00460,2011,41,35-44,Female,Corpus uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.5,high_burden
KE-NRB-2018-00461,2018,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,6.2,high_burden
KE-NRB-2017-00462,2017,54,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Alive,10.1,high_burden
KE-NRB-2018-00463,2018,38,35-44,Female,Corpus uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.6,high_burden
KE-NRB-2010-00464,2010,20,15-24,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,6.0,high_burden
KE-NRB-2010-00465,2010,72,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,13.0,high_burden
KE-NRB-2012-00466,2012,57,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-00467,2018,26,25-34,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-00468,2017,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,6.2,high_burden
KE-NRB-2014-00469,2014,53,45-54,Male,Bladder,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,5.3,high_burden
KE-NRB-2018-00470,2018,56,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.6,high_burden
KE-NRB-2011-00471,2011,73,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemotherapy only,Alive,21.2,high_burden
KE-NRB-2014-00472,2014,82,75+,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,56.5,high_burden
KE-NRB-2010-00473,2010,46,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,33.5,high_burden
KE-NRB-2015-00474,2015,20,15-24,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,44.7,high_burden
KE-NRB-2010-00475,2010,68,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-00476,2015,26,25-34,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,17.3,high_burden
KE-NRB-2009-00477,2009,74,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.3,high_burden
KE-NRB-2018-00478,2018,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Urban,N/A,Dead,3.8,high_burden
KE-NRB-2009-00479,2009,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.5,high_burden
KE-NRB-2018-00480,2018,39,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,10.9,high_burden
KE-NRB-2015-00481,2015,51,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemotherapy only,Dead,19.4,high_burden
KE-NRB-2017-00482,2017,46,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-00483,2018,38,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,1.9,high_burden
KE-NRB-2013-00484,2013,51,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-00485,2018,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.5,high_burden
KE-NRB-2011-00486,2011,32,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.6,high_burden
KE-NRB-2017-00487,2017,39,35-44,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2015-00488,2015,64,55-64,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.9,high_burden
KE-NRB-2017-00489,2017,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.0,high_burden
KE-NRB-2011-00490,2011,67,65-74,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.5,high_burden
KE-NRB-2015-00491,2015,39,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.0,high_burden
KE-NRB-2012-00492,2012,39,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.7,high_burden
KE-NRB-2017-00493,2017,83,75+,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,8.2,high_burden
KE-NRB-2018-00494,2018,13,0-14,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,43.2,high_burden
KE-NRB-2016-00495,2016,80,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.5,high_burden
KE-NRB-2018-00496,2018,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,16.5,high_burden
KE-NRB-2010-00497,2010,51,45-54,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-00498,2015,33,25-34,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,8.5,high_burden
KE-NRB-2016-00499,2016,60,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.6,high_burden
KE-NRB-2014-00500,2014,58,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,6.6,high_burden
KE-NRB-2016-00501,2016,68,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.6,high_burden
KE-NRB-2011-00502,2011,46,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,9.8,high_burden
KE-NRB-2016-00503,2016,64,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,20.1,high_burden
KE-NRB-2016-00504,2016,73,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-00505,2017,60,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,19.3,high_burden
KE-NRB-2011-00506,2011,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,7.3,high_burden
KE-NRB-2016-00507,2016,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,0.7,high_burden
KE-NRB-2018-00508,2018,53,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,44.9,high_burden
KE-NRB-2016-00509,2016,60,55-64,Male,Prostate,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery only,Dead,17.0,high_burden
KE-NRB-2016-00510,2016,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2013-00511,2013,45,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-00512,2014,68,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-00513,2011,53,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.1,high_burden
KE-NRB-2018-00514,2018,40,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.1,high_burden
KE-NRB-2017-00515,2017,58,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.0,high_burden
KE-NRB-2018-00516,2018,59,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,7.2,high_burden
KE-NRB-2016-00517,2016,67,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,17.6,high_burden
KE-NRB-2015-00518,2015,69,65-74,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2018-00519,2018,63,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,18.8,high_burden
KE-NRB-2015-00520,2015,77,75+,Female,Breast,Sarcoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,25.7,high_burden
KE-NRB-2016-00521,2016,46,45-54,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.5,high_burden
KE-NRB-2010-00522,2010,56,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,54.7,high_burden
KE-NRB-2012-00523,2012,68,65-74,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,6.2,high_burden
KE-NRB-2012-00524,2012,26,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-00525,2010,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,33.2,high_burden
KE-NRB-2017-00526,2017,56,55-64,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,3.7,high_burden
KE-NRB-2011-00527,2011,39,35-44,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,10.5,high_burden
KE-NRB-2010-00528,2010,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.9,high_burden
KE-NRB-2018-00529,2018,67,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,29.8,high_burden
KE-NRB-2015-00530,2015,31,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.6,high_burden
KE-NRB-2009-00531,2009,67,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,31.9,high_burden
KE-NRB-2014-00532,2014,51,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,34.2,high_burden
KE-NRB-2010-00533,2010,64,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,8.6,high_burden
KE-NRB-2009-00534,2009,29,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,21.2,high_burden
KE-NRB-2010-00535,2010,37,35-44,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.4,high_burden
KE-NRB-2011-00536,2011,65,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.3,high_burden
KE-NRB-2015-00537,2015,78,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,31.7,high_burden
KE-NRB-2011-00538,2011,72,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,1.2,high_burden
KE-NRB-2010-00539,2010,40,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,53.0,high_burden
KE-NRB-2015-00540,2015,41,35-44,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,24.5,high_burden
KE-NRB-2015-00541,2015,74,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,34.6,high_burden
KE-NRB-2013-00542,2013,62,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,42.3,high_burden
KE-NRB-2014-00543,2014,61,55-64,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.9,high_burden
KE-NRB-2017-00544,2017,46,45-54,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.1,high_burden
KE-NRB-2016-00545,2016,39,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-00546,2016,70,65-74,Male,Bladder,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-00547,2011,60,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,50.5,high_burden
KE-NRB-2014-00548,2014,54,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.8,high_burden
KE-NRB-2013-00549,2013,19,15-24,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,37.1,high_burden
KE-NRB-2018-00550,2018,57,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-00551,2011,50,45-54,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-00552,2010,57,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,12.8,high_burden
KE-NRB-2015-00553,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.3,high_burden
KE-NRB-2010-00554,2010,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.8,high_burden
KE-NRB-2017-00555,2017,28,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,32.5,high_burden
KE-NRB-2018-00556,2018,31,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,41.5,high_burden
KE-NRB-2012-00557,2012,72,65-74,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-00558,2013,73,65-74,Male,Multiple myeloma,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-00559,2013,82,75+,Male,Pancreas,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Lost to follow-up,54.5,high_burden
KE-NRB-2013-00560,2013,44,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.5,high_burden
KE-NRB-2018-00561,2018,25,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.6,high_burden
KE-NRB-2010-00562,2010,53,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,8.4,high_burden
KE-NRB-2017-00563,2017,26,25-34,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.1,high_burden
KE-NRB-2013-00564,2013,31,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.6,high_burden
KE-NRB-2010-00565,2010,54,45-54,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,41.1,high_burden
KE-NRB-2012-00566,2012,41,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.8,high_burden
KE-NRB-2013-00567,2013,51,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,3.9,high_burden
KE-NRB-2016-00568,2016,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.0,high_burden
KE-NRB-2016-00569,2016,29,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,11.8,high_burden
KE-NRB-2011-00570,2011,59,55-64,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,50.4,high_burden
KE-NRB-2014-00571,2014,47,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-00572,2014,30,25-34,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,18.4,high_burden
KE-NRB-2012-00573,2012,49,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-00574,2017,26,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2010-00575,2010,44,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,35.8,high_burden
KE-NRB-2010-00576,2010,55,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Palliative care only,Lost to follow-up,15.3,high_burden
KE-NRB-2018-00577,2018,95,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-00578,2012,55,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.2,high_burden
KE-NRB-2011-00579,2011,26,25-34,Male,Prostate,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,43.7,high_burden
KE-NRB-2012-00580,2012,27,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,20.5,high_burden
KE-NRB-2018-00581,2018,74,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,17.8,high_burden
KE-NRB-2017-00582,2017,9,0-14,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,17.3,high_burden
KE-NRB-2016-00583,2016,28,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,21.3,high_burden
KE-NRB-2015-00584,2015,39,35-44,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.8,high_burden
KE-NRB-2011-00585,2011,26,25-34,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,28.5,high_burden
KE-NRB-2014-00586,2014,64,55-64,Female,Ovary,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,44.2,high_burden
KE-NRB-2010-00587,2010,27,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,22.9,high_burden
KE-NRB-2014-00588,2014,51,45-54,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-00589,2015,30,25-34,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,28.1,high_burden
KE-NRB-2015-00590,2015,21,15-24,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,15.0,high_burden
KE-NRB-2013-00591,2013,45,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2018-00592,2018,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2013-00593,2013,44,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-00594,2014,35,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.2,high_burden
KE-NRB-2012-00595,2012,0,0-14,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2016-00596,2016,94,75+,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.7,high_burden
KE-NRB-2013-00597,2013,78,75+,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.6,high_burden
KE-NRB-2009-00598,2009,71,65-74,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,4.4,high_burden
KE-NRB-2011-00599,2011,50,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-00600,2016,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,2.4,high_burden
KE-NRB-2013-00601,2013,76,75+,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.6,high_burden
KE-NRB-2018-00602,2018,27,25-34,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,55.2,high_burden
KE-NRB-2012-00603,2012,68,65-74,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.7,high_burden
KE-NRB-2014-00604,2014,64,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,0.3,high_burden
KE-NRB-2014-00605,2014,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.2,high_burden
KE-NRB-2017-00606,2017,43,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-00607,2013,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,46.1,high_burden
KE-NRB-2011-00608,2011,65,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-00609,2015,3,0-14,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,26.4,high_burden
KE-NRB-2015-00610,2015,35,35-44,Male,Multiple myeloma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-00611,2010,71,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.6,high_burden
KE-NRB-2013-00612,2013,58,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.9,high_burden
KE-NRB-2015-00613,2015,93,75+,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,32.4,high_burden
KE-NRB-2013-00614,2013,71,65-74,Male,Prostate,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,16.5,high_burden
KE-NRB-2012-00615,2012,67,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.5,high_burden
KE-NRB-2012-00616,2012,91,75+,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,15.9,high_burden
KE-NRB-2013-00617,2013,62,55-64,Male,Skin (melanoma),Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,4.2,high_burden
KE-NRB-2012-00618,2012,55,55-64,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-00619,2012,73,65-74,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,27.4,high_burden
KE-NRB-2009-00620,2009,55,55-64,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-00621,2013,29,25-34,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-00622,2013,59,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-00623,2010,35,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-00624,2011,71,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,17.8,high_burden
KE-NRB-2016-00625,2016,37,35-44,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.2,high_burden
KE-NRB-2009-00626,2009,27,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-00627,2014,89,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.8,high_burden
KE-NRB-2009-00628,2009,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,11.6,high_burden
KE-NRB-2018-00629,2018,54,45-54,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.5,high_burden
KE-NRB-2016-00630,2016,86,75+,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.9,high_burden
KE-NRB-2018-00631,2018,31,25-34,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Alive,32.7,high_burden
KE-NRB-2017-00632,2017,50,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,40.4,high_burden
KE-NRB-2009-00633,2009,54,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.9,high_burden
KE-NRB-2009-00634,2009,48,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,45.9,high_burden
KE-NRB-2017-00635,2017,41,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,8.1,high_burden
KE-NRB-2016-00636,2016,50,45-54,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.1,high_burden
KE-NRB-2016-00637,2016,46,45-54,Male,Stomach,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.2,high_burden
KE-NRB-2011-00638,2011,32,25-34,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.2,high_burden
KE-NRB-2014-00639,2014,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,22.7,high_burden
KE-NRB-2017-00640,2017,58,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,9.8,high_burden
KE-NRB-2018-00641,2018,24,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,45.3,high_burden
KE-NRB-2014-00642,2014,45,45-54,Male,Brain and CNS,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,24.4,high_burden
KE-NRB-2016-00643,2016,49,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,high_burden
KE-NRB-2016-00644,2016,68,65-74,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.4,high_burden
KE-NRB-2014-00645,2014,63,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.7,high_burden
KE-NRB-2012-00646,2012,36,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,23.7,high_burden
KE-NRB-2013-00647,2013,52,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.3,high_burden
KE-NRB-2014-00648,2014,40,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-00649,2014,44,35-44,Male,Leukemia,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Dead,13.2,high_burden
KE-NRB-2016-00650,2016,81,75+,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,48.2,high_burden
KE-NRB-2013-00651,2013,44,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-00652,2016,52,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.3,high_burden
KE-NRB-2015-00653,2015,67,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,16.4,high_burden
KE-NRB-2017-00654,2017,31,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,35.2,high_burden
KE-NRB-2014-00655,2014,36,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,0.5,high_burden
KE-NRB-2016-00656,2016,37,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.1,high_burden
KE-NRB-2018-00657,2018,66,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-00658,2018,71,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,13.8,high_burden
KE-NRB-2017-00659,2017,38,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,45.3,high_burden
KE-NRB-2015-00660,2015,18,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,40.7,high_burden
KE-NRB-2012-00661,2012,54,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.6,high_burden
KE-NRB-2013-00662,2013,68,65-74,Male,Pancreas,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,2.8,high_burden
KE-NRB-2014-00663,2014,43,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,17.9,high_burden
KE-NRB-2018-00664,2018,66,65-74,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.7,high_burden
KE-NRB-2018-00665,2018,9,0-14,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,35.2,high_burden
KE-NRB-2015-00666,2015,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2009-00667,2009,56,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,45.4,high_burden
KE-NRB-2016-00668,2016,50,45-54,Male,Stomach,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.4,high_burden
KE-NRB-2018-00669,2018,25,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.0,high_burden
KE-NRB-2013-00670,2013,49,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,27.2,high_burden
KE-NRB-2014-00671,2014,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,21.0,high_burden
KE-NRB-2017-00672,2017,62,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.6,high_burden
KE-NRB-2010-00673,2010,67,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-00674,2010,44,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,4.6,high_burden
KE-NRB-2010-00675,2010,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.6,high_burden
KE-NRB-2014-00676,2014,55,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,22.5,high_burden
KE-NRB-2011-00677,2011,52,45-54,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,11.1,high_burden
KE-NRB-2013-00678,2013,32,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.8,high_burden
KE-NRB-2011-00679,2011,71,65-74,Male,Other,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-00680,2012,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,19.4,high_burden
KE-NRB-2015-00681,2015,52,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,39.3,high_burden
KE-NRB-2016-00682,2016,35,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.4,high_burden
KE-NRB-2014-00683,2014,26,25-34,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,21.4,high_burden
KE-NRB-2016-00684,2016,59,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.1,high_burden
KE-NRB-2009-00685,2009,36,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-00686,2017,52,45-54,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,20.5,high_burden
KE-NRB-2015-00687,2015,23,15-24,Male,Oesophagus,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-00688,2016,29,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,10.0,high_burden
KE-NRB-2015-00689,2015,46,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.2,high_burden
KE-NRB-2010-00690,2010,38,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,36.2,high_burden
KE-NRB-2011-00691,2011,66,65-74,Male,Oesophagus,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-00692,2011,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,0.3,high_burden
KE-NRB-2010-00693,2010,60,55-64,Male,Prostate,Unspecified,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,5.2,high_burden
KE-NRB-2017-00694,2017,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,high_burden
KE-NRB-2016-00695,2016,51,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,0.6,high_burden
KE-NRB-2017-00696,2017,56,55-64,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.0,high_burden
KE-NRB-2016-00697,2016,49,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,40.9,high_burden
KE-NRB-2013-00698,2013,56,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.3,high_burden
KE-NRB-2015-00699,2015,66,65-74,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.9,high_burden
KE-NRB-2013-00700,2013,36,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.9,high_burden
KE-NRB-2017-00701,2017,21,15-24,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.2,high_burden
KE-NRB-2009-00702,2009,65,65-74,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,37.8,high_burden
KE-NRB-2015-00703,2015,40,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,10.3,high_burden
KE-NRB-2012-00704,2012,87,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,29.2,high_burden
KE-NRB-2018-00705,2018,54,45-54,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.8,high_burden
KE-NRB-2015-00706,2015,60,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,5.8,high_burden
KE-NRB-2016-00707,2016,55,55-64,Male,Liver,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,37.4,high_burden
KE-NRB-2012-00708,2012,65,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,10.7,high_burden
KE-NRB-2013-00709,2013,59,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.1,high_burden
KE-NRB-2016-00710,2016,66,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,5.1,high_burden
KE-NRB-2013-00711,2013,53,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-00712,2017,37,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Chemotherapy only,Alive,7.7,high_burden
KE-NRB-2018-00713,2018,27,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,7.5,high_burden
KE-NRB-2014-00714,2014,79,75+,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-00715,2009,57,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,31.6,high_burden
KE-NRB-2016-00716,2016,48,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,31.5,high_burden
KE-NRB-2014-00717,2014,53,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.7,high_burden
KE-NRB-2009-00718,2009,47,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2014-00719,2014,38,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.3,high_burden
KE-NRB-2011-00720,2011,35,35-44,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-00721,2016,25,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Peri-urban,N/A,Alive,35.5,high_burden
KE-NRB-2017-00722,2017,56,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.6,high_burden
KE-NRB-2017-00723,2017,25,25-34,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-00724,2013,35,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,59.8,high_burden
KE-NRB-2010-00725,2010,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,12.2,high_burden
KE-NRB-2016-00726,2016,65,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,38.2,high_burden
KE-NRB-2012-00727,2012,64,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-00728,2018,69,65-74,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.1,high_burden
KE-NRB-2017-00729,2017,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,1.7,high_burden
KE-NRB-2009-00730,2009,26,25-34,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,7.1,high_burden
KE-NRB-2016-00731,2016,29,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Lost to follow-up,60.0,high_burden
KE-NRB-2012-00732,2012,22,15-24,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,18.0,high_burden
KE-NRB-2016-00733,2016,37,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,2.1,high_burden
KE-NRB-2014-00734,2014,61,55-64,Female,Corpus uteri,Leukemia,Unknown,Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2017-00735,2017,66,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.2,high_burden
KE-NRB-2016-00736,2016,71,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.1,high_burden
KE-NRB-2014-00737,2014,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.7,high_burden
KE-NRB-2016-00738,2016,38,35-44,Female,Ovary,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-00739,2011,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,29.3,high_burden
KE-NRB-2012-00740,2012,52,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-00741,2018,71,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,54.3,high_burden
KE-NRB-2017-00742,2017,66,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,6.9,high_burden
KE-NRB-2017-00743,2017,35,35-44,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.1,high_burden
KE-NRB-2010-00744,2010,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,35.4,high_burden
KE-NRB-2009-00745,2009,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-00746,2014,43,35-44,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,No treatment,Alive,36.3,high_burden
KE-NRB-2011-00747,2011,49,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.0,high_burden
KE-NRB-2013-00748,2013,58,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.3,high_burden
KE-NRB-2010-00749,2010,56,55-64,Male,Leukemia,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,47.5,high_burden
KE-NRB-2016-00750,2016,38,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.1,high_burden
KE-NRB-2018-00751,2018,54,45-54,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.0,high_burden
KE-NRB-2018-00752,2018,56,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,34.0,high_burden
KE-NRB-2009-00753,2009,74,65-74,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,56.6,high_burden
KE-NRB-2018-00754,2018,58,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,2.5,high_burden
KE-NRB-2016-00755,2016,59,55-64,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,42.6,high_burden
KE-NRB-2010-00756,2010,93,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,12.3,high_burden
KE-NRB-2012-00757,2012,62,55-64,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,31.4,high_burden
KE-NRB-2012-00758,2012,61,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.1,high_burden
KE-NRB-2010-00759,2010,30,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.1,high_burden
KE-NRB-2011-00760,2011,53,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,2.0,high_burden
KE-NRB-2010-00761,2010,73,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,42.4,high_burden
KE-NRB-2017-00762,2017,37,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.7,high_burden
KE-NRB-2017-00763,2017,31,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.1,high_burden
KE-NRB-2014-00764,2014,51,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,8.3,high_burden
KE-NRB-2012-00765,2012,54,45-54,Female,Breast,Leukemia,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,5.2,high_burden
KE-NRB-2016-00766,2016,74,65-74,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,23.3,high_burden
KE-NRB-2017-00767,2017,60,55-64,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.5,high_burden
KE-NRB-2017-00768,2017,70,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.0,high_burden
KE-NRB-2017-00769,2017,55,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,1.4,high_burden
KE-NRB-2012-00770,2012,27,25-34,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,39.1,high_burden
KE-NRB-2017-00771,2017,58,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,9.6,high_burden
KE-NRB-2013-00772,2013,62,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,5.5,high_burden
KE-NRB-2018-00773,2018,60,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,0.5,high_burden
KE-NRB-2016-00774,2016,72,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.3,high_burden
KE-NRB-2018-00775,2018,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.3,high_burden
KE-NRB-2011-00776,2011,38,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,10.4,high_burden
KE-NRB-2017-00777,2017,63,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.1,high_burden
KE-NRB-2016-00778,2016,40,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.8,high_burden
KE-NRB-2009-00779,2009,67,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,56.8,high_burden
KE-NRB-2013-00780,2013,81,75+,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,31.9,high_burden
KE-NRB-2011-00781,2011,37,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.8,high_burden
KE-NRB-2011-00782,2011,42,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Lost to follow-up,31.0,high_burden
KE-NRB-2014-00783,2014,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,15.4,high_burden
KE-NRB-2009-00784,2009,69,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,2.6,high_burden
KE-NRB-2013-00785,2013,94,75+,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.6,high_burden
KE-NRB-2014-00786,2014,13,0-14,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2017-00787,2017,32,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Lost to follow-up,10.7,high_burden
KE-NRB-2015-00788,2015,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,45.2,high_burden
KE-NRB-2010-00789,2010,71,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,56.4,high_burden
KE-NRB-2013-00790,2013,58,55-64,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,26.4,high_burden
KE-NRB-2012-00791,2012,59,55-64,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,47.9,high_burden
KE-NRB-2016-00792,2016,61,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,43.7,high_burden
KE-NRB-2016-00793,2016,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,17.1,high_burden
KE-NRB-2017-00794,2017,72,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.0,high_burden
KE-NRB-2012-00795,2012,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.0,high_burden
KE-NRB-2014-00796,2014,57,55-64,Female,Breast,Lymphoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Alive,1.9,high_burden
KE-NRB-2017-00797,2017,52,45-54,Male,Non-Hodgkin lymphoma,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-00798,2015,31,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,8.8,high_burden
KE-NRB-2014-00799,2014,52,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,8.9,high_burden
KE-NRB-2014-00800,2014,47,45-54,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.3,high_burden
KE-NRB-2016-00801,2016,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,23.4,high_burden
KE-NRB-2011-00802,2011,58,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.8,high_burden
KE-NRB-2014-00803,2014,44,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-00804,2015,44,35-44,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.9,high_burden
KE-NRB-2014-00805,2014,70,65-74,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,25.1,high_burden
KE-NRB-2017-00806,2017,71,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,48.1,high_burden
KE-NRB-2017-00807,2017,74,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-00808,2013,63,55-64,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,18.7,high_burden
KE-NRB-2011-00809,2011,79,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,41.0,high_burden
KE-NRB-2009-00810,2009,41,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.4,high_burden
KE-NRB-2010-00811,2010,45,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,4.4,high_burden
KE-NRB-2015-00812,2015,35,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,35.1,high_burden
KE-NRB-2012-00813,2012,45,45-54,Female,Thyroid,Lymphoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,11.7,high_burden
KE-NRB-2018-00814,2018,39,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2014-00815,2014,54,45-54,Male,Bladder,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.3,high_burden
KE-NRB-2017-00816,2017,42,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,4.1,high_burden
KE-NRB-2012-00817,2012,59,55-64,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,23.0,high_burden
KE-NRB-2010-00818,2010,44,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.3,high_burden
KE-NRB-2011-00819,2011,81,75+,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.3,high_burden
KE-NRB-2017-00820,2017,61,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,40.0,high_burden
KE-NRB-2017-00821,2017,35,35-44,Male,Pancreas,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,57.1,high_burden
KE-NRB-2015-00822,2015,57,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,8.4,high_burden
KE-NRB-2017-00823,2017,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,11.8,high_burden
KE-NRB-2012-00824,2012,36,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2009-00825,2009,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-00826,2018,61,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-00827,2009,63,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-00828,2014,59,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-00829,2015,67,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,11.4,high_burden
KE-NRB-2009-00830,2009,60,55-64,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,4.5,high_burden
KE-NRB-2016-00831,2016,78,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,10.4,high_burden
KE-NRB-2017-00832,2017,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-00833,2018,54,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-00834,2011,66,65-74,Male,Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,54.2,high_burden
KE-NRB-2014-00835,2014,43,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.4,high_burden
KE-NRB-2017-00836,2017,60,55-64,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,18.2,high_burden
KE-NRB-2016-00837,2016,38,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,18.6,high_burden
KE-NRB-2016-00838,2016,34,25-34,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Alive,1.7,high_burden
KE-NRB-2017-00839,2017,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,31.4,high_burden
KE-NRB-2009-00840,2009,28,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.7,high_burden
KE-NRB-2012-00841,2012,33,25-34,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,43.1,high_burden
KE-NRB-2015-00842,2015,40,35-44,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.7,high_burden
KE-NRB-2014-00843,2014,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.6,high_burden
KE-NRB-2012-00844,2012,42,35-44,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.1,high_burden
KE-NRB-2011-00845,2011,61,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2013-00846,2013,31,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,40.7,high_burden
KE-NRB-2018-00847,2018,54,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.6,high_burden
KE-NRB-2017-00848,2017,47,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-00849,2015,51,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,17.8,high_burden
KE-NRB-2015-00850,2015,50,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-00851,2013,78,75+,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-00852,2012,93,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.4,high_burden
KE-NRB-2014-00853,2014,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,7.6,high_burden
KE-NRB-2012-00854,2012,6,0-14,Male,Lung,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,35.3,high_burden
KE-NRB-2018-00855,2018,51,45-54,Female,Ovary,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,27.0,high_burden
KE-NRB-2010-00856,2010,70,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,3.5,high_burden
KE-NRB-2018-00857,2018,63,55-64,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,35.0,high_burden
KE-NRB-2014-00858,2014,71,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,16.6,high_burden
KE-NRB-2013-00859,2013,47,45-54,Female,Breast,Unspecified,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,25.7,high_burden
KE-NRB-2012-00860,2012,25,25-34,Male,Brain and CNS,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.2,high_burden
KE-NRB-2018-00861,2018,71,65-74,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Benign/uncertain,Urban,N/A,Dead,8.8,high_burden
KE-NRB-2010-00862,2010,82,75+,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.0,high_burden
KE-NRB-2016-00863,2016,51,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-00864,2013,53,45-54,Male,Lung,Squamous cell carcinoma,Unknown,Other,Malignant,Urban,Surgery + Chemotherapy,Alive,37.0,high_burden
KE-NRB-2015-00865,2015,48,45-54,Male,Oesophagus,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,Surgery only,Dead,9.2,high_burden
KE-NRB-2012-00866,2012,91,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,2.7,high_burden
KE-NRB-2016-00867,2016,35,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.7,high_burden
KE-NRB-2012-00868,2012,28,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-00869,2017,50,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,9.7,high_burden
KE-NRB-2016-00870,2016,77,75+,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.5,high_burden
KE-NRB-2013-00871,2013,47,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.3,high_burden
KE-NRB-2010-00872,2010,63,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,55.5,high_burden
KE-NRB-2012-00873,2012,59,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,25.2,high_burden
KE-NRB-2018-00874,2018,58,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,19.1,high_burden
KE-NRB-2013-00875,2013,49,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,22.4,high_burden
KE-NRB-2010-00876,2010,38,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-00877,2014,32,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,9.9,high_burden
KE-NRB-2018-00878,2018,66,65-74,Male,Kaposi sarcoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,35.3,high_burden
KE-NRB-2013-00879,2013,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.4,high_burden
KE-NRB-2013-00880,2013,46,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,In situ,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2013-00881,2013,70,65-74,Male,Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2015-00882,2015,74,65-74,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,1.5,high_burden
KE-NRB-2015-00883,2015,37,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.5,high_burden
KE-NRB-2014-00884,2014,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,3.1,high_burden
KE-NRB-2010-00885,2010,48,45-54,Male,Bladder,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,34.9,high_burden
KE-NRB-2014-00886,2014,95,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-00887,2017,66,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,17.6,high_burden
KE-NRB-2015-00888,2015,56,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,48.2,high_burden
KE-NRB-2014-00889,2014,68,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,24.9,high_burden
KE-NRB-2014-00890,2014,67,65-74,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,22.5,high_burden
KE-NRB-2014-00891,2014,27,25-34,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Palliative care only,Alive,38.1,high_burden
KE-NRB-2017-00892,2017,59,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,28.0,high_burden
KE-NRB-2016-00893,2016,26,25-34,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2017-00894,2017,70,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,45.1,high_burden
KE-NRB-2018-00895,2018,68,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,49.4,high_burden
KE-NRB-2015-00896,2015,67,65-74,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.8,high_burden
KE-NRB-2009-00897,2009,66,65-74,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-00898,2014,14,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.7,high_burden
KE-NRB-2009-00899,2009,56,55-64,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,24.2,high_burden
KE-NRB-2012-00900,2012,45,45-54,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-00901,2017,60,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.2,high_burden
KE-NRB-2017-00902,2017,63,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.9,high_burden
KE-NRB-2013-00903,2013,95,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.7,high_burden
KE-NRB-2018-00904,2018,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.6,high_burden
KE-NRB-2015-00905,2015,57,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,40.2,high_burden
KE-NRB-2018-00906,2018,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,16.8,high_burden
KE-NRB-2014-00907,2014,32,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,12.9,high_burden
KE-NRB-2010-00908,2010,41,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,28.3,high_burden
KE-NRB-2014-00909,2014,40,35-44,Male,Kaposi sarcoma,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,7.1,high_burden
KE-NRB-2010-00910,2010,39,35-44,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,33.1,high_burden
KE-NRB-2014-00911,2014,24,15-24,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,high_burden
KE-NRB-2014-00912,2014,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,6.0,high_burden
KE-NRB-2013-00913,2013,48,45-54,Male,Brain and CNS,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,24.0,high_burden
KE-NRB-2011-00914,2011,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.7,high_burden
KE-NRB-2014-00915,2014,70,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,5.4,high_burden
KE-NRB-2014-00916,2014,71,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.6,high_burden
KE-NRB-2015-00917,2015,56,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,6.1,high_burden
KE-NRB-2012-00918,2012,52,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.7,high_burden
KE-NRB-2011-00919,2011,48,45-54,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,1.1,high_burden
KE-NRB-2015-00920,2015,66,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-00921,2014,66,65-74,Male,Kidney,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,13.0,high_burden
KE-NRB-2015-00922,2015,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,46.5,high_burden
KE-NRB-2015-00923,2015,66,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.9,high_burden
KE-NRB-2017-00924,2017,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.8,high_burden
KE-NRB-2015-00925,2015,66,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-00926,2018,69,65-74,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-00927,2010,64,55-64,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,3.3,high_burden
KE-NRB-2016-00928,2016,26,25-34,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,40.7,high_burden
KE-NRB-2012-00929,2012,29,25-34,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-00930,2012,3,0-14,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Unknown,Death certificate only,Benign/uncertain,Urban,N/A,Alive,7.2,high_burden
KE-NRB-2017-00931,2017,35,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-00932,2016,93,75+,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,54.4,high_burden
KE-NRB-2017-00933,2017,38,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-00934,2016,72,65-74,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-00935,2018,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.9,high_burden
KE-NRB-2010-00936,2010,21,15-24,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.3,high_burden
KE-NRB-2018-00937,2018,51,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Surgery only,Dead,13.7,high_burden
KE-NRB-2016-00938,2016,52,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.2,high_burden
KE-NRB-2011-00939,2011,41,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,44.6,high_burden
KE-NRB-2016-00940,2016,60,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,9.5,high_burden
KE-NRB-2016-00941,2016,49,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.3,high_burden
KE-NRB-2012-00942,2012,56,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-00943,2009,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.7,high_burden
KE-NRB-2012-00944,2012,40,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-00945,2015,44,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.3,high_burden
KE-NRB-2018-00946,2018,57,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.1,high_burden
KE-NRB-2018-00947,2018,88,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.2,high_burden
KE-NRB-2018-00948,2018,67,65-74,Male,Oesophagus,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-00949,2013,63,55-64,Female,Cervix uteri,Sarcoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,7.5,high_burden
KE-NRB-2018-00950,2018,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-00951,2017,43,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,33.1,high_burden
KE-NRB-2018-00952,2018,41,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,37.7,high_burden
KE-NRB-2011-00953,2011,38,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Dead,6.7,high_burden
KE-NRB-2010-00954,2010,60,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,20.0,high_burden
KE-NRB-2018-00955,2018,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2011-00956,2011,32,25-34,Male,Prostate,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,25.7,high_burden
KE-NRB-2016-00957,2016,64,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2013-00958,2013,63,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,11.5,high_burden
KE-NRB-2011-00959,2011,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,1.7,high_burden
KE-NRB-2011-00960,2011,46,45-54,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.2,high_burden
KE-NRB-2010-00961,2010,36,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,33.6,high_burden
KE-NRB-2017-00962,2017,42,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,10.6,high_burden
KE-NRB-2012-00963,2012,64,55-64,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-00964,2013,56,55-64,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-00965,2010,45,45-54,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.0,high_burden
KE-NRB-2018-00966,2018,43,35-44,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,18.8,high_burden
KE-NRB-2016-00967,2016,68,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,10.8,high_burden
KE-NRB-2014-00968,2014,29,25-34,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.3,high_burden
KE-NRB-2015-00969,2015,56,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,55.3,high_burden
KE-NRB-2016-00970,2016,51,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2017-00971,2017,74,65-74,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,2.1,high_burden
KE-NRB-2012-00972,2012,61,55-64,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.2,high_burden
KE-NRB-2014-00973,2014,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,10.7,high_burden
KE-NRB-2014-00974,2014,60,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery only,Lost to follow-up,12.2,high_burden
KE-NRB-2012-00975,2012,61,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,18.6,high_burden
KE-NRB-2013-00976,2013,26,25-34,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,31.9,high_burden
KE-NRB-2017-00977,2017,36,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,30.9,high_burden
KE-NRB-2010-00978,2010,55,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,8.0,high_burden
KE-NRB-2013-00979,2013,62,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.0,high_burden
KE-NRB-2011-00980,2011,33,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-00981,2018,54,45-54,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,9.3,high_burden
KE-NRB-2009-00982,2009,74,65-74,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.1,high_burden
KE-NRB-2013-00983,2013,73,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.6,high_burden
KE-NRB-2018-00984,2018,38,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,8.5,high_burden
KE-NRB-2009-00985,2009,53,45-54,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,19.4,high_burden
KE-NRB-2014-00986,2014,12,0-14,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.1,high_burden
KE-NRB-2018-00987,2018,55,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,28.7,high_burden
KE-NRB-2018-00988,2018,47,45-54,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,36.6,high_burden
KE-NRB-2018-00989,2018,29,25-34,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-00990,2013,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,31.5,high_burden
KE-NRB-2014-00991,2014,39,35-44,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,50.1,high_burden
KE-NRB-2016-00992,2016,47,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.9,high_burden
KE-NRB-2018-00993,2018,29,25-34,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,43.8,high_burden
KE-NRB-2011-00994,2011,51,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Alive,23.5,high_burden
KE-NRB-2017-00995,2017,45,45-54,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.9,high_burden
KE-NRB-2017-00996,2017,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,44.2,high_burden
KE-NRB-2016-00997,2016,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,42.3,high_burden
KE-NRB-2014-00998,2014,47,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,58.8,high_burden
KE-NRB-2010-00999,2010,57,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,39.4,high_burden
KE-NRB-2010-01000,2010,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2010-01001,2010,86,75+,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,33.8,high_burden
KE-NRB-2017-01002,2017,59,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,11.9,high_burden
KE-NRB-2016-01003,2016,45,45-54,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,19.0,high_burden
KE-NRB-2016-01004,2016,18,15-24,Female,Cervix uteri,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.4,high_burden
KE-NRB-2012-01005,2012,54,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,20.9,high_burden
KE-NRB-2018-01006,2018,42,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,9.8,high_burden
KE-NRB-2018-01007,2018,70,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-01008,2015,49,45-54,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.3,high_burden
KE-NRB-2015-01009,2015,46,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,1.7,high_burden
KE-NRB-2015-01010,2015,62,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,42.2,high_burden
KE-NRB-2018-01011,2018,64,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,15.9,high_burden
KE-NRB-2016-01012,2016,73,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.2,high_burden
KE-NRB-2015-01013,2015,74,65-74,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.3,high_burden
KE-NRB-2013-01014,2013,72,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,34.3,high_burden
KE-NRB-2015-01015,2015,46,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,57.6,high_burden
KE-NRB-2009-01016,2009,81,75+,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-01017,2012,42,35-44,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,41.4,high_burden
KE-NRB-2015-01018,2015,39,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,25.0,high_burden
KE-NRB-2016-01019,2016,89,75+,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.3,high_burden
KE-NRB-2016-01020,2016,61,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,43.6,high_burden
KE-NRB-2010-01021,2010,28,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.9,high_burden
KE-NRB-2015-01022,2015,28,25-34,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.0,high_burden
KE-NRB-2014-01023,2014,34,25-34,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-01024,2015,64,55-64,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-01025,2017,47,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,12.2,high_burden
KE-NRB-2013-01026,2013,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.2,high_burden
KE-NRB-2012-01027,2012,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.9,high_burden
KE-NRB-2014-01028,2014,68,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,27.5,high_burden
KE-NRB-2009-01029,2009,93,75+,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,12.8,high_burden
KE-NRB-2013-01030,2013,86,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2017-01031,2017,29,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-01032,2010,66,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-01033,2016,71,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.5,high_burden
KE-NRB-2010-01034,2010,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,53.2,high_burden
KE-NRB-2018-01035,2018,56,55-64,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.4,high_burden
KE-NRB-2009-01036,2009,15,15-24,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2015-01037,2015,41,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,22.6,high_burden
KE-NRB-2015-01038,2015,48,45-54,Female,Thyroid,Unspecified,Poorly differentiated (Grade III),Other,Benign/uncertain,Urban,N/A,Alive,11.0,high_burden
KE-NRB-2018-01039,2018,51,45-54,Male,Leukemia,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-01040,2015,87,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,12.0,high_burden
KE-NRB-2017-01041,2017,43,35-44,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,13.9,high_burden
KE-NRB-2012-01042,2012,59,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.3,high_burden
KE-NRB-2017-01043,2017,62,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,6.2,high_burden
KE-NRB-2013-01044,2013,50,45-54,Male,Non-Hodgkin lymphoma,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,4.8,high_burden
KE-NRB-2013-01045,2013,38,35-44,Male,Pancreas,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.8,high_burden
KE-NRB-2015-01046,2015,16,15-24,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-01047,2011,24,15-24,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,30.6,high_burden
KE-NRB-2010-01048,2010,34,25-34,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,40.7,high_burden
KE-NRB-2018-01049,2018,40,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-01050,2018,57,55-64,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,15.1,high_burden
KE-NRB-2013-01051,2013,57,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.2,high_burden
KE-NRB-2013-01052,2013,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.2,high_burden
KE-NRB-2011-01053,2011,67,65-74,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,12.8,high_burden
KE-NRB-2011-01054,2011,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-01055,2013,48,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-01056,2018,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.2,high_burden
KE-NRB-2010-01057,2010,54,45-54,Male,Stomach,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,31.2,high_burden
KE-NRB-2017-01058,2017,40,35-44,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.3,high_burden
KE-NRB-2018-01059,2018,38,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,21.1,high_burden
KE-NRB-2015-01060,2015,72,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,39.9,high_burden
KE-NRB-2012-01061,2012,52,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.4,high_burden
KE-NRB-2018-01062,2018,18,15-24,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,19.6,high_burden
KE-NRB-2011-01063,2011,46,45-54,Female,Breast,Lymphoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-01064,2018,92,75+,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.4,high_burden
KE-NRB-2014-01065,2014,69,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,15.4,high_burden
KE-NRB-2017-01066,2017,33,25-34,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,34.8,high_burden
KE-NRB-2017-01067,2017,71,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-01068,2015,53,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,22.1,high_burden
KE-NRB-2012-01069,2012,50,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.0,high_burden
KE-NRB-2016-01070,2016,15,15-24,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,13.4,high_burden
KE-NRB-2012-01071,2012,55,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2018-01072,2018,47,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-01073,2014,29,25-34,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.5,high_burden
KE-NRB-2009-01074,2009,39,35-44,Male,Brain and CNS,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.7,high_burden
KE-NRB-2018-01075,2018,63,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,29.3,high_burden
KE-NRB-2016-01076,2016,28,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.1,high_burden
KE-NRB-2010-01077,2010,35,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2016-01078,2016,65,65-74,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-01079,2012,44,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-01080,2014,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2009-01081,2009,62,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2015-01082,2015,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-01083,2017,64,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.8,high_burden
KE-NRB-2014-01084,2014,48,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.4,high_burden
KE-NRB-2018-01085,2018,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,44.0,high_burden
KE-NRB-2018-01086,2018,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,10.9,high_burden
KE-NRB-2018-01087,2018,47,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.0,high_burden
KE-NRB-2010-01088,2010,45,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,23.2,high_burden
KE-NRB-2014-01089,2014,39,35-44,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-01090,2014,58,55-64,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,11.6,high_burden
KE-NRB-2013-01091,2013,58,55-64,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,29.2,high_burden
KE-NRB-2014-01092,2014,70,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.3,high_burden
KE-NRB-2016-01093,2016,64,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.5,high_burden
KE-NRB-2013-01094,2013,19,15-24,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,2.2,high_burden
KE-NRB-2015-01095,2015,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,4.9,high_burden
KE-NRB-2013-01096,2013,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,19.5,high_burden
KE-NRB-2011-01097,2011,40,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-01098,2018,60,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,0.6,high_burden
KE-NRB-2013-01099,2013,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,56.5,high_burden
KE-NRB-2015-01100,2015,59,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,11.4,high_burden
KE-NRB-2011-01101,2011,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.6,high_burden
KE-NRB-2018-01102,2018,53,45-54,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,1.6,high_burden
KE-NRB-2013-01103,2013,25,25-34,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,3.5,high_burden
KE-NRB-2011-01104,2011,43,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,20.9,high_burden
KE-NRB-2017-01105,2017,55,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,4.4,high_burden
KE-NRB-2010-01106,2010,42,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.5,high_burden
KE-NRB-2018-01107,2018,54,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2016-01108,2016,42,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-01109,2017,44,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,0.1,high_burden
KE-NRB-2013-01110,2013,36,35-44,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.7,high_burden
KE-NRB-2013-01111,2013,32,25-34,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,12.1,high_burden
KE-NRB-2014-01112,2014,60,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,14.8,high_burden
KE-NRB-2017-01113,2017,55,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,18.4,high_burden
KE-NRB-2010-01114,2010,73,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.8,high_burden
KE-NRB-2013-01115,2013,30,25-34,Male,Lung,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.5,high_burden
KE-NRB-2016-01116,2016,57,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,31.2,high_burden
KE-NRB-2010-01117,2010,50,45-54,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-01118,2012,74,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Dead,22.7,high_burden
KE-NRB-2012-01119,2012,50,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,17.6,high_burden
KE-NRB-2011-01120,2011,28,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.0,high_burden
KE-NRB-2015-01121,2015,30,25-34,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,17.8,high_burden
KE-NRB-2016-01122,2016,41,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,54.2,high_burden
KE-NRB-2016-01123,2016,63,55-64,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,3.5,high_burden
KE-NRB-2018-01124,2018,52,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,11.3,high_burden
KE-NRB-2016-01125,2016,36,35-44,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.4,high_burden
KE-NRB-2009-01126,2009,59,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,27.2,high_burden
KE-NRB-2015-01127,2015,89,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-01128,2009,56,55-64,Male,Liver,Sarcoma,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Alive,12.0,high_burden
KE-NRB-2018-01129,2018,40,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,47.9,high_burden
KE-NRB-2015-01130,2015,60,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,47.2,high_burden
KE-NRB-2016-01131,2016,49,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,49.3,high_burden
KE-NRB-2017-01132,2017,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,42.5,high_burden
KE-NRB-2018-01133,2018,57,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.5,high_burden
KE-NRB-2013-01134,2013,56,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-01135,2011,53,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,42.2,high_burden
KE-NRB-2010-01136,2010,55,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.4,high_burden
KE-NRB-2013-01137,2013,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,6.3,high_burden
KE-NRB-2018-01138,2018,70,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,30.2,high_burden
KE-NRB-2010-01139,2010,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-01140,2015,3,0-14,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.6,high_burden
KE-NRB-2015-01141,2015,63,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,28.7,high_burden
KE-NRB-2009-01142,2009,79,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,5.6,high_burden
KE-NRB-2015-01143,2015,53,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.3,high_burden
KE-NRB-2017-01144,2017,59,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,57.2,high_burden
KE-NRB-2014-01145,2014,47,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,40.4,high_burden
KE-NRB-2017-01146,2017,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,35.8,high_burden
KE-NRB-2017-01147,2017,41,35-44,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-01148,2015,91,75+,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.9,high_burden
KE-NRB-2012-01149,2012,63,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.7,high_burden
KE-NRB-2016-01150,2016,49,45-54,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,50.6,high_burden
KE-NRB-2009-01151,2009,61,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,26.5,high_burden
KE-NRB-2009-01152,2009,38,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.4,high_burden
KE-NRB-2011-01153,2011,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-01154,2017,58,55-64,Male,Bladder,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,23.2,high_burden
KE-NRB-2012-01155,2012,42,35-44,Male,Non-Hodgkin lymphoma,Unspecified,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Radiotherapy only,Alive,18.0,high_burden
KE-NRB-2014-01156,2014,74,65-74,Male,Oesophagus,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,42.7,high_burden
KE-NRB-2018-01157,2018,31,25-34,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,10.6,high_burden
KE-NRB-2017-01158,2017,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.2,high_burden
KE-NRB-2016-01159,2016,34,25-34,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,39.4,high_burden
KE-NRB-2009-01160,2009,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,7.0,high_burden
KE-NRB-2016-01161,2016,50,45-54,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,12.4,high_burden
KE-NRB-2017-01162,2017,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,24.6,high_burden
KE-NRB-2011-01163,2011,59,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.9,high_burden
KE-NRB-2013-01164,2013,52,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-01165,2015,23,15-24,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,17.8,high_burden
KE-NRB-2012-01166,2012,43,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-01167,2016,12,0-14,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,27.1,high_burden
KE-NRB-2015-01168,2015,76,75+,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,58.8,high_burden
KE-NRB-2014-01169,2014,51,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.1,high_burden
KE-NRB-2011-01170,2011,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,44.4,high_burden
KE-NRB-2014-01171,2014,90,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-01172,2009,61,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01173,2014,90,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.5,high_burden
KE-NRB-2012-01174,2012,50,45-54,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.8,high_burden
KE-NRB-2017-01175,2017,40,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,55.8,high_burden
KE-NRB-2010-01176,2010,36,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2013-01177,2013,23,15-24,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01178,2011,49,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Peri-urban,N/A,Alive,53.4,high_burden
KE-NRB-2017-01179,2017,67,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,44.3,high_burden
KE-NRB-2016-01180,2016,43,35-44,Male,Oesophagus,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,5.6,high_burden
KE-NRB-2009-01181,2009,46,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,19.4,high_burden
KE-NRB-2011-01182,2011,75,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,22.7,high_burden
KE-NRB-2017-01183,2017,46,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-01184,2012,89,75+,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,25.6,high_burden
KE-NRB-2016-01185,2016,69,65-74,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.2,high_burden
KE-NRB-2017-01186,2017,67,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,19.5,high_burden
KE-NRB-2012-01187,2012,44,35-44,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,25.5,high_burden
KE-NRB-2018-01188,2018,47,45-54,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,16.5,high_burden
KE-NRB-2016-01189,2016,45,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,22.5,high_burden
KE-NRB-2013-01190,2013,53,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.8,high_burden
KE-NRB-2016-01191,2016,62,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,6.6,high_burden
KE-NRB-2018-01192,2018,39,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,51.3,high_burden
KE-NRB-2016-01193,2016,33,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,35.1,high_burden
KE-NRB-2017-01194,2017,46,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,51.0,high_burden
KE-NRB-2015-01195,2015,67,65-74,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.8,high_burden
KE-NRB-2009-01196,2009,28,25-34,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.5,high_burden
KE-NRB-2010-01197,2010,49,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-01198,2011,38,35-44,Female,Ovary,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,3.7,high_burden
KE-NRB-2017-01199,2017,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,58.5,high_burden
KE-NRB-2010-01200,2010,54,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-01201,2013,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-01202,2016,64,55-64,Female,Ovary,Sarcoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.7,high_burden
KE-NRB-2017-01203,2017,42,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,14.3,high_burden
KE-NRB-2015-01204,2015,9,0-14,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,4.8,high_burden
KE-NRB-2015-01205,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,4.2,high_burden
KE-NRB-2013-01206,2013,58,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-01207,2017,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01208,2011,44,35-44,Male,Prostate,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-01209,2011,29,25-34,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,49.1,high_burden
KE-NRB-2010-01210,2010,42,35-44,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,10.6,high_burden
KE-NRB-2015-01211,2015,47,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2009-01212,2009,67,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,11.0,high_burden
KE-NRB-2010-01213,2010,74,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-01214,2018,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-01215,2015,58,55-64,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,16.6,high_burden
KE-NRB-2016-01216,2016,90,75+,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.3,high_burden
KE-NRB-2018-01217,2018,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-01218,2017,46,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,2.8,high_burden
KE-NRB-2018-01219,2018,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,5.3,high_burden
KE-NRB-2012-01220,2012,47,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.6,high_burden
KE-NRB-2009-01221,2009,34,25-34,Male,Brain and CNS,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,47.9,high_burden
KE-NRB-2011-01222,2011,61,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,15.2,high_burden
KE-NRB-2014-01223,2014,53,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,25.8,high_burden
KE-NRB-2014-01224,2014,35,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.1,high_burden
KE-NRB-2015-01225,2015,8,0-14,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.6,high_burden
KE-NRB-2013-01226,2013,89,75+,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01227,2014,67,65-74,Female,Cervix uteri,Sarcoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-01228,2014,53,45-54,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.2,high_burden
KE-NRB-2013-01229,2013,45,45-54,Male,Pancreas,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,5.8,high_burden
KE-NRB-2014-01230,2014,60,55-64,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,12.2,high_burden
KE-NRB-2015-01231,2015,25,25-34,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-01232,2011,71,65-74,Male,Pancreas,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.1,high_burden
KE-NRB-2011-01233,2011,53,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01234,2011,29,25-34,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,13.7,high_burden
KE-NRB-2017-01235,2017,76,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,53.6,high_burden
KE-NRB-2015-01236,2015,48,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-01237,2013,39,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.5,high_burden
KE-NRB-2017-01238,2017,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-01239,2018,36,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,20.9,high_burden
KE-NRB-2013-01240,2013,58,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.7,high_burden
KE-NRB-2018-01241,2018,47,45-54,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-01242,2018,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.0,high_burden
KE-NRB-2010-01243,2010,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-01244,2015,35,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,22.3,high_burden
KE-NRB-2017-01245,2017,58,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-01246,2009,40,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-01247,2011,47,45-54,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-01248,2016,56,55-64,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.0,high_burden
KE-NRB-2012-01249,2012,18,15-24,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-01250,2014,45,45-54,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.6,high_burden
KE-NRB-2017-01251,2017,47,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,No treatment,Alive,6.7,high_burden
KE-NRB-2012-01252,2012,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-01253,2016,31,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,55.0,high_burden
KE-NRB-2016-01254,2016,30,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.9,high_burden
KE-NRB-2009-01255,2009,55,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,8.7,high_burden
KE-NRB-2013-01256,2013,47,45-54,Male,Stomach,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-01257,2012,32,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,7.6,high_burden
KE-NRB-2017-01258,2017,67,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.0,high_burden
KE-NRB-2013-01259,2013,69,65-74,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,0.2,high_burden
KE-NRB-2016-01260,2016,79,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,26.0,high_burden
KE-NRB-2018-01261,2018,58,55-64,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,20.0,high_burden
KE-NRB-2017-01262,2017,39,35-44,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,2.3,high_burden
KE-NRB-2016-01263,2016,63,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,22.2,high_burden
KE-NRB-2017-01264,2017,59,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.5,high_burden
KE-NRB-2015-01265,2015,72,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.5,high_burden
KE-NRB-2018-01266,2018,91,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.9,high_burden
KE-NRB-2017-01267,2017,70,65-74,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,10.4,high_burden
KE-NRB-2014-01268,2014,55,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,49.7,high_burden
KE-NRB-2017-01269,2017,66,65-74,Male,Lung,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.5,high_burden
KE-NRB-2013-01270,2013,71,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.6,high_burden
KE-NRB-2018-01271,2018,36,35-44,Female,Other,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,59.6,high_burden
KE-NRB-2010-01272,2010,33,25-34,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01273,2011,55,55-64,Male,Oesophagus,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,20.6,high_burden
KE-NRB-2016-01274,2016,69,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,24.8,high_burden
KE-NRB-2011-01275,2011,42,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2015-01276,2015,17,15-24,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,19.0,high_burden
KE-NRB-2011-01277,2011,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.9,high_burden
KE-NRB-2012-01278,2012,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.0,high_burden
KE-NRB-2012-01279,2012,64,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,0.7,high_burden
KE-NRB-2014-01280,2014,25,25-34,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-01281,2017,45,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,45.4,high_burden
KE-NRB-2010-01282,2010,94,75+,Male,Prostate,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-01283,2013,84,75+,Female,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,2.0,high_burden
KE-NRB-2013-01284,2013,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,51.6,high_burden
KE-NRB-2011-01285,2011,59,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,1.9,high_burden
KE-NRB-2010-01286,2010,53,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.7,high_burden
KE-NRB-2010-01287,2010,75,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-01288,2018,61,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-01289,2018,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.5,high_burden
KE-NRB-2014-01290,2014,40,35-44,Female,Other,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Alive,25.8,high_burden
KE-NRB-2017-01291,2017,55,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Rural,N/A,Dead,10.9,high_burden
KE-NRB-2018-01292,2018,34,25-34,Female,Breast,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,25.6,high_burden
KE-NRB-2016-01293,2016,72,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.5,high_burden
KE-NRB-2016-01294,2016,56,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,40.5,high_burden
KE-NRB-2016-01295,2016,67,65-74,Male,Leukemia,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-01296,2009,55,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2009-01297,2009,72,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.5,high_burden
KE-NRB-2011-01298,2011,54,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.3,high_burden
KE-NRB-2012-01299,2012,58,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.8,high_burden
KE-NRB-2018-01300,2018,40,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2018-01301,2018,52,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Alive,24.4,high_burden
KE-NRB-2017-01302,2017,38,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.6,high_burden
KE-NRB-2018-01303,2018,60,55-64,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-01304,2012,51,45-54,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,50.0,high_burden
KE-NRB-2018-01305,2018,66,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-01306,2017,41,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-01307,2011,59,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Alive,48.9,high_burden
KE-NRB-2017-01308,2017,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.4,high_burden
KE-NRB-2010-01309,2010,35,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.9,high_burden
KE-NRB-2015-01310,2015,70,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-01311,2013,40,35-44,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.4,high_burden
KE-NRB-2015-01312,2015,67,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2011-01313,2011,8,0-14,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Radiotherapy only,Dead,46.0,high_burden
KE-NRB-2011-01314,2011,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2015-01315,2015,61,55-64,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,29.0,high_burden
KE-NRB-2018-01316,2018,62,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,6.5,high_burden
KE-NRB-2012-01317,2012,51,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,4.5,high_burden
KE-NRB-2016-01318,2016,45,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2010-01319,2010,15,15-24,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,11.7,high_burden
KE-NRB-2011-01320,2011,56,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-01321,2017,50,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,21.3,high_burden
KE-NRB-2016-01322,2016,28,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.6,high_burden
KE-NRB-2012-01323,2012,73,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,3.5,high_burden
KE-NRB-2018-01324,2018,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-01325,2013,50,45-54,Female,Corpus uteri,Sarcoma,Well differentiated (Grade I),Other,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-01326,2012,64,55-64,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.1,high_burden
KE-NRB-2015-01327,2015,31,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,39.4,high_burden
KE-NRB-2015-01328,2015,62,55-64,Male,Bladder,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.5,high_burden
KE-NRB-2009-01329,2009,42,35-44,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,5.3,high_burden
KE-NRB-2017-01330,2017,31,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,14.0,high_burden
KE-NRB-2013-01331,2013,50,45-54,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,51.9,high_burden
KE-NRB-2013-01332,2013,56,55-64,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Dead,15.5,high_burden
KE-NRB-2017-01333,2017,36,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.6,high_burden
KE-NRB-2018-01334,2018,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,22.8,high_burden
KE-NRB-2014-01335,2014,75,75+,Female,Breast,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-01336,2013,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2018-01337,2018,59,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.1,high_burden
KE-NRB-2014-01338,2014,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,20.0,high_burden
KE-NRB-2011-01339,2011,70,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01340,2011,37,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-01341,2015,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2015-01342,2015,84,75+,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,25.5,high_burden
KE-NRB-2017-01343,2017,85,75+,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-01344,2016,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.1,high_burden
KE-NRB-2010-01345,2010,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,31.7,high_burden
KE-NRB-2011-01346,2011,32,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,35.1,high_burden
KE-NRB-2014-01347,2014,69,65-74,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-01348,2015,53,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,40.3,high_burden
KE-NRB-2016-01349,2016,58,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,54.3,high_burden
KE-NRB-2012-01350,2012,40,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-01351,2018,16,15-24,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,3.5,high_burden
KE-NRB-2009-01352,2009,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.3,high_burden
KE-NRB-2017-01353,2017,67,65-74,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,42.5,high_burden
KE-NRB-2011-01354,2011,58,55-64,Female,Other,Unspecified,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,35.5,high_burden
KE-NRB-2015-01355,2015,61,55-64,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,3.3,high_burden
KE-NRB-2012-01356,2012,39,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2017-01357,2017,48,45-54,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,0.1,high_burden
KE-NRB-2013-01358,2013,24,15-24,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,17.9,high_burden
KE-NRB-2018-01359,2018,53,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Dead,5.7,high_burden
KE-NRB-2011-01360,2011,62,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,19.3,high_burden
KE-NRB-2009-01361,2009,58,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,34.0,high_burden
KE-NRB-2014-01362,2014,55,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.4,high_burden
KE-NRB-2011-01363,2011,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,6.0,high_burden
KE-NRB-2017-01364,2017,45,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.4,high_burden
KE-NRB-2010-01365,2010,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2018-01366,2018,38,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,18.4,high_burden
KE-NRB-2014-01367,2014,55,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,2.6,high_burden
KE-NRB-2012-01368,2012,52,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-01369,2014,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,3.8,high_burden
KE-NRB-2010-01370,2010,48,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,26.5,high_burden
KE-NRB-2015-01371,2015,95,75+,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Radiotherapy only,Dead,14.9,high_burden
KE-NRB-2014-01372,2014,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.2,high_burden
KE-NRB-2010-01373,2010,83,75+,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,3.4,high_burden
KE-NRB-2017-01374,2017,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,31.0,high_burden
KE-NRB-2018-01375,2018,54,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.9,high_burden
KE-NRB-2016-01376,2016,46,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.4,high_burden
KE-NRB-2010-01377,2010,62,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,21.3,high_burden
KE-NRB-2018-01378,2018,67,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.7,high_burden
KE-NRB-2015-01379,2015,52,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,27.6,high_burden
KE-NRB-2009-01380,2009,32,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,21.1,high_burden
KE-NRB-2017-01381,2017,71,65-74,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,8.6,high_burden
KE-NRB-2018-01382,2018,32,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,52.5,high_burden
KE-NRB-2017-01383,2017,61,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.1,high_burden
KE-NRB-2016-01384,2016,37,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,21.4,high_burden
KE-NRB-2013-01385,2013,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,1.3,high_burden
KE-NRB-2014-01386,2014,62,55-64,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,31.9,high_burden
KE-NRB-2011-01387,2011,47,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.9,high_burden
KE-NRB-2015-01388,2015,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,24.7,high_burden
KE-NRB-2009-01389,2009,47,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,15.3,high_burden
KE-NRB-2009-01390,2009,33,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,22.0,high_burden
KE-NRB-2010-01391,2010,48,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,11.8,high_burden
KE-NRB-2012-01392,2012,80,75+,Female,Ovary,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-01393,2012,81,75+,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,12.8,high_burden
KE-NRB-2014-01394,2014,45,45-54,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.3,high_burden
KE-NRB-2015-01395,2015,36,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,4.3,high_burden
KE-NRB-2014-01396,2014,62,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.6,high_burden
KE-NRB-2014-01397,2014,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-01398,2012,73,65-74,Male,Lung,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.6,high_burden
KE-NRB-2012-01399,2012,88,75+,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,32.8,high_burden
KE-NRB-2015-01400,2015,44,35-44,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,7.3,high_burden
KE-NRB-2012-01401,2012,59,55-64,Male,Pancreas,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.3,high_burden
KE-NRB-2018-01402,2018,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-01403,2015,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.4,high_burden
KE-NRB-2011-01404,2011,44,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,37.8,high_burden
KE-NRB-2015-01405,2015,4,0-14,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-01406,2011,26,25-34,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.8,high_burden
KE-NRB-2013-01407,2013,71,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-01408,2017,29,25-34,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-01409,2018,34,25-34,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.1,high_burden
KE-NRB-2016-01410,2016,28,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,16.6,high_burden
KE-NRB-2009-01411,2009,58,55-64,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,34.9,high_burden
KE-NRB-2016-01412,2016,57,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,10.5,high_burden
KE-NRB-2011-01413,2011,81,75+,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,29.8,high_burden
KE-NRB-2016-01414,2016,74,65-74,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.0,high_burden
KE-NRB-2016-01415,2016,42,35-44,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.1,high_burden
KE-NRB-2012-01416,2012,41,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.3,high_burden
KE-NRB-2013-01417,2013,74,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,27.2,high_burden
KE-NRB-2011-01418,2011,44,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,40.1,high_burden
KE-NRB-2014-01419,2014,94,75+,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,55.8,high_burden
KE-NRB-2018-01420,2018,70,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2010-01421,2010,37,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,3.3,high_burden
KE-NRB-2013-01422,2013,48,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,No treatment,Dead,51.7,high_burden
KE-NRB-2014-01423,2014,60,55-64,Female,Cervix uteri,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-01424,2017,47,45-54,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,21.4,high_burden
KE-NRB-2014-01425,2014,58,55-64,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01426,2014,85,75+,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-01427,2016,40,35-44,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.5,high_burden
KE-NRB-2013-01428,2013,55,55-64,Female,Breast,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,21.0,high_burden
KE-NRB-2011-01429,2011,61,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,6.0,high_burden
KE-NRB-2009-01430,2009,40,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01431,2011,43,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-01432,2015,38,35-44,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,18.6,high_burden
KE-NRB-2018-01433,2018,64,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-01434,2017,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,42.9,high_burden
KE-NRB-2016-01435,2016,58,55-64,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-01436,2011,26,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.5,high_burden
KE-NRB-2016-01437,2016,58,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.6,high_burden
KE-NRB-2015-01438,2015,68,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,4.7,high_burden
KE-NRB-2017-01439,2017,48,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.3,high_burden
KE-NRB-2017-01440,2017,71,65-74,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-01441,2012,60,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-01442,2010,36,35-44,Male,Multiple myeloma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,34.9,high_burden
KE-NRB-2009-01443,2009,73,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.3,high_burden
KE-NRB-2011-01444,2011,74,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,22.1,high_burden
KE-NRB-2018-01445,2018,80,75+,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,25.1,high_burden
KE-NRB-2015-01446,2015,47,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,23.8,high_burden
KE-NRB-2018-01447,2018,60,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,14.4,high_burden
KE-NRB-2018-01448,2018,66,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-01449,2014,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.7,high_burden
KE-NRB-2015-01450,2015,55,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,1.0,high_burden
KE-NRB-2013-01451,2013,58,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2011-01452,2011,37,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,3.0,high_burden
KE-NRB-2012-01453,2012,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-01454,2015,59,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,25.4,high_burden
KE-NRB-2015-01455,2015,46,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,27.2,high_burden
KE-NRB-2013-01456,2013,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Alive,45.9,high_burden
KE-NRB-2018-01457,2018,32,25-34,Male,Other,Leukemia,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Dead,5.1,high_burden
KE-NRB-2010-01458,2010,79,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,23.1,high_burden
KE-NRB-2015-01459,2015,61,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.3,high_burden
KE-NRB-2010-01460,2010,55,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2009-01461,2009,30,25-34,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,3.5,high_burden
KE-NRB-2018-01462,2018,91,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2016-01463,2016,54,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,24.6,high_burden
KE-NRB-2015-01464,2015,37,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,6.6,high_burden
KE-NRB-2009-01465,2009,48,45-54,Male,Other,Lymphoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,12.2,high_burden
KE-NRB-2016-01466,2016,48,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Clinical only,In situ,Urban,N/A,Alive,1.9,high_burden
KE-NRB-2009-01467,2009,73,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,12.4,high_burden
KE-NRB-2014-01468,2014,44,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.8,high_burden
KE-NRB-2018-01469,2018,59,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01470,2014,34,25-34,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.8,high_burden
KE-NRB-2014-01471,2014,68,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.7,high_burden
KE-NRB-2012-01472,2012,49,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,9.4,high_burden
KE-NRB-2017-01473,2017,64,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.6,high_burden
KE-NRB-2018-01474,2018,63,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,11.1,high_burden
KE-NRB-2012-01475,2012,65,65-74,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-01476,2018,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.2,high_burden
KE-NRB-2010-01477,2010,30,25-34,Female,Breast,Unspecified,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,55.5,high_burden
KE-NRB-2015-01478,2015,50,45-54,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,58.9,high_burden
KE-NRB-2013-01479,2013,53,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.7,high_burden
KE-NRB-2015-01480,2015,36,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.8,high_burden
KE-NRB-2013-01481,2013,41,35-44,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.0,high_burden
KE-NRB-2013-01482,2013,35,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,6.6,high_burden
KE-NRB-2017-01483,2017,69,65-74,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,29.0,high_burden
KE-NRB-2009-01484,2009,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-01485,2018,90,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,0.6,high_burden
KE-NRB-2009-01486,2009,2,0-14,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,25.9,high_burden
KE-NRB-2012-01487,2012,70,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-01488,2014,72,65-74,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2016-01489,2016,44,35-44,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,18.5,high_burden
KE-NRB-2017-01490,2017,45,45-54,Female,Other,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Palliative care only,Alive,3.5,high_burden
KE-NRB-2012-01491,2012,56,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,16.2,high_burden
KE-NRB-2015-01492,2015,65,65-74,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.5,high_burden
KE-NRB-2018-01493,2018,53,45-54,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2013-01494,2013,45,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,19.4,high_burden
KE-NRB-2017-01495,2017,41,35-44,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.0,high_burden
KE-NRB-2015-01496,2015,89,75+,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-01497,2010,95,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-01498,2017,89,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-01499,2013,55,55-64,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.5,high_burden
KE-NRB-2013-01500,2013,71,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,24.1,high_burden
KE-NRB-2017-01501,2017,47,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-01502,2009,94,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,39.5,high_burden
KE-NRB-2010-01503,2010,32,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,0.1,high_burden
KE-NRB-2009-01504,2009,30,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.6,high_burden
KE-NRB-2017-01505,2017,27,25-34,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Alive,38.7,high_burden
KE-NRB-2018-01506,2018,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,27.9,high_burden
KE-NRB-2014-01507,2014,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,15.3,high_burden
KE-NRB-2017-01508,2017,19,15-24,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-01509,2018,72,65-74,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,high_burden
KE-NRB-2017-01510,2017,22,15-24,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.2,high_burden
KE-NRB-2011-01511,2011,42,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.9,high_burden
KE-NRB-2011-01512,2011,41,35-44,Female,Breast,Leukemia,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Dead,24.8,high_burden
KE-NRB-2009-01513,2009,3,0-14,Male,Leukemia,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,16.7,high_burden
KE-NRB-2012-01514,2012,54,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.9,high_burden
KE-NRB-2018-01515,2018,53,45-54,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,5.2,high_burden
KE-NRB-2016-01516,2016,72,65-74,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01517,2014,74,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.6,high_burden
KE-NRB-2011-01518,2011,45,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,33.9,high_burden
KE-NRB-2017-01519,2017,59,55-64,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.5,high_burden
KE-NRB-2013-01520,2013,65,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,17.1,high_burden
KE-NRB-2015-01521,2015,21,15-24,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,4.2,high_burden
KE-NRB-2016-01522,2016,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.8,high_burden
KE-NRB-2014-01523,2014,92,75+,Female,Breast,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Dead,11.5,high_burden
KE-NRB-2011-01524,2011,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,3.2,high_burden
KE-NRB-2015-01525,2015,74,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.8,high_burden
KE-NRB-2012-01526,2012,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Radiotherapy only,Dead,38.2,high_burden
KE-NRB-2012-01527,2012,94,75+,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,0.5,high_burden
KE-NRB-2015-01528,2015,56,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.8,high_burden
KE-NRB-2018-01529,2018,74,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,27.3,high_burden
KE-NRB-2012-01530,2012,53,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2015-01531,2015,14,0-14,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,26.7,high_burden
KE-NRB-2012-01532,2012,67,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,49.0,high_burden
KE-NRB-2014-01533,2014,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,31.9,high_burden
KE-NRB-2015-01534,2015,47,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,2.2,high_burden
KE-NRB-2018-01535,2018,74,65-74,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.5,high_burden
KE-NRB-2016-01536,2016,41,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,16.0,high_burden
KE-NRB-2015-01537,2015,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.5,high_burden
KE-NRB-2017-01538,2017,60,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,46.0,high_burden
KE-NRB-2015-01539,2015,33,25-34,Female,Cervix uteri,Adenocarcinoma,Unknown,Clinical only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-01540,2015,59,55-64,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.9,high_burden
KE-NRB-2018-01541,2018,69,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.8,high_burden
KE-NRB-2010-01542,2010,48,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.4,high_burden
KE-NRB-2018-01543,2018,13,0-14,Male,Prostate,Lymphoma,Unknown,Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,23.3,high_burden
KE-NRB-2013-01544,2013,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-01545,2018,38,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Radiotherapy,Dead,14.8,high_burden
KE-NRB-2013-01546,2013,47,45-54,Male,Pancreas,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.0,high_burden
KE-NRB-2009-01547,2009,27,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Radiotherapy only,Alive,7.0,high_burden
KE-NRB-2018-01548,2018,50,45-54,Female,Other,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,10.5,high_burden
KE-NRB-2015-01549,2015,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.4,high_burden
KE-NRB-2017-01550,2017,49,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.2,high_burden
KE-NRB-2010-01551,2010,69,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-01552,2016,66,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-01553,2015,64,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.6,high_burden
KE-NRB-2014-01554,2014,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Palliative care only,Lost to follow-up,60.0,high_burden
KE-NRB-2015-01555,2015,67,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,41.5,high_burden
KE-NRB-2016-01556,2016,26,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,8.0,high_burden
KE-NRB-2013-01557,2013,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-01558,2018,45,45-54,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,27.6,high_burden
KE-NRB-2018-01559,2018,26,25-34,Female,Thyroid,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,0.8,high_burden
KE-NRB-2010-01560,2010,60,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.9,high_burden
KE-NRB-2009-01561,2009,95,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,10.1,high_burden
KE-NRB-2010-01562,2010,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.9,high_burden
KE-NRB-2015-01563,2015,43,35-44,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-01564,2010,30,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-01565,2015,63,55-64,Male,Liver,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.3,high_burden
KE-NRB-2012-01566,2012,64,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-01567,2011,56,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,14.9,high_burden
KE-NRB-2012-01568,2012,92,75+,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,32.3,high_burden
KE-NRB-2017-01569,2017,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.6,high_burden
KE-NRB-2016-01570,2016,70,65-74,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-01571,2010,88,75+,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.3,high_burden
KE-NRB-2017-01572,2017,70,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-01573,2012,61,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,3.4,high_burden
KE-NRB-2017-01574,2017,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,35.6,high_burden
KE-NRB-2018-01575,2018,71,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.9,high_burden
KE-NRB-2017-01576,2017,27,25-34,Female,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,0.4,high_burden
KE-NRB-2016-01577,2016,57,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,24.1,high_burden
KE-NRB-2013-01578,2013,52,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.8,high_burden
KE-NRB-2016-01579,2016,37,35-44,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,18.2,high_burden
KE-NRB-2012-01580,2012,47,45-54,Male,Lung,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-01581,2017,58,55-64,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,46.0,high_burden
KE-NRB-2015-01582,2015,64,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,12.8,high_burden
KE-NRB-2014-01583,2014,30,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,2.6,high_burden
KE-NRB-2016-01584,2016,47,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,11.9,high_burden
KE-NRB-2010-01585,2010,59,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.2,high_burden
KE-NRB-2014-01586,2014,47,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-01587,2012,55,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,8.8,high_burden
KE-NRB-2016-01588,2016,93,75+,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,21.7,high_burden
KE-NRB-2016-01589,2016,59,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,30.2,high_burden
KE-NRB-2016-01590,2016,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,34.0,high_burden
KE-NRB-2013-01591,2013,90,75+,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.1,high_burden
KE-NRB-2015-01592,2015,41,35-44,Male,Kaposi sarcoma,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,17.7,high_burden
KE-NRB-2018-01593,2018,38,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.5,high_burden
KE-NRB-2014-01594,2014,0,0-14,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,15.7,high_burden
KE-NRB-2018-01595,2018,81,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.4,high_burden
KE-NRB-2018-01596,2018,49,45-54,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-01597,2015,55,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Alive,29.2,high_burden
KE-NRB-2010-01598,2010,58,55-64,Male,Oesophagus,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.3,high_burden
KE-NRB-2013-01599,2013,49,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-01600,2012,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,54.8,high_burden
KE-NRB-2016-01601,2016,86,75+,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,38.0,high_burden
KE-NRB-2016-01602,2016,57,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,6.2,high_burden
KE-NRB-2010-01603,2010,78,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,8.6,high_burden
KE-NRB-2015-01604,2015,62,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-01605,2012,45,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,24.3,high_burden
KE-NRB-2013-01606,2013,53,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,23.1,high_burden
KE-NRB-2018-01607,2018,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-01608,2013,55,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,0.4,high_burden
KE-NRB-2011-01609,2011,26,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,25.2,high_burden
KE-NRB-2015-01610,2015,44,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,20.5,high_burden
KE-NRB-2016-01611,2016,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,5.5,high_burden
KE-NRB-2013-01612,2013,22,15-24,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,19.2,high_burden
KE-NRB-2010-01613,2010,78,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,11.4,high_burden
KE-NRB-2018-01614,2018,47,45-54,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.6,high_burden
KE-NRB-2010-01615,2010,73,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.6,high_burden
KE-NRB-2017-01616,2017,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,45.0,high_burden
KE-NRB-2015-01617,2015,69,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.0,high_burden
KE-NRB-2015-01618,2015,25,25-34,Female,Cervix uteri,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,5.1,high_burden
KE-NRB-2012-01619,2012,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,2.9,high_burden
KE-NRB-2018-01620,2018,48,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,3.3,high_burden
KE-NRB-2010-01621,2010,0,0-14,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,48.3,high_burden
KE-NRB-2010-01622,2010,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-01623,2018,42,35-44,Male,Oesophagus,Lymphoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,8.8,high_burden
KE-NRB-2015-01624,2015,48,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,37.4,high_burden
KE-NRB-2016-01625,2016,47,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Lost to follow-up,39.9,high_burden
KE-NRB-2012-01626,2012,4,0-14,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,4.5,high_burden
KE-NRB-2011-01627,2011,87,75+,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.9,high_burden
KE-NRB-2009-01628,2009,47,45-54,Male,Leukemia,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.8,high_burden
KE-NRB-2012-01629,2012,78,75+,Male,Bladder,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,5.6,high_burden
KE-NRB-2009-01630,2009,7,0-14,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,0.2,high_burden
KE-NRB-2013-01631,2013,47,45-54,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Benign/uncertain,Urban,N/A,Dead,5.3,high_burden
KE-NRB-2011-01632,2011,35,35-44,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.4,high_burden
KE-NRB-2010-01633,2010,5,0-14,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Dead,7.5,high_burden
KE-NRB-2009-01634,2009,37,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,16.2,high_burden
KE-NRB-2015-01635,2015,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,12.2,high_burden
KE-NRB-2014-01636,2014,92,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.3,high_burden
KE-NRB-2017-01637,2017,45,45-54,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.4,high_burden
KE-NRB-2017-01638,2017,33,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,15.0,high_burden
KE-NRB-2013-01639,2013,57,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.5,high_burden
KE-NRB-2018-01640,2018,47,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Radiotherapy only,Dead,14.9,high_burden
KE-NRB-2015-01641,2015,71,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,7.5,high_burden
KE-NRB-2017-01642,2017,63,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,43.7,high_burden
KE-NRB-2014-01643,2014,39,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-01644,2015,58,55-64,Male,Multiple myeloma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.6,high_burden
KE-NRB-2016-01645,2016,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,9.5,high_burden
KE-NRB-2013-01646,2013,57,55-64,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,18.5,high_burden
KE-NRB-2016-01647,2016,47,45-54,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Lost to follow-up,60.0,high_burden
KE-NRB-2014-01648,2014,62,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,34.6,high_burden
KE-NRB-2015-01649,2015,27,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,57.8,high_burden
KE-NRB-2010-01650,2010,54,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.1,high_burden
KE-NRB-2018-01651,2018,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,16.5,high_burden
KE-NRB-2016-01652,2016,41,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-01653,2018,70,65-74,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.5,high_burden
KE-NRB-2018-01654,2018,70,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,1.9,high_burden
KE-NRB-2015-01655,2015,59,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.3,high_burden
KE-NRB-2010-01656,2010,71,65-74,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.9,high_burden
KE-NRB-2009-01657,2009,58,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.6,high_burden
KE-NRB-2018-01658,2018,65,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.4,high_burden
KE-NRB-2012-01659,2012,63,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,29.4,high_burden
KE-NRB-2012-01660,2012,28,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,8.3,high_burden
KE-NRB-2009-01661,2009,71,65-74,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,29.3,high_burden
KE-NRB-2013-01662,2013,66,65-74,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Rural,N/A,Dead,5.2,high_burden
KE-NRB-2011-01663,2011,32,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,5.3,high_burden
KE-NRB-2018-01664,2018,71,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-01665,2015,67,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-01666,2012,50,45-54,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2015-01667,2015,45,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,41.1,high_burden
KE-NRB-2017-01668,2017,74,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.0,high_burden
KE-NRB-2016-01669,2016,43,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-01670,2017,45,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,44.3,high_burden
KE-NRB-2014-01671,2014,27,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.4,high_burden
KE-NRB-2015-01672,2015,39,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-01673,2016,47,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,40.3,high_burden
KE-NRB-2017-01674,2017,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,32.1,high_burden
KE-NRB-2017-01675,2017,38,35-44,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,high_burden
KE-NRB-2012-01676,2012,72,65-74,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,51.8,high_burden
KE-NRB-2012-01677,2012,69,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.8,high_burden
KE-NRB-2015-01678,2015,63,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-01679,2011,90,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.0,high_burden
KE-NRB-2011-01680,2011,60,55-64,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,8.1,high_burden
KE-NRB-2017-01681,2017,67,65-74,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,55.5,high_burden
KE-NRB-2013-01682,2013,64,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-01683,2017,55,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,1.0,high_burden
KE-NRB-2018-01684,2018,58,55-64,Male,Prostate,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,37.3,high_burden
KE-NRB-2014-01685,2014,41,35-44,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,31.6,high_burden
KE-NRB-2013-01686,2013,42,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.9,high_burden
KE-NRB-2017-01687,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,18.8,high_burden
KE-NRB-2013-01688,2013,76,75+,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,48.5,high_burden
KE-NRB-2014-01689,2014,59,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,11.9,high_burden
KE-NRB-2013-01690,2013,53,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.8,high_burden
KE-NRB-2009-01691,2009,64,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.1,high_burden
KE-NRB-2018-01692,2018,20,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-01693,2013,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01694,2011,47,45-54,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,5.5,high_burden
KE-NRB-2012-01695,2012,35,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,19.6,high_burden
KE-NRB-2015-01696,2015,57,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,8.7,high_burden
KE-NRB-2009-01697,2009,33,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.7,high_burden
KE-NRB-2010-01698,2010,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,11.5,high_burden
KE-NRB-2016-01699,2016,68,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,40.0,high_burden
KE-NRB-2015-01700,2015,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,47.8,high_burden
KE-NRB-2017-01701,2017,89,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.9,high_burden
KE-NRB-2010-01702,2010,65,65-74,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,1.3,high_burden
KE-NRB-2018-01703,2018,65,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Palliative care only,Dead,7.5,high_burden
KE-NRB-2013-01704,2013,63,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,37.5,high_burden
KE-NRB-2009-01705,2009,35,35-44,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,30.4,high_burden
KE-NRB-2012-01706,2012,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,42.5,high_burden
KE-NRB-2011-01707,2011,64,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,42.0,high_burden
KE-NRB-2017-01708,2017,34,25-34,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2016-01709,2016,61,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-01710,2011,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.7,high_burden
KE-NRB-2017-01711,2017,53,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,3.3,high_burden
KE-NRB-2014-01712,2014,51,45-54,Male,Leukemia,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-01713,2011,40,35-44,Female,Other,Other specified,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,4.5,high_burden
KE-NRB-2016-01714,2016,67,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.2,high_burden
KE-NRB-2017-01715,2017,27,25-34,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.2,high_burden
KE-NRB-2014-01716,2014,73,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.2,high_burden
KE-NRB-2013-01717,2013,50,45-54,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-01718,2013,41,35-44,Female,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,19.4,high_burden
KE-NRB-2016-01719,2016,74,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,15.2,high_burden
KE-NRB-2016-01720,2016,62,55-64,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,18.0,high_burden
KE-NRB-2014-01721,2014,52,45-54,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-01722,2016,72,65-74,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Alive,12.9,high_burden
KE-NRB-2018-01723,2018,64,55-64,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.3,high_burden
KE-NRB-2011-01724,2011,31,25-34,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-01725,2014,59,55-64,Male,Colorectum,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Surgery only,Dead,0.5,high_burden
KE-NRB-2015-01726,2015,60,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,43.2,high_burden
KE-NRB-2015-01727,2015,50,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-01728,2015,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,4.0,high_burden
KE-NRB-2016-01729,2016,41,35-44,Female,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-01730,2013,27,25-34,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-01731,2018,37,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2012-01732,2012,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.7,high_burden
KE-NRB-2014-01733,2014,48,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,27.9,high_burden
KE-NRB-2018-01734,2018,38,35-44,Male,Non-Hodgkin lymphoma,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,40.3,high_burden
KE-NRB-2016-01735,2016,36,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,32.2,high_burden
KE-NRB-2010-01736,2010,25,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.7,high_burden
KE-NRB-2018-01737,2018,52,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.0,high_burden
KE-NRB-2013-01738,2013,49,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,46.6,high_burden
KE-NRB-2014-01739,2014,50,45-54,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,31.0,high_burden
KE-NRB-2011-01740,2011,73,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,24.7,high_burden
KE-NRB-2015-01741,2015,53,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.6,high_burden
KE-NRB-2016-01742,2016,60,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,39.3,high_burden
KE-NRB-2015-01743,2015,73,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,8.6,high_burden
KE-NRB-2011-01744,2011,51,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.4,high_burden
KE-NRB-2017-01745,2017,47,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.0,high_burden
KE-NRB-2018-01746,2018,43,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,16.0,high_burden
KE-NRB-2012-01747,2012,48,45-54,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,32.1,high_burden
KE-NRB-2017-01748,2017,66,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Radiotherapy only,Dead,22.6,high_burden
KE-NRB-2014-01749,2014,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.0,high_burden
KE-NRB-2013-01750,2013,26,25-34,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.0,high_burden
KE-NRB-2016-01751,2016,50,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Surgery only,Dead,12.0,high_burden
KE-NRB-2017-01752,2017,69,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,8.2,high_burden
KE-NRB-2017-01753,2017,69,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Alive,54.6,high_burden
KE-NRB-2012-01754,2012,62,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,25.2,high_burden
KE-NRB-2014-01755,2014,55,55-64,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,38.3,high_burden
KE-NRB-2015-01756,2015,53,45-54,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-01757,2017,88,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,44.7,high_burden
KE-NRB-2013-01758,2013,65,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,1.5,high_burden
KE-NRB-2014-01759,2014,62,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-01760,2016,84,75+,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,2.0,high_burden
KE-NRB-2017-01761,2017,92,75+,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.1,high_burden
KE-NRB-2011-01762,2011,46,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,19.5,high_burden
KE-NRB-2009-01763,2009,51,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,8.5,high_burden
KE-NRB-2012-01764,2012,47,45-54,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.0,high_burden
KE-NRB-2018-01765,2018,62,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,23.8,high_burden
KE-NRB-2017-01766,2017,71,65-74,Female,Corpus uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.3,high_burden
KE-NRB-2017-01767,2017,70,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,15.4,high_burden
KE-NRB-2012-01768,2012,10,0-14,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,42.6,high_burden
KE-NRB-2017-01769,2017,40,35-44,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2017-01770,2017,65,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,55.2,high_burden
KE-NRB-2012-01771,2012,47,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.5,high_burden
KE-NRB-2016-01772,2016,19,15-24,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.6,high_burden
KE-NRB-2018-01773,2018,40,35-44,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,10.2,high_burden
KE-NRB-2018-01774,2018,54,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.0,high_burden
KE-NRB-2012-01775,2012,67,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,35.2,high_burden
KE-NRB-2011-01776,2011,60,55-64,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,45.0,high_burden
KE-NRB-2014-01777,2014,77,75+,Male,Bladder,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.2,high_burden
KE-NRB-2010-01778,2010,56,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.8,high_burden
KE-NRB-2013-01779,2013,65,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.7,high_burden
KE-NRB-2010-01780,2010,64,55-64,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,19.2,high_burden
KE-NRB-2016-01781,2016,27,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.6,high_burden
KE-NRB-2015-01782,2015,37,35-44,Female,Ovary,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,18.2,high_burden
KE-NRB-2011-01783,2011,70,65-74,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Radiotherapy only,Alive,1.2,high_burden
KE-NRB-2013-01784,2013,32,25-34,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,22.8,high_burden
KE-NRB-2016-01785,2016,54,45-54,Male,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.3,high_burden
KE-NRB-2015-01786,2015,70,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,48.0,high_burden
KE-NRB-2015-01787,2015,63,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,0.2,high_burden
KE-NRB-2016-01788,2016,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.4,high_burden
KE-NRB-2012-01789,2012,15,15-24,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,14.5,high_burden
KE-NRB-2012-01790,2012,63,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.3,high_burden
KE-NRB-2011-01791,2011,51,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,16.8,high_burden
KE-NRB-2016-01792,2016,31,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-01793,2015,56,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-01794,2017,51,45-54,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01795,2014,55,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,1.0,high_burden
KE-NRB-2010-01796,2010,55,55-64,Male,Oesophagus,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,23.9,high_burden
KE-NRB-2010-01797,2010,59,55-64,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.1,high_burden
KE-NRB-2014-01798,2014,66,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-01799,2018,28,25-34,Male,Bladder,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.6,high_burden
KE-NRB-2018-01800,2018,62,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.7,high_burden
KE-NRB-2013-01801,2013,6,0-14,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Dead,6.5,high_burden
KE-NRB-2013-01802,2013,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,11.3,high_burden
KE-NRB-2014-01803,2014,29,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-01804,2018,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,23.1,high_burden
KE-NRB-2012-01805,2012,31,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,0.5,high_burden
KE-NRB-2017-01806,2017,37,35-44,Male,Multiple myeloma,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,No treatment,Dead,24.6,high_burden
KE-NRB-2012-01807,2012,43,35-44,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,37.3,high_burden
KE-NRB-2018-01808,2018,58,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.7,high_burden
KE-NRB-2010-01809,2010,38,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.4,high_burden
KE-NRB-2010-01810,2010,37,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-01811,2013,66,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,15.2,high_burden
KE-NRB-2016-01812,2016,92,75+,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,41.5,high_burden
KE-NRB-2010-01813,2010,59,55-64,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,12.4,high_burden
KE-NRB-2013-01814,2013,70,65-74,Female,Breast,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,19.5,high_burden
KE-NRB-2015-01815,2015,56,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.1,high_burden
KE-NRB-2016-01816,2016,73,65-74,Male,Prostate,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,17.1,high_burden
KE-NRB-2017-01817,2017,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-01818,2015,19,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-01819,2013,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,9.8,high_burden
KE-NRB-2010-01820,2010,45,45-54,Female,Ovary,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Alive,51.5,high_burden
KE-NRB-2011-01821,2011,49,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,4.3,high_burden
KE-NRB-2009-01822,2009,92,75+,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.3,high_burden
KE-NRB-2016-01823,2016,68,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.2,high_burden
KE-NRB-2016-01824,2016,53,45-54,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,41.5,high_burden
KE-NRB-2018-01825,2018,90,75+,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.7,high_burden
KE-NRB-2013-01826,2013,50,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,9.7,high_burden
KE-NRB-2018-01827,2018,33,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.9,high_burden
KE-NRB-2010-01828,2010,55,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-01829,2018,24,15-24,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2014-01830,2014,6,0-14,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,6.9,high_burden
KE-NRB-2017-01831,2017,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-01832,2018,42,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.1,high_burden
KE-NRB-2010-01833,2010,30,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.1,high_burden
KE-NRB-2014-01834,2014,47,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,8.7,high_burden
KE-NRB-2018-01835,2018,29,25-34,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-01836,2017,52,45-54,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,23.4,high_burden
KE-NRB-2015-01837,2015,57,55-64,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,47.9,high_burden
KE-NRB-2016-01838,2016,73,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-01839,2014,69,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,17.5,high_burden
KE-NRB-2017-01840,2017,51,45-54,Male,Lung,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,16.6,high_burden
KE-NRB-2018-01841,2018,47,45-54,Male,Bladder,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,46.6,high_burden
KE-NRB-2009-01842,2009,51,45-54,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,5.2,high_burden
KE-NRB-2016-01843,2016,47,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,10.3,high_burden
KE-NRB-2017-01844,2017,64,55-64,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,45.1,high_burden
KE-NRB-2012-01845,2012,40,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,27.3,high_burden
KE-NRB-2016-01846,2016,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Other,Malignant,Urban,Surgery + Chemotherapy,Alive,50.5,high_burden
KE-NRB-2012-01847,2012,73,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,27.9,high_burden
KE-NRB-2013-01848,2013,62,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,42.6,high_burden
KE-NRB-2015-01849,2015,48,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,9.7,high_burden
KE-NRB-2013-01850,2013,27,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.4,high_burden
KE-NRB-2011-01851,2011,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,35.5,high_burden
KE-NRB-2009-01852,2009,57,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,1.7,high_burden
KE-NRB-2015-01853,2015,35,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,20.0,high_burden
KE-NRB-2010-01854,2010,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.8,high_burden
KE-NRB-2011-01855,2011,85,75+,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.1,high_burden
KE-NRB-2016-01856,2016,49,45-54,Female,Breast,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Dead,7.7,high_burden
KE-NRB-2014-01857,2014,95,75+,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-01858,2012,85,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,5.3,high_burden
KE-NRB-2013-01859,2013,70,65-74,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.0,high_burden
KE-NRB-2017-01860,2017,64,55-64,Male,Kidney,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,13.2,high_burden
KE-NRB-2015-01861,2015,58,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,3.5,high_burden
KE-NRB-2011-01862,2011,38,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,40.4,high_burden
KE-NRB-2017-01863,2017,36,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.5,high_burden
KE-NRB-2012-01864,2012,73,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,10.6,high_burden
KE-NRB-2017-01865,2017,48,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,6.9,high_burden
KE-NRB-2015-01866,2015,42,35-44,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,30.1,high_burden
KE-NRB-2018-01867,2018,50,45-54,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,No treatment,Alive,13.1,high_burden
KE-NRB-2014-01868,2014,63,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.2,high_burden
KE-NRB-2009-01869,2009,60,55-64,Male,Liver,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.4,high_burden
KE-NRB-2013-01870,2013,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.9,high_burden
KE-NRB-2010-01871,2010,55,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,26.2,high_burden
KE-NRB-2017-01872,2017,57,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,20.1,high_burden
KE-NRB-2013-01873,2013,58,55-64,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.4,high_burden
KE-NRB-2010-01874,2010,57,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,0.1,high_burden
KE-NRB-2013-01875,2013,52,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.0,high_burden
KE-NRB-2014-01876,2014,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.5,high_burden
KE-NRB-2012-01877,2012,48,45-54,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,37.8,high_burden
KE-NRB-2015-01878,2015,45,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.3,high_burden
KE-NRB-2011-01879,2011,25,25-34,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.7,high_burden
KE-NRB-2013-01880,2013,69,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.9,high_burden
KE-NRB-2009-01881,2009,67,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,45.0,high_burden
KE-NRB-2009-01882,2009,91,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.2,high_burden
KE-NRB-2010-01883,2010,51,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-01884,2013,84,75+,Male,Brain and CNS,Other specified,Unknown,Other,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,16.6,high_burden
KE-NRB-2017-01885,2017,90,75+,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.6,high_burden
KE-NRB-2012-01886,2012,75,75+,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,50.2,high_burden
KE-NRB-2016-01887,2016,52,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.6,high_burden
KE-NRB-2015-01888,2015,45,45-54,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,59.1,high_burden
KE-NRB-2012-01889,2012,27,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.5,high_burden
KE-NRB-2011-01890,2011,59,55-64,Male,Kaposi sarcoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,27.1,high_burden
KE-NRB-2015-01891,2015,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.1,high_burden
KE-NRB-2016-01892,2016,22,15-24,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2012-01893,2012,72,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,57.2,high_burden
KE-NRB-2017-01894,2017,71,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-01895,2015,62,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-01896,2012,30,25-34,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.9,high_burden
KE-NRB-2012-01897,2012,56,55-64,Female,Cervix uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-01898,2015,74,65-74,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.7,high_burden
KE-NRB-2017-01899,2017,91,75+,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,27.0,high_burden
KE-NRB-2018-01900,2018,89,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,10.9,high_burden
KE-NRB-2018-01901,2018,33,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,52.3,high_burden
KE-NRB-2017-01902,2017,68,65-74,Female,Thyroid,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.8,high_burden
KE-NRB-2016-01903,2016,54,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,32.7,high_burden
KE-NRB-2017-01904,2017,62,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-01905,2016,55,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.5,high_burden
KE-NRB-2012-01906,2012,43,35-44,Male,Lung,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2014-01907,2014,58,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.9,high_burden
KE-NRB-2018-01908,2018,68,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,40.6,high_burden
KE-NRB-2015-01909,2015,94,75+,Female,Other,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Alive,14.4,high_burden
KE-NRB-2009-01910,2009,15,15-24,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,45.8,high_burden
KE-NRB-2016-01911,2016,60,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,34.2,high_burden
KE-NRB-2013-01912,2013,66,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,46.3,high_burden
KE-NRB-2009-01913,2009,52,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Alive,1.5,high_burden
KE-NRB-2018-01914,2018,70,65-74,Female,Thyroid,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,54.2,high_burden
KE-NRB-2016-01915,2016,28,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,1.2,high_burden
KE-NRB-2010-01916,2010,47,45-54,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.6,high_burden
KE-NRB-2017-01917,2017,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,36.6,high_burden
KE-NRB-2017-01918,2017,26,25-34,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,2.0,high_burden
KE-NRB-2017-01919,2017,51,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.6,high_burden
KE-NRB-2012-01920,2012,35,35-44,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.3,high_burden
KE-NRB-2017-01921,2017,93,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.2,high_burden
KE-NRB-2015-01922,2015,69,65-74,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,57.7,high_burden
KE-NRB-2012-01923,2012,73,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-01924,2017,58,55-64,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Dead,28.1,high_burden
KE-NRB-2015-01925,2015,33,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,23.2,high_burden
KE-NRB-2016-01926,2016,52,45-54,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,17.2,high_burden
KE-NRB-2011-01927,2011,43,35-44,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,28.1,high_burden
KE-NRB-2009-01928,2009,46,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.0,high_burden
KE-NRB-2018-01929,2018,65,65-74,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.3,high_burden
KE-NRB-2014-01930,2014,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,17.5,high_burden
KE-NRB-2013-01931,2013,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2009-01932,2009,61,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.5,high_burden
KE-NRB-2013-01933,2013,62,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,24.0,high_burden
KE-NRB-2017-01934,2017,44,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.2,high_burden
KE-NRB-2018-01935,2018,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-01936,2016,48,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,12.8,high_burden
KE-NRB-2011-01937,2011,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.0,high_burden
KE-NRB-2016-01938,2016,65,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,22.4,high_burden
KE-NRB-2017-01939,2017,35,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,33.8,high_burden
KE-NRB-2015-01940,2015,68,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,0.9,high_burden
KE-NRB-2018-01941,2018,27,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,39.6,high_burden
KE-NRB-2018-01942,2018,54,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-01943,2011,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-01944,2014,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,38.1,high_burden
KE-NRB-2015-01945,2015,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-01946,2018,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,1.0,high_burden
KE-NRB-2011-01947,2011,47,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,53.5,high_burden
KE-NRB-2010-01948,2010,67,65-74,Male,Colorectum,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.3,high_burden
KE-NRB-2012-01949,2012,28,25-34,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.5,high_burden
KE-NRB-2015-01950,2015,41,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.4,high_burden
KE-NRB-2013-01951,2013,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,13.2,high_burden
KE-NRB-2012-01952,2012,35,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,5.9,high_burden
KE-NRB-2012-01953,2012,34,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.7,high_burden
KE-NRB-2018-01954,2018,64,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,33.1,high_burden
KE-NRB-2017-01955,2017,56,55-64,Male,Prostate,Unspecified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2016-01956,2016,59,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,27.0,high_burden
KE-NRB-2014-01957,2014,73,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-01958,2010,69,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,12.0,high_burden
KE-NRB-2014-01959,2014,50,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,3.7,high_burden
KE-NRB-2014-01960,2014,78,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.6,high_burden
KE-NRB-2013-01961,2013,47,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2017-01962,2017,23,15-24,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.2,high_burden
KE-NRB-2010-01963,2010,58,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,16.3,high_burden
KE-NRB-2018-01964,2018,27,25-34,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-01965,2017,64,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,14.7,high_burden
KE-NRB-2018-01966,2018,42,35-44,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,10.7,high_burden
KE-NRB-2013-01967,2013,27,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.1,high_burden
KE-NRB-2016-01968,2016,65,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-01969,2009,61,55-64,Male,Brain and CNS,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,31.2,high_burden
KE-NRB-2011-01970,2011,60,55-64,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2018-01971,2018,71,65-74,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,27.5,high_burden
KE-NRB-2018-01972,2018,43,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,59.9,high_burden
KE-NRB-2014-01973,2014,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.7,high_burden
KE-NRB-2012-01974,2012,37,35-44,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,0.9,high_burden
KE-NRB-2015-01975,2015,68,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,46.4,high_burden
KE-NRB-2017-01976,2017,57,55-64,Male,Prostate,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,13.0,high_burden
KE-NRB-2016-01977,2016,49,45-54,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,56.4,high_burden
KE-NRB-2010-01978,2010,17,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.1,high_burden
KE-NRB-2018-01979,2018,49,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-01980,2015,46,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,17.4,high_burden
KE-NRB-2016-01981,2016,63,55-64,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.5,high_burden
KE-NRB-2016-01982,2016,71,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-01983,2011,46,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.7,high_burden
KE-NRB-2014-01984,2014,83,75+,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,14.5,high_burden
KE-NRB-2015-01985,2015,58,55-64,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-01986,2012,71,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,5.3,high_burden
KE-NRB-2018-01987,2018,70,65-74,Male,Stomach,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-01988,2018,72,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,2.6,high_burden
KE-NRB-2015-01989,2015,27,25-34,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,9.4,high_burden
KE-NRB-2017-01990,2017,59,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.6,high_burden
KE-NRB-2012-01991,2012,37,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-01992,2012,52,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,43.2,high_burden
KE-NRB-2017-01993,2017,73,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.7,high_burden
KE-NRB-2016-01994,2016,41,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,55.6,high_burden
KE-NRB-2018-01995,2018,15,15-24,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,26.9,high_burden
KE-NRB-2017-01996,2017,39,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.2,high_burden
KE-NRB-2014-01997,2014,63,55-64,Male,Stomach,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.0,high_burden
KE-NRB-2014-01998,2014,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,10.5,high_burden
KE-NRB-2012-01999,2012,36,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.7,high_burden
KE-NRB-2018-02000,2018,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,4.9,high_burden
KE-NRB-2013-02001,2013,45,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-02002,2016,74,65-74,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,16.7,high_burden
KE-NRB-2011-02003,2011,61,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,29.7,high_burden
KE-NRB-2015-02004,2015,33,25-34,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,4.0,high_burden
KE-NRB-2009-02005,2009,20,15-24,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,22.7,high_burden
KE-NRB-2015-02006,2015,56,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-02007,2013,69,65-74,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.4,high_burden
KE-NRB-2018-02008,2018,41,35-44,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-02009,2015,49,45-54,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,1.8,high_burden
KE-NRB-2013-02010,2013,42,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-02011,2015,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.9,high_burden
KE-NRB-2015-02012,2015,63,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,5.9,high_burden
KE-NRB-2017-02013,2017,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-02014,2017,12,0-14,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-02015,2018,49,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.5,high_burden
KE-NRB-2011-02016,2011,66,65-74,Male,Bladder,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,2.8,high_burden
KE-NRB-2012-02017,2012,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,55.0,high_burden
KE-NRB-2016-02018,2016,19,15-24,Female,Ovary,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.0,high_burden
KE-NRB-2013-02019,2013,30,25-34,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,38.2,high_burden
KE-NRB-2014-02020,2014,57,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.2,high_burden
KE-NRB-2010-02021,2010,56,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.7,high_burden
KE-NRB-2014-02022,2014,79,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-02023,2012,40,35-44,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,22.4,high_burden
KE-NRB-2016-02024,2016,63,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-02025,2016,18,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,2.5,high_burden
KE-NRB-2017-02026,2017,66,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,39.2,high_burden
KE-NRB-2018-02027,2018,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.2,high_burden
KE-NRB-2016-02028,2016,30,25-34,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.5,high_burden
KE-NRB-2011-02029,2011,53,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.7,high_burden
KE-NRB-2013-02030,2013,39,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.9,high_burden
KE-NRB-2017-02031,2017,48,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.7,high_burden
KE-NRB-2011-02032,2011,67,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.2,high_burden
KE-NRB-2012-02033,2012,32,25-34,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-02034,2010,50,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,46.5,high_burden
KE-NRB-2014-02035,2014,61,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Dead,7.1,high_burden
KE-NRB-2010-02036,2010,28,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,30.9,high_burden
KE-NRB-2015-02037,2015,52,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,11.8,high_burden
KE-NRB-2018-02038,2018,48,45-54,Male,Stomach,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.6,high_burden
KE-NRB-2014-02039,2014,33,25-34,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-02040,2010,49,45-54,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-02041,2016,19,15-24,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.3,high_burden
KE-NRB-2014-02042,2014,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,49.3,high_burden
KE-NRB-2010-02043,2010,51,45-54,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.2,high_burden
KE-NRB-2012-02044,2012,35,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.6,high_burden
KE-NRB-2018-02045,2018,90,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,9.5,high_burden
KE-NRB-2013-02046,2013,58,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.2,high_burden
KE-NRB-2012-02047,2012,37,35-44,Male,Brain and CNS,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-02048,2016,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2018-02049,2018,65,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,0.4,high_burden
KE-NRB-2015-02050,2015,44,35-44,Male,Prostate,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-02051,2014,82,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.6,high_burden
KE-NRB-2018-02052,2018,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02053,2017,27,25-34,Female,Other,Adenocarcinoma,Unknown,Clinical only,In situ,Urban,N/A,Dead,28.7,high_burden
KE-NRB-2011-02054,2011,93,75+,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-02055,2017,28,25-34,Female,Other,Adenocarcinoma,Unknown,Other,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-02056,2016,58,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.8,high_burden
KE-NRB-2009-02057,2009,25,25-34,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.5,high_burden
KE-NRB-2017-02058,2017,64,55-64,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2012-02059,2012,61,55-64,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,2.2,high_burden
KE-NRB-2011-02060,2011,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,7.1,high_burden
KE-NRB-2013-02061,2013,37,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.6,high_burden
KE-NRB-2015-02062,2015,57,55-64,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,20.4,high_burden
KE-NRB-2017-02063,2017,58,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02064,2014,72,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,46.6,high_burden
KE-NRB-2015-02065,2015,50,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery only,Dead,2.4,high_burden
KE-NRB-2012-02066,2012,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,10.4,high_burden
KE-NRB-2016-02067,2016,42,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.4,high_burden
KE-NRB-2017-02068,2017,36,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.1,high_burden
KE-NRB-2018-02069,2018,76,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,3.3,high_burden
KE-NRB-2017-02070,2017,29,25-34,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,32.1,high_burden
KE-NRB-2017-02071,2017,48,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,37.0,high_burden
KE-NRB-2016-02072,2016,51,45-54,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,44.8,high_burden
KE-NRB-2010-02073,2010,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.4,high_burden
KE-NRB-2017-02074,2017,42,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.3,high_burden
KE-NRB-2014-02075,2014,59,55-64,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,1.7,high_burden
KE-NRB-2016-02076,2016,65,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.9,high_burden
KE-NRB-2015-02077,2015,64,55-64,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,50.4,high_burden
KE-NRB-2017-02078,2017,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.0,high_burden
KE-NRB-2015-02079,2015,45,45-54,Male,Non-Hodgkin lymphoma,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,59.2,high_burden
KE-NRB-2016-02080,2016,91,75+,Male,Other,Other specified,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-02081,2015,48,45-54,Male,Kidney,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.6,high_burden
KE-NRB-2018-02082,2018,69,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,26.0,high_burden
KE-NRB-2016-02083,2016,38,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.7,high_burden
KE-NRB-2013-02084,2013,4,0-14,Male,Pancreas,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.3,high_burden
KE-NRB-2016-02085,2016,74,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-02086,2010,71,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,3.5,high_burden
KE-NRB-2015-02087,2015,45,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.7,high_burden
KE-NRB-2015-02088,2015,66,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,19.5,high_burden
KE-NRB-2016-02089,2016,50,45-54,Male,Stomach,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Dead,5.6,high_burden
KE-NRB-2011-02090,2011,51,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,5.4,high_burden
KE-NRB-2015-02091,2015,27,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.2,high_burden
KE-NRB-2015-02092,2015,53,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.2,high_burden
KE-NRB-2014-02093,2014,71,65-74,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.5,high_burden
KE-NRB-2013-02094,2013,36,35-44,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,3.6,high_burden
KE-NRB-2018-02095,2018,61,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,24.5,high_burden
KE-NRB-2010-02096,2010,81,75+,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.6,high_burden
KE-NRB-2015-02097,2015,67,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,9.6,high_burden
KE-NRB-2011-02098,2011,45,45-54,Male,Stomach,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,38.4,high_burden
KE-NRB-2014-02099,2014,50,45-54,Male,Bladder,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.3,high_burden
KE-NRB-2014-02100,2014,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.0,high_burden
KE-NRB-2018-02101,2018,63,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.4,high_burden
KE-NRB-2015-02102,2015,53,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.1,high_burden
KE-NRB-2014-02103,2014,29,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-02104,2015,62,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,8.0,high_burden
KE-NRB-2016-02105,2016,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,57.3,high_burden
KE-NRB-2010-02106,2010,68,65-74,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,27.1,high_burden
KE-NRB-2009-02107,2009,45,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,20.6,high_burden
KE-NRB-2010-02108,2010,79,75+,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,13.0,high_burden
KE-NRB-2012-02109,2012,71,65-74,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.5,high_burden
KE-NRB-2014-02110,2014,27,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,31.1,high_burden
KE-NRB-2017-02111,2017,50,45-54,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,8.5,high_burden
KE-NRB-2016-02112,2016,60,55-64,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-02113,2010,86,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,32.2,high_burden
KE-NRB-2018-02114,2018,80,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.4,high_burden
KE-NRB-2011-02115,2011,82,75+,Male,Lung,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-02116,2013,73,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Lost to follow-up,33.3,high_burden
KE-NRB-2011-02117,2011,49,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.3,high_burden
KE-NRB-2009-02118,2009,56,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,1.2,high_burden
KE-NRB-2014-02119,2014,47,45-54,Female,Ovary,Other specified,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02120,2017,47,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-02121,2011,67,65-74,Female,Breast,Other specified,Undifferentiated (Grade IV),Imaging + clinical,In situ,Peri-urban,N/A,Alive,1.8,high_burden
KE-NRB-2018-02122,2018,18,15-24,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,17.3,high_burden
KE-NRB-2012-02123,2012,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,28.8,high_burden
KE-NRB-2015-02124,2015,65,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2013-02125,2013,41,35-44,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,10.5,high_burden
KE-NRB-2010-02126,2010,30,25-34,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2014-02127,2014,61,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.9,high_burden
KE-NRB-2013-02128,2013,41,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,4.3,high_burden
KE-NRB-2011-02129,2011,52,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.9,high_burden
KE-NRB-2009-02130,2009,46,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,20.1,high_burden
KE-NRB-2010-02131,2010,48,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.3,high_burden
KE-NRB-2016-02132,2016,30,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,22.7,high_burden
KE-NRB-2014-02133,2014,71,65-74,Female,Thyroid,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Dead,19.3,high_burden
KE-NRB-2009-02134,2009,74,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.4,high_burden
KE-NRB-2012-02135,2012,68,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,23.3,high_burden
KE-NRB-2018-02136,2018,55,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,8.9,high_burden
KE-NRB-2017-02137,2017,76,75+,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,16.7,high_burden
KE-NRB-2010-02138,2010,76,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,8.6,high_burden
KE-NRB-2014-02139,2014,29,25-34,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.5,high_burden
KE-NRB-2016-02140,2016,42,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.3,high_burden
KE-NRB-2018-02141,2018,45,45-54,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,8.7,high_burden
KE-NRB-2012-02142,2012,30,25-34,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02143,2017,51,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,43.7,high_burden
KE-NRB-2016-02144,2016,59,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,22.7,high_burden
KE-NRB-2016-02145,2016,71,65-74,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,9.1,high_burden
KE-NRB-2017-02146,2017,72,65-74,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.6,high_burden
KE-NRB-2014-02147,2014,37,35-44,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.9,high_burden
KE-NRB-2010-02148,2010,71,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,17.5,high_burden
KE-NRB-2013-02149,2013,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,40.6,high_burden
KE-NRB-2016-02150,2016,93,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,16.7,high_burden
KE-NRB-2016-02151,2016,42,35-44,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-02152,2017,47,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,33.0,high_burden
KE-NRB-2011-02153,2011,40,35-44,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.6,high_burden
KE-NRB-2018-02154,2018,48,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.2,high_burden
KE-NRB-2015-02155,2015,67,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,12.7,high_burden
KE-NRB-2015-02156,2015,74,65-74,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2017-02157,2017,49,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2016-02158,2016,32,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,27.9,high_burden
KE-NRB-2016-02159,2016,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,7.1,high_burden
KE-NRB-2010-02160,2010,61,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,7.4,high_burden
KE-NRB-2013-02161,2013,85,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.9,high_burden
KE-NRB-2016-02162,2016,69,65-74,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.1,high_burden
KE-NRB-2011-02163,2011,43,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.5,high_burden
KE-NRB-2012-02164,2012,84,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,24.4,high_burden
KE-NRB-2011-02165,2011,47,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-02166,2015,42,35-44,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,7.8,high_burden
KE-NRB-2013-02167,2013,57,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2016-02168,2016,73,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,6.7,high_burden
KE-NRB-2010-02169,2010,80,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,5.5,high_burden
KE-NRB-2017-02170,2017,47,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,42.5,high_burden
KE-NRB-2011-02171,2011,10,0-14,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.0,high_burden
KE-NRB-2015-02172,2015,40,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.5,high_burden
KE-NRB-2012-02173,2012,35,35-44,Male,Kaposi sarcoma,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,9.1,high_burden
KE-NRB-2014-02174,2014,53,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,18.6,high_burden
KE-NRB-2011-02175,2011,69,65-74,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-02176,2010,25,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,8.2,high_burden
KE-NRB-2017-02177,2017,75,75+,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,33.9,high_burden
KE-NRB-2017-02178,2017,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,55.7,high_burden
KE-NRB-2012-02179,2012,89,75+,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Alive,18.1,high_burden
KE-NRB-2013-02180,2013,60,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,7.0,high_burden
KE-NRB-2016-02181,2016,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-02182,2016,52,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.4,high_burden
KE-NRB-2013-02183,2013,36,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,1.2,high_burden
KE-NRB-2009-02184,2009,69,65-74,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,0.2,high_burden
KE-NRB-2018-02185,2018,36,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.5,high_burden
KE-NRB-2013-02186,2013,53,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,39.1,high_burden
KE-NRB-2014-02187,2014,35,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-02188,2011,65,65-74,Male,Hodgkin lymphoma,Leukemia,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.3,high_burden
KE-NRB-2012-02189,2012,41,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,36.3,high_burden
KE-NRB-2012-02190,2012,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,10.6,high_burden
KE-NRB-2010-02191,2010,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.7,high_burden
KE-NRB-2009-02192,2009,87,75+,Male,Stomach,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.4,high_burden
KE-NRB-2014-02193,2014,70,65-74,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-02194,2009,51,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,1.5,high_burden
KE-NRB-2014-02195,2014,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,54.7,high_burden
KE-NRB-2009-02196,2009,30,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.5,high_burden
KE-NRB-2010-02197,2010,48,45-54,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.3,high_burden
KE-NRB-2017-02198,2017,61,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,31.7,high_burden
KE-NRB-2016-02199,2016,33,25-34,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,41.2,high_burden
KE-NRB-2014-02200,2014,37,35-44,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-02201,2010,46,45-54,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,17.3,high_burden
KE-NRB-2010-02202,2010,27,25-34,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.1,high_burden
KE-NRB-2017-02203,2017,49,45-54,Male,Bladder,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2014-02204,2014,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-02205,2013,66,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,30.1,high_burden
KE-NRB-2017-02206,2017,1,0-14,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,4.8,high_burden
KE-NRB-2018-02207,2018,41,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,high_burden
KE-NRB-2014-02208,2014,44,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,0.7,high_burden
KE-NRB-2017-02209,2017,1,0-14,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,33.6,high_burden
KE-NRB-2014-02210,2014,67,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,22.3,high_burden
KE-NRB-2015-02211,2015,61,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.9,high_burden
KE-NRB-2018-02212,2018,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.0,high_burden
KE-NRB-2017-02213,2017,53,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.5,high_burden
KE-NRB-2016-02214,2016,40,35-44,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.7,high_burden
KE-NRB-2015-02215,2015,47,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,29.5,high_burden
KE-NRB-2012-02216,2012,72,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-02217,2018,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-02218,2011,51,45-54,Male,Prostate,Leukemia,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,13.4,high_burden
KE-NRB-2012-02219,2012,68,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,33.2,high_burden
KE-NRB-2016-02220,2016,50,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-02221,2013,55,55-64,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,12.5,high_burden
KE-NRB-2018-02222,2018,30,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.7,high_burden
KE-NRB-2017-02223,2017,80,75+,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.0,high_burden
KE-NRB-2016-02224,2016,70,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,22.5,high_burden
KE-NRB-2016-02225,2016,35,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.9,high_burden
KE-NRB-2012-02226,2012,64,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,19.6,high_burden
KE-NRB-2010-02227,2010,64,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,23.5,high_burden
KE-NRB-2013-02228,2013,60,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-02229,2017,51,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.8,high_burden
KE-NRB-2013-02230,2013,53,45-54,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,38.7,high_burden
KE-NRB-2016-02231,2016,27,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.8,high_burden
KE-NRB-2018-02232,2018,39,35-44,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.1,high_burden
KE-NRB-2009-02233,2009,57,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,5.1,high_burden
KE-NRB-2014-02234,2014,44,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-02235,2012,74,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,56.4,high_burden
KE-NRB-2016-02236,2016,52,45-54,Female,Ovary,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.5,high_burden
KE-NRB-2016-02237,2016,67,65-74,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,21.8,high_burden
KE-NRB-2015-02238,2015,39,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,6.1,high_burden
KE-NRB-2014-02239,2014,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,53.1,high_burden
KE-NRB-2018-02240,2018,57,55-64,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-02241,2015,47,45-54,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.7,high_burden
KE-NRB-2016-02242,2016,36,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,54.8,high_burden
KE-NRB-2013-02243,2013,46,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,58.6,high_burden
KE-NRB-2015-02244,2015,62,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,17.9,high_burden
KE-NRB-2010-02245,2010,15,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-02246,2016,57,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,44.7,high_burden
KE-NRB-2018-02247,2018,43,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,45.9,high_burden
KE-NRB-2015-02248,2015,35,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,27.2,high_burden
KE-NRB-2009-02249,2009,73,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,2.7,high_burden
KE-NRB-2013-02250,2013,75,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,14.0,high_burden
KE-NRB-2016-02251,2016,36,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,44.9,high_burden
KE-NRB-2012-02252,2012,30,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,49.1,high_burden
KE-NRB-2013-02253,2013,64,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.3,high_burden
KE-NRB-2017-02254,2017,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.6,high_burden
KE-NRB-2013-02255,2013,61,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,3.2,high_burden
KE-NRB-2009-02256,2009,59,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-02257,2017,93,75+,Male,Oesophagus,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-02258,2015,72,65-74,Female,Other,Other specified,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-02259,2015,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,0.2,high_burden
KE-NRB-2016-02260,2016,24,15-24,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,16.6,high_burden
KE-NRB-2018-02261,2018,53,45-54,Male,Skin (melanoma),Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-02262,2010,94,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,54.5,high_burden
KE-NRB-2014-02263,2014,38,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-02264,2009,69,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-02265,2016,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.0,high_burden
KE-NRB-2012-02266,2012,51,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.1,high_burden
KE-NRB-2014-02267,2014,51,45-54,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,0.5,high_burden
KE-NRB-2017-02268,2017,45,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.1,high_burden
KE-NRB-2014-02269,2014,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,33.8,high_burden
KE-NRB-2016-02270,2016,62,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-02271,2011,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,54.3,high_burden
KE-NRB-2012-02272,2012,47,45-54,Female,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-02273,2015,59,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,33.4,high_burden
KE-NRB-2016-02274,2016,24,15-24,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,55.6,high_burden
KE-NRB-2012-02275,2012,46,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Palliative care only,Lost to follow-up,7.7,high_burden
KE-NRB-2010-02276,2010,28,25-34,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,55.1,high_burden
KE-NRB-2013-02277,2013,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.4,high_burden
KE-NRB-2014-02278,2014,37,35-44,Male,Multiple myeloma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-02279,2017,36,35-44,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2013-02280,2013,53,45-54,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,2.3,high_burden
KE-NRB-2012-02281,2012,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-02282,2018,5,0-14,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.3,high_burden
KE-NRB-2017-02283,2017,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Dead,7.3,high_burden
KE-NRB-2017-02284,2017,35,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.7,high_burden
KE-NRB-2018-02285,2018,61,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,16.1,high_burden
KE-NRB-2018-02286,2018,34,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,36.9,high_burden
KE-NRB-2018-02287,2018,35,35-44,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-02288,2017,29,25-34,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,14.8,high_burden
KE-NRB-2010-02289,2010,62,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-02290,2017,51,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.0,high_burden
KE-NRB-2018-02291,2018,67,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.9,high_burden
KE-NRB-2012-02292,2012,50,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.8,high_burden
KE-NRB-2018-02293,2018,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-02294,2011,71,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.0,high_burden
KE-NRB-2014-02295,2014,47,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,1.5,high_burden
KE-NRB-2016-02296,2016,52,45-54,Male,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,17.2,high_burden
KE-NRB-2015-02297,2015,88,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.9,high_burden
KE-NRB-2009-02298,2009,69,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,60.0,high_burden
KE-NRB-2012-02299,2012,40,35-44,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,14.6,high_burden
KE-NRB-2013-02300,2013,46,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,58.6,high_burden
KE-NRB-2012-02301,2012,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-02302,2018,61,55-64,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,1.3,high_burden
KE-NRB-2014-02303,2014,25,25-34,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,4.4,high_burden
KE-NRB-2014-02304,2014,61,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,16.6,high_burden
KE-NRB-2017-02305,2017,49,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-02306,2018,72,65-74,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,51.9,high_burden
KE-NRB-2014-02307,2014,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,9.1,high_burden
KE-NRB-2013-02308,2013,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Dead,18.3,high_burden
KE-NRB-2015-02309,2015,72,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,44.4,high_burden
KE-NRB-2018-02310,2018,55,55-64,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,27.6,high_burden
KE-NRB-2015-02311,2015,38,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,27.2,high_burden
KE-NRB-2014-02312,2014,43,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,5.9,high_burden
KE-NRB-2013-02313,2013,23,15-24,Female,Corpus uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,26.2,high_burden
KE-NRB-2013-02314,2013,46,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,7.7,high_burden
KE-NRB-2013-02315,2013,67,65-74,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.6,high_burden
KE-NRB-2018-02316,2018,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.2,high_burden
KE-NRB-2018-02317,2018,41,35-44,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.2,high_burden
KE-NRB-2014-02318,2014,76,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Rural,N/A,Alive,47.6,high_burden
KE-NRB-2016-02319,2016,60,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,46.6,high_burden
KE-NRB-2016-02320,2016,55,55-64,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,47.1,high_burden
KE-NRB-2016-02321,2016,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.4,high_burden
KE-NRB-2018-02322,2018,45,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,19.4,high_burden
KE-NRB-2018-02323,2018,17,15-24,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,23.6,high_burden
KE-NRB-2018-02324,2018,50,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,29.7,high_burden
KE-NRB-2018-02325,2018,56,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,In situ,Urban,N/A,Alive,54.6,high_burden
KE-NRB-2013-02326,2013,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Lost to follow-up,17.8,high_burden
KE-NRB-2016-02327,2016,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,35.4,high_burden
KE-NRB-2017-02328,2017,9,0-14,Female,Cervix uteri,Adenocarcinoma,Unknown,Other,Malignant,Rural,Palliative care only,Alive,30.7,high_burden
KE-NRB-2015-02329,2015,90,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.1,high_burden
KE-NRB-2015-02330,2015,37,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Alive,2.4,high_burden
KE-NRB-2010-02331,2010,59,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.2,high_burden
KE-NRB-2017-02332,2017,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,23.5,high_burden
KE-NRB-2014-02333,2014,47,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.3,high_burden
KE-NRB-2017-02334,2017,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2010-02335,2010,52,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.4,high_burden
KE-NRB-2010-02336,2010,71,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.2,high_burden
KE-NRB-2012-02337,2012,68,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.4,high_burden
KE-NRB-2013-02338,2013,43,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02339,2017,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.7,high_burden
KE-NRB-2010-02340,2010,70,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,7.5,high_burden
KE-NRB-2018-02341,2018,72,65-74,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,18.3,high_burden
KE-NRB-2012-02342,2012,63,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,27.1,high_burden
KE-NRB-2012-02343,2012,65,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.3,high_burden
KE-NRB-2015-02344,2015,45,45-54,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,49.8,high_burden
KE-NRB-2015-02345,2015,90,75+,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,14.9,high_burden
KE-NRB-2017-02346,2017,95,75+,Male,Other,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,8.6,high_burden
KE-NRB-2015-02347,2015,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,20.6,high_burden
KE-NRB-2018-02348,2018,73,65-74,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.8,high_burden
KE-NRB-2013-02349,2013,49,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,10.8,high_burden
KE-NRB-2014-02350,2014,47,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Dead,17.6,high_burden
KE-NRB-2017-02351,2017,64,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,5.0,high_burden
KE-NRB-2013-02352,2013,26,25-34,Female,Breast,Leukemia,Unknown,Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Alive,24.2,high_burden
KE-NRB-2013-02353,2013,22,15-24,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.7,high_burden
KE-NRB-2014-02354,2014,62,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,27.0,high_burden
KE-NRB-2016-02355,2016,84,75+,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,53.8,high_burden
KE-NRB-2010-02356,2010,62,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,5.8,high_burden
KE-NRB-2017-02357,2017,38,35-44,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,22.8,high_burden
KE-NRB-2015-02358,2015,68,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2017-02359,2017,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,32.0,high_burden
KE-NRB-2018-02360,2018,79,75+,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,11.9,high_burden
KE-NRB-2010-02361,2010,59,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,51.5,high_burden
KE-NRB-2012-02362,2012,58,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-02363,2015,79,75+,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,7.6,high_burden
KE-NRB-2017-02364,2017,50,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,53.2,high_burden
KE-NRB-2012-02365,2012,92,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-02366,2016,81,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,34.7,high_burden
KE-NRB-2016-02367,2016,65,65-74,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,38.0,high_burden
KE-NRB-2010-02368,2010,59,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.0,high_burden
KE-NRB-2018-02369,2018,56,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,15.7,high_burden
KE-NRB-2017-02370,2017,4,0-14,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,34.1,high_burden
KE-NRB-2012-02371,2012,61,55-64,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.8,high_burden
KE-NRB-2015-02372,2015,95,75+,Male,Lung,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2009-02373,2009,69,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,8.8,high_burden
KE-NRB-2016-02374,2016,26,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,27.9,high_burden
KE-NRB-2013-02375,2013,25,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.4,high_burden
KE-NRB-2017-02376,2017,74,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,19.0,high_burden
KE-NRB-2016-02377,2016,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,6.1,high_burden
KE-NRB-2018-02378,2018,82,75+,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Other,Benign/uncertain,Urban,N/A,Alive,11.6,high_burden
KE-NRB-2009-02379,2009,59,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,23.5,high_burden
KE-NRB-2018-02380,2018,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,23.7,high_burden
KE-NRB-2016-02381,2016,28,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,19.6,high_burden
KE-NRB-2011-02382,2011,50,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,10.8,high_burden
KE-NRB-2017-02383,2017,71,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,0.2,high_burden
KE-NRB-2017-02384,2017,6,0-14,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2011-02385,2011,47,45-54,Male,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,22.2,high_burden
KE-NRB-2016-02386,2016,49,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,3.6,high_burden
KE-NRB-2013-02387,2013,75,75+,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.5,high_burden
KE-NRB-2016-02388,2016,91,75+,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,7.9,high_burden
KE-NRB-2012-02389,2012,54,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,58.7,high_burden
KE-NRB-2011-02390,2011,44,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.8,high_burden
KE-NRB-2016-02391,2016,47,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,16.2,high_burden
KE-NRB-2011-02392,2011,49,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,57.1,high_burden
KE-NRB-2017-02393,2017,76,75+,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-02394,2016,93,75+,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,47.2,high_burden
KE-NRB-2018-02395,2018,42,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,14.9,high_burden
KE-NRB-2017-02396,2017,72,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,8.5,high_burden
KE-NRB-2014-02397,2014,81,75+,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,10.1,high_burden
KE-NRB-2014-02398,2014,31,25-34,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,31.8,high_burden
KE-NRB-2009-02399,2009,60,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.2,high_burden
KE-NRB-2012-02400,2012,28,25-34,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,8.4,high_burden
KE-NRB-2017-02401,2017,52,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,32.5,high_burden
KE-NRB-2009-02402,2009,75,75+,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-02403,2017,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,15.0,high_burden
KE-NRB-2013-02404,2013,53,45-54,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.0,high_burden
KE-NRB-2009-02405,2009,58,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,57.2,high_burden
KE-NRB-2016-02406,2016,23,15-24,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,34.2,high_burden
KE-NRB-2017-02407,2017,47,45-54,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,12.3,high_burden
KE-NRB-2018-02408,2018,63,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-02409,2013,72,65-74,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,6.8,high_burden
KE-NRB-2013-02410,2013,43,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,3.3,high_burden
KE-NRB-2018-02411,2018,67,65-74,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,35.6,high_burden
KE-NRB-2012-02412,2012,40,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2016-02413,2016,47,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.0,high_burden
KE-NRB-2014-02414,2014,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,29.1,high_burden
KE-NRB-2011-02415,2011,39,35-44,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.0,high_burden
KE-NRB-2010-02416,2010,67,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-02417,2012,37,35-44,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,21.8,high_burden
KE-NRB-2017-02418,2017,58,55-64,Male,Stomach,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.5,high_burden
KE-NRB-2012-02419,2012,60,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-02420,2010,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,32.6,high_burden
KE-NRB-2015-02421,2015,49,45-54,Male,Liver,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,4.4,high_burden
KE-NRB-2011-02422,2011,73,65-74,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,20.8,high_burden
KE-NRB-2017-02423,2017,44,35-44,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,3.3,high_burden
KE-NRB-2015-02424,2015,73,65-74,Male,Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.5,high_burden
KE-NRB-2012-02425,2012,51,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2012-02426,2012,65,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,6.5,high_burden
KE-NRB-2015-02427,2015,35,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,23.3,high_burden
KE-NRB-2011-02428,2011,37,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,3.0,high_burden
KE-NRB-2016-02429,2016,91,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,51.5,high_burden
KE-NRB-2018-02430,2018,68,65-74,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-02431,2010,59,55-64,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,6.4,high_burden
KE-NRB-2011-02432,2011,49,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,46.9,high_burden
KE-NRB-2013-02433,2013,53,45-54,Male,Bladder,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,21.1,high_burden
KE-NRB-2018-02434,2018,64,55-64,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2016-02435,2016,50,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,50.5,high_burden
KE-NRB-2015-02436,2015,37,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,1.3,high_burden
KE-NRB-2010-02437,2010,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,26.6,high_burden
KE-NRB-2011-02438,2011,50,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-02439,2009,45,45-54,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,29.7,high_burden
KE-NRB-2015-02440,2015,73,65-74,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-02441,2013,32,25-34,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,25.4,high_burden
KE-NRB-2012-02442,2012,39,35-44,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Palliative care only,Dead,2.9,high_burden
KE-NRB-2013-02443,2013,47,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,high_burden
KE-NRB-2016-02444,2016,22,15-24,Female,Thyroid,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,16.5,high_burden
KE-NRB-2018-02445,2018,64,55-64,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,3.4,high_burden
KE-NRB-2016-02446,2016,72,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,17.6,high_burden
KE-NRB-2018-02447,2018,48,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,47.1,high_burden
KE-NRB-2011-02448,2011,68,65-74,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,46.6,high_burden
KE-NRB-2018-02449,2018,40,35-44,Female,Other,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02450,2014,27,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,4.4,high_burden
KE-NRB-2013-02451,2013,60,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Rural,Surgery + Chemotherapy,Dead,38.1,high_burden
KE-NRB-2018-02452,2018,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,15.0,high_burden
KE-NRB-2014-02453,2014,59,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.7,high_burden
KE-NRB-2013-02454,2013,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,16.4,high_burden
KE-NRB-2017-02455,2017,53,45-54,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-02456,2013,73,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.8,high_burden
KE-NRB-2011-02457,2011,57,55-64,Male,Colorectum,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,24.6,high_burden
KE-NRB-2017-02458,2017,45,45-54,Male,Stomach,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,16.6,high_burden
KE-NRB-2014-02459,2014,57,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,10.9,high_burden
KE-NRB-2017-02460,2017,50,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-02461,2014,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.8,high_burden
KE-NRB-2018-02462,2018,54,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,15.0,high_burden
KE-NRB-2017-02463,2017,69,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,36.2,high_burden
KE-NRB-2014-02464,2014,66,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.9,high_burden
KE-NRB-2009-02465,2009,42,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.4,high_burden
KE-NRB-2014-02466,2014,73,65-74,Male,Lung,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,6.2,high_burden
KE-NRB-2014-02467,2014,62,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.8,high_burden
KE-NRB-2013-02468,2013,34,25-34,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,23.3,high_burden
KE-NRB-2016-02469,2016,57,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,50.9,high_burden
KE-NRB-2018-02470,2018,63,55-64,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,20.0,high_burden
KE-NRB-2016-02471,2016,44,35-44,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,2.8,high_burden
KE-NRB-2016-02472,2016,71,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,38.4,high_burden
KE-NRB-2014-02473,2014,55,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.8,high_burden
KE-NRB-2011-02474,2011,9,0-14,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.4,high_burden
KE-NRB-2015-02475,2015,67,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.3,high_burden
KE-NRB-2014-02476,2014,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,48.7,high_burden
KE-NRB-2012-02477,2012,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,34.5,high_burden
KE-NRB-2018-02478,2018,52,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,22.8,high_burden
KE-NRB-2015-02479,2015,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-02480,2012,68,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,8.7,high_burden
KE-NRB-2014-02481,2014,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Benign/uncertain,Urban,N/A,Alive,41.2,high_burden
KE-NRB-2018-02482,2018,35,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.0,high_burden
KE-NRB-2010-02483,2010,50,45-54,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,16.3,high_burden
KE-NRB-2014-02484,2014,48,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-02485,2012,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,3.5,high_burden
KE-NRB-2010-02486,2010,64,55-64,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,27.3,high_burden
KE-NRB-2011-02487,2011,31,25-34,Male,Multiple myeloma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,3.4,high_burden
KE-NRB-2011-02488,2011,25,25-34,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,20.1,high_burden
KE-NRB-2010-02489,2010,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,31.9,high_burden
KE-NRB-2016-02490,2016,39,35-44,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,19.8,high_burden
KE-NRB-2018-02491,2018,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,33.9,high_burden
KE-NRB-2017-02492,2017,28,25-34,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02493,2017,52,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-02494,2009,42,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-02495,2017,63,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-02496,2017,42,35-44,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.8,high_burden
KE-NRB-2018-02497,2018,59,55-64,Male,Skin (melanoma),Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,52.0,high_burden
KE-NRB-2013-02498,2013,27,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,16.8,high_burden
KE-NRB-2013-02499,2013,60,55-64,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-02500,2013,49,45-54,Male,Liver,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,10.5,high_burden
KE-NRB-2017-02501,2017,34,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Rural,Surgery + Chemotherapy,Alive,27.7,high_burden
KE-NRB-2018-02502,2018,43,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,7.5,high_burden
KE-NRB-2012-02503,2012,46,45-54,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-02504,2011,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.0,high_burden
KE-NRB-2013-02505,2013,83,75+,Female,Breast,Other specified,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2012-02506,2012,65,65-74,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,20.6,high_burden
KE-NRB-2013-02507,2013,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,41.0,high_burden
KE-NRB-2014-02508,2014,3,0-14,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.3,high_burden
KE-NRB-2014-02509,2014,38,35-44,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Dead,1.2,high_burden
KE-NRB-2014-02510,2014,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,32.4,high_burden
KE-NRB-2014-02511,2014,62,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,2.4,high_burden
KE-NRB-2010-02512,2010,63,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,56.7,high_burden
KE-NRB-2015-02513,2015,64,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,25.1,high_burden
KE-NRB-2014-02514,2014,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,1.7,high_burden
KE-NRB-2018-02515,2018,72,65-74,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.0,high_burden
KE-NRB-2017-02516,2017,60,55-64,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.8,high_burden
KE-NRB-2013-02517,2013,64,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-02518,2011,72,65-74,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.8,high_burden
KE-NRB-2015-02519,2015,38,35-44,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,40.5,high_burden
KE-NRB-2017-02520,2017,63,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.1,high_burden
KE-NRB-2009-02521,2009,28,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,26.1,high_burden
KE-NRB-2014-02522,2014,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,45.6,high_burden
KE-NRB-2018-02523,2018,47,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,28.8,high_burden
KE-NRB-2017-02524,2017,63,55-64,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.2,high_burden
KE-NRB-2014-02525,2014,60,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,24.3,high_burden
KE-NRB-2016-02526,2016,69,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-02527,2018,57,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,31.0,high_burden
KE-NRB-2014-02528,2014,87,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.7,high_burden
KE-NRB-2017-02529,2017,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,18.9,high_burden
KE-NRB-2017-02530,2017,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-02531,2015,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,13.5,high_burden
KE-NRB-2010-02532,2010,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,50.0,high_burden
KE-NRB-2014-02533,2014,27,25-34,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,6.8,high_burden
KE-NRB-2014-02534,2014,52,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Alive,27.1,high_burden
KE-NRB-2017-02535,2017,55,55-64,Male,Lung,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,36.4,high_burden
KE-NRB-2012-02536,2012,25,25-34,Male,Liver,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,8.7,high_burden
KE-NRB-2017-02537,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.4,high_burden
KE-NRB-2016-02538,2016,38,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.8,high_burden
KE-NRB-2009-02539,2009,50,45-54,Female,Breast,Adenocarcinoma,Unknown,Clinical only,In situ,Urban,N/A,Dead,9.0,high_burden
KE-NRB-2015-02540,2015,35,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,20.5,high_burden
KE-NRB-2010-02541,2010,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-02542,2011,32,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,39.6,high_burden
KE-NRB-2013-02543,2013,64,55-64,Male,Non-Hodgkin lymphoma,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-02544,2010,54,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,1.6,high_burden
KE-NRB-2016-02545,2016,39,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,41.6,high_burden
KE-NRB-2011-02546,2011,37,35-44,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,24.9,high_burden
KE-NRB-2014-02547,2014,70,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,22.0,high_burden
KE-NRB-2014-02548,2014,40,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,23.8,high_burden
KE-NRB-2017-02549,2017,32,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.2,high_burden
KE-NRB-2017-02550,2017,84,75+,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,60.0,high_burden
KE-NRB-2010-02551,2010,47,45-54,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,54.9,high_burden
KE-NRB-2014-02552,2014,41,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2017-02553,2017,84,75+,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-02554,2009,54,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-02555,2015,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,26.8,high_burden
KE-NRB-2016-02556,2016,70,65-74,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,12.2,high_burden
KE-NRB-2018-02557,2018,66,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,51.5,high_burden
KE-NRB-2017-02558,2017,57,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,33.4,high_burden
KE-NRB-2013-02559,2013,40,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,13.4,high_burden
KE-NRB-2010-02560,2010,65,65-74,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.0,high_burden
KE-NRB-2018-02561,2018,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,3.3,high_burden
KE-NRB-2014-02562,2014,64,55-64,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-02563,2013,46,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-02564,2014,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,No treatment,Alive,16.5,high_burden
KE-NRB-2013-02565,2013,67,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Dead,20.8,high_burden
KE-NRB-2011-02566,2011,64,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.8,high_burden
KE-NRB-2017-02567,2017,48,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.1,high_burden
KE-NRB-2014-02568,2014,64,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,No treatment,Dead,4.4,high_burden
KE-NRB-2017-02569,2017,45,45-54,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,22.4,high_burden
KE-NRB-2014-02570,2014,63,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,16.7,high_burden
KE-NRB-2010-02571,2010,95,75+,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-02572,2012,39,35-44,Male,Prostate,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,53.4,high_burden
KE-NRB-2014-02573,2014,38,35-44,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,8.3,high_burden
KE-NRB-2009-02574,2009,40,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,28.4,high_burden
KE-NRB-2015-02575,2015,93,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-02576,2014,15,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,41.1,high_burden
KE-NRB-2018-02577,2018,66,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-02578,2010,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,44.8,high_burden
KE-NRB-2015-02579,2015,54,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-02580,2016,69,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Alive,8.9,high_burden
KE-NRB-2014-02581,2014,70,65-74,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,17.1,high_burden
KE-NRB-2014-02582,2014,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.0,high_burden
KE-NRB-2015-02583,2015,78,75+,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,17.5,high_burden
KE-NRB-2012-02584,2012,72,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Dead,60.0,high_burden
KE-NRB-2010-02585,2010,30,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,0.8,high_burden
KE-NRB-2018-02586,2018,30,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.4,high_burden
KE-NRB-2013-02587,2013,62,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,11.3,high_burden
KE-NRB-2018-02588,2018,57,55-64,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,13.3,high_burden
KE-NRB-2016-02589,2016,43,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-02590,2013,58,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,9.2,high_burden
KE-NRB-2009-02591,2009,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.3,high_burden
KE-NRB-2012-02592,2012,80,75+,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,2.5,high_burden
KE-NRB-2012-02593,2012,58,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,16.4,high_burden
KE-NRB-2009-02594,2009,16,15-24,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-02595,2011,61,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.8,high_burden
KE-NRB-2017-02596,2017,31,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-02597,2012,43,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.6,high_burden
KE-NRB-2015-02598,2015,40,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,15.3,high_burden
KE-NRB-2018-02599,2018,45,45-54,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.4,high_burden
KE-NRB-2018-02600,2018,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,4.5,high_burden
KE-NRB-2015-02601,2015,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-02602,2011,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.4,high_burden
KE-NRB-2017-02603,2017,64,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-02604,2012,72,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,34.6,high_burden
KE-NRB-2014-02605,2014,20,15-24,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,27.1,high_burden
KE-NRB-2011-02606,2011,48,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Palliative care only,Dead,11.4,high_burden
KE-NRB-2017-02607,2017,25,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,49.2,high_burden
KE-NRB-2010-02608,2010,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,45.7,high_burden
KE-NRB-2016-02609,2016,43,35-44,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.8,high_burden
KE-NRB-2014-02610,2014,50,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,11.1,high_burden
KE-NRB-2015-02611,2015,64,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.2,high_burden
KE-NRB-2016-02612,2016,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,59.2,high_burden
KE-NRB-2013-02613,2013,51,45-54,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.0,high_burden
KE-NRB-2016-02614,2016,44,35-44,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,48.8,high_burden
KE-NRB-2015-02615,2015,72,65-74,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.2,high_burden
KE-NRB-2017-02616,2017,70,65-74,Male,Kidney,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,33.0,high_burden
KE-NRB-2012-02617,2012,27,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,21.1,high_burden
KE-NRB-2015-02618,2015,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,15.6,high_burden
KE-NRB-2014-02619,2014,27,25-34,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.1,high_burden
KE-NRB-2009-02620,2009,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,38.0,high_burden
KE-NRB-2018-02621,2018,47,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.0,high_burden
KE-NRB-2018-02622,2018,36,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,11.3,high_burden
KE-NRB-2016-02623,2016,61,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,22.7,high_burden
KE-NRB-2015-02624,2015,51,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,9.0,high_burden
KE-NRB-2017-02625,2017,66,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,10.3,high_burden
KE-NRB-2018-02626,2018,31,25-34,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,39.9,high_burden
KE-NRB-2013-02627,2013,39,35-44,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Dead,6.7,high_burden
KE-NRB-2012-02628,2012,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.7,high_burden
KE-NRB-2018-02629,2018,35,35-44,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-02630,2009,55,55-64,Female,Ovary,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2014-02631,2014,71,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,59.5,high_burden
KE-NRB-2015-02632,2015,95,75+,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,2.2,high_burden
KE-NRB-2016-02633,2016,37,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2011-02634,2011,59,55-64,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.0,high_burden
KE-NRB-2013-02635,2013,74,65-74,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,18.6,high_burden
KE-NRB-2014-02636,2014,32,25-34,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.0,high_burden
KE-NRB-2015-02637,2015,65,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-02638,2012,63,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,14.8,high_burden
KE-NRB-2013-02639,2013,46,45-54,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,12.5,high_burden
KE-NRB-2009-02640,2009,43,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,56.9,high_burden
KE-NRB-2010-02641,2010,65,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,16.8,high_burden
KE-NRB-2012-02642,2012,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,20.2,high_burden
KE-NRB-2015-02643,2015,68,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,29.2,high_burden
KE-NRB-2015-02644,2015,56,55-64,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,14.6,high_burden
KE-NRB-2013-02645,2013,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.2,high_burden
KE-NRB-2015-02646,2015,56,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,24.9,high_burden
KE-NRB-2010-02647,2010,74,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-02648,2016,41,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,27.1,high_burden
KE-NRB-2016-02649,2016,20,15-24,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.0,high_burden
KE-NRB-2016-02650,2016,40,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.9,high_burden
KE-NRB-2018-02651,2018,67,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,7.9,high_burden
KE-NRB-2009-02652,2009,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,29.1,high_burden
KE-NRB-2011-02653,2011,53,45-54,Male,Other,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,31.3,high_burden
KE-NRB-2017-02654,2017,58,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,22.8,high_burden
KE-NRB-2018-02655,2018,52,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-02656,2010,57,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.1,high_burden
KE-NRB-2016-02657,2016,65,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,14.1,high_burden
KE-NRB-2010-02658,2010,28,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-02659,2016,47,45-54,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,high_burden
KE-NRB-2010-02660,2010,21,15-24,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.2,high_burden
KE-NRB-2016-02661,2016,51,45-54,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,3.3,high_burden
KE-NRB-2018-02662,2018,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,13.7,high_burden
KE-NRB-2018-02663,2018,26,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-02664,2011,38,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,58.7,high_burden
KE-NRB-2014-02665,2014,44,35-44,Male,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.0,high_burden
KE-NRB-2010-02666,2010,38,35-44,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,28.9,high_burden
KE-NRB-2018-02667,2018,29,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.7,high_burden
KE-NRB-2018-02668,2018,45,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,40.9,high_burden
KE-NRB-2014-02669,2014,62,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.0,high_burden
KE-NRB-2010-02670,2010,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Rural,N/A,Alive,1.1,high_burden
KE-NRB-2014-02671,2014,49,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,55.2,high_burden
KE-NRB-2013-02672,2013,59,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2010-02673,2010,49,45-54,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2013-02674,2013,35,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,12.2,high_burden
KE-NRB-2009-02675,2009,80,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2015-02676,2015,26,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,8.5,high_burden
KE-NRB-2015-02677,2015,54,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02678,2017,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Palliative care only,Dead,0.7,high_burden
KE-NRB-2010-02679,2010,52,45-54,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-02680,2012,60,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02681,2017,55,55-64,Male,Bladder,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-02682,2015,45,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,2.4,high_burden
KE-NRB-2016-02683,2016,77,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,21.7,high_burden
KE-NRB-2010-02684,2010,44,35-44,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,10.5,high_burden
KE-NRB-2017-02685,2017,62,55-64,Male,Pancreas,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.0,high_burden
KE-NRB-2013-02686,2013,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,23.0,high_burden
KE-NRB-2012-02687,2012,82,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,3.4,high_burden
KE-NRB-2017-02688,2017,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,12.3,high_burden
KE-NRB-2013-02689,2013,73,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2016-02690,2016,54,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-02691,2015,73,65-74,Female,Breast,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,5.7,high_burden
KE-NRB-2017-02692,2017,30,25-34,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-02693,2009,50,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,4.4,high_burden
KE-NRB-2014-02694,2014,48,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Lost to follow-up,24.4,high_burden
KE-NRB-2011-02695,2011,54,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,10.9,high_burden
KE-NRB-2009-02696,2009,50,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.4,high_burden
KE-NRB-2013-02697,2013,81,75+,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,26.6,high_burden
KE-NRB-2011-02698,2011,49,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,0.7,high_burden
KE-NRB-2016-02699,2016,19,15-24,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,In situ,Urban,N/A,Dead,21.1,high_burden
KE-NRB-2014-02700,2014,49,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,0.1,high_burden
KE-NRB-2015-02701,2015,73,65-74,Male,Colorectum,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.6,high_burden
KE-NRB-2018-02702,2018,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,40.0,high_burden
KE-NRB-2011-02703,2011,49,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.7,high_burden
KE-NRB-2015-02704,2015,42,35-44,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-02705,2011,73,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.0,high_burden
KE-NRB-2011-02706,2011,79,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-02707,2017,54,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.2,high_burden
KE-NRB-2010-02708,2010,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.6,high_burden
KE-NRB-2011-02709,2011,33,25-34,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,10.9,high_burden
KE-NRB-2014-02710,2014,67,65-74,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-02711,2017,73,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,30.8,high_burden
KE-NRB-2015-02712,2015,32,25-34,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2014-02713,2014,41,35-44,Male,Skin (melanoma),Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,26.9,high_burden
KE-NRB-2017-02714,2017,64,55-64,Male,Stomach,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,7.0,high_burden
KE-NRB-2010-02715,2010,29,25-34,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,53.1,high_burden
KE-NRB-2017-02716,2017,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.0,high_burden
KE-NRB-2010-02717,2010,64,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-02718,2018,46,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,3.7,high_burden
KE-NRB-2010-02719,2010,71,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.6,high_burden
KE-NRB-2015-02720,2015,71,65-74,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-02721,2018,60,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2014-02722,2014,35,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-02723,2014,46,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,2.8,high_burden
KE-NRB-2017-02724,2017,47,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Alive,42.0,high_burden
KE-NRB-2017-02725,2017,60,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-02726,2017,38,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,1.2,high_burden
KE-NRB-2016-02727,2016,68,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-02728,2013,30,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.4,high_burden
KE-NRB-2010-02729,2010,58,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.0,high_burden
KE-NRB-2014-02730,2014,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,31.4,high_burden
KE-NRB-2013-02731,2013,49,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.8,high_burden
KE-NRB-2017-02732,2017,29,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-02733,2012,57,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,10.2,high_burden
KE-NRB-2015-02734,2015,71,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,25.5,high_burden
KE-NRB-2017-02735,2017,48,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,27.9,high_burden
KE-NRB-2017-02736,2017,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,24.3,high_burden
KE-NRB-2011-02737,2011,14,0-14,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,In situ,Urban,N/A,Dead,11.0,high_burden
KE-NRB-2018-02738,2018,27,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.9,high_burden
KE-NRB-2009-02739,2009,62,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2017-02740,2017,16,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,16.6,high_burden
KE-NRB-2009-02741,2009,66,65-74,Female,Breast,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Dead,36.5,high_burden
KE-NRB-2010-02742,2010,52,45-54,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,30.6,high_burden
KE-NRB-2016-02743,2016,92,75+,Male,Kaposi sarcoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.8,high_burden
KE-NRB-2011-02744,2011,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,46.5,high_burden
KE-NRB-2013-02745,2013,65,65-74,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,4.9,high_burden
KE-NRB-2011-02746,2011,88,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-02747,2009,67,65-74,Male,Leukemia,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.5,high_burden
KE-NRB-2009-02748,2009,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,30.3,high_burden
KE-NRB-2016-02749,2016,39,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.2,high_burden
KE-NRB-2018-02750,2018,7,0-14,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.9,high_burden
KE-NRB-2010-02751,2010,70,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,No treatment,Dead,24.4,high_burden
KE-NRB-2016-02752,2016,50,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.9,high_burden
KE-NRB-2013-02753,2013,30,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,14.1,high_burden
KE-NRB-2016-02754,2016,45,45-54,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.6,high_burden
KE-NRB-2017-02755,2017,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,6.7,high_burden
KE-NRB-2014-02756,2014,69,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,1.6,high_burden
KE-NRB-2014-02757,2014,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,26.2,high_burden
KE-NRB-2018-02758,2018,31,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,25.4,high_burden
KE-NRB-2014-02759,2014,24,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,25.2,high_burden
KE-NRB-2013-02760,2013,51,45-54,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.2,high_burden
KE-NRB-2016-02761,2016,49,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-02762,2014,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,36.5,high_burden
KE-NRB-2016-02763,2016,60,55-64,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-02764,2015,55,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,37.9,high_burden
KE-NRB-2012-02765,2012,43,35-44,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.1,high_burden
KE-NRB-2016-02766,2016,35,35-44,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,48.3,high_burden
KE-NRB-2011-02767,2011,47,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,9.9,high_burden
KE-NRB-2016-02768,2016,56,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2018-02769,2018,44,35-44,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.0,high_burden
KE-NRB-2016-02770,2016,61,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,18.3,high_burden
KE-NRB-2016-02771,2016,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,57.0,high_burden
KE-NRB-2017-02772,2017,56,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.2,high_burden
KE-NRB-2010-02773,2010,35,35-44,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.1,high_burden
KE-NRB-2009-02774,2009,69,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,55.8,high_burden
KE-NRB-2014-02775,2014,63,55-64,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,40.4,high_burden
KE-NRB-2017-02776,2017,69,65-74,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,2.8,high_burden
KE-NRB-2010-02777,2010,34,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,9.4,high_burden
KE-NRB-2016-02778,2016,57,55-64,Male,Oesophagus,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.3,high_burden
KE-NRB-2013-02779,2013,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,3.2,high_burden
KE-NRB-2016-02780,2016,51,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,14.5,high_burden
KE-NRB-2016-02781,2016,57,55-64,Male,Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,45.0,high_burden
KE-NRB-2014-02782,2014,40,35-44,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,28.4,high_burden
KE-NRB-2009-02783,2009,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,12.0,high_burden
KE-NRB-2018-02784,2018,51,45-54,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,12.8,high_burden
KE-NRB-2014-02785,2014,72,65-74,Male,Oesophagus,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.7,high_burden
KE-NRB-2018-02786,2018,25,25-34,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,47.3,high_burden
KE-NRB-2013-02787,2013,42,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-02788,2014,62,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.0,high_burden
KE-NRB-2011-02789,2011,34,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,31.2,high_burden
KE-NRB-2017-02790,2017,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,28.7,high_burden
KE-NRB-2018-02791,2018,59,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.3,high_burden
KE-NRB-2010-02792,2010,48,45-54,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,28.2,high_burden
KE-NRB-2016-02793,2016,72,65-74,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02794,2014,64,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-02795,2018,59,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,12.5,high_burden
KE-NRB-2015-02796,2015,58,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.3,high_burden
KE-NRB-2014-02797,2014,39,35-44,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,17.6,high_burden
KE-NRB-2011-02798,2011,34,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,12.7,high_burden
KE-NRB-2010-02799,2010,63,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2010-02800,2010,91,75+,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,10.6,high_burden
KE-NRB-2016-02801,2016,50,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,39.3,high_burden
KE-NRB-2011-02802,2011,35,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-02803,2010,59,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,24.4,high_burden
KE-NRB-2012-02804,2012,58,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,25.8,high_burden
KE-NRB-2016-02805,2016,64,55-64,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,35.0,high_burden
KE-NRB-2011-02806,2011,57,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.3,high_burden
KE-NRB-2017-02807,2017,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-02808,2012,82,75+,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-02809,2018,44,35-44,Male,Pancreas,Sarcoma,Unknown,Imaging + clinical,In situ,Peri-urban,N/A,Alive,34.7,high_burden
KE-NRB-2012-02810,2012,58,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,18.8,high_burden
KE-NRB-2017-02811,2017,16,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,6.9,high_burden
KE-NRB-2015-02812,2015,67,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,11.9,high_burden
KE-NRB-2010-02813,2010,46,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.6,high_burden
KE-NRB-2015-02814,2015,59,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,32.7,high_burden
KE-NRB-2016-02815,2016,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,43.3,high_burden
KE-NRB-2017-02816,2017,28,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,12.6,high_burden
KE-NRB-2010-02817,2010,72,65-74,Male,Pancreas,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,28.2,high_burden
KE-NRB-2011-02818,2011,77,75+,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,36.4,high_burden
KE-NRB-2014-02819,2014,7,0-14,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,55.4,high_burden
KE-NRB-2018-02820,2018,37,35-44,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-02821,2018,66,65-74,Male,Non-Hodgkin lymphoma,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,16.8,high_burden
KE-NRB-2016-02822,2016,64,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,20.8,high_burden
KE-NRB-2018-02823,2018,85,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-02824,2009,54,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,1.8,high_burden
KE-NRB-2013-02825,2013,43,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.7,high_burden
KE-NRB-2015-02826,2015,40,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2015-02827,2015,69,65-74,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,30.0,high_burden
KE-NRB-2015-02828,2015,68,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,30.8,high_burden
KE-NRB-2016-02829,2016,28,25-34,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,57.7,high_burden
KE-NRB-2014-02830,2014,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,47.9,high_burden
KE-NRB-2013-02831,2013,46,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,38.4,high_burden
KE-NRB-2017-02832,2017,49,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,34.9,high_burden
KE-NRB-2016-02833,2016,67,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,33.2,high_burden
KE-NRB-2018-02834,2018,42,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,19.1,high_burden
KE-NRB-2013-02835,2013,42,35-44,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.1,high_burden
KE-NRB-2013-02836,2013,54,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,28.8,high_burden
KE-NRB-2017-02837,2017,67,65-74,Male,Kidney,Other specified,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,45.2,high_burden
KE-NRB-2017-02838,2017,37,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,11.0,high_burden
KE-NRB-2009-02839,2009,38,35-44,Female,Other,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Radiotherapy only,Dead,2.0,high_burden
KE-NRB-2018-02840,2018,60,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,19.0,high_burden
KE-NRB-2013-02841,2013,39,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,60.0,high_burden
KE-NRB-2016-02842,2016,48,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,1.7,high_burden
KE-NRB-2015-02843,2015,60,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,40.6,high_burden
KE-NRB-2016-02844,2016,42,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Lost to follow-up,3.3,high_burden
KE-NRB-2016-02845,2016,62,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,44.3,high_burden
KE-NRB-2018-02846,2018,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-02847,2010,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-02848,2013,30,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,high_burden
KE-NRB-2018-02849,2018,44,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,21.4,high_burden
KE-NRB-2015-02850,2015,52,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2014-02851,2014,23,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-02852,2018,51,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,23.4,high_burden
KE-NRB-2016-02853,2016,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,11.8,high_burden
KE-NRB-2013-02854,2013,29,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.8,high_burden
KE-NRB-2010-02855,2010,71,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,34.9,high_burden
KE-NRB-2016-02856,2016,47,45-54,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,38.8,high_burden
KE-NRB-2015-02857,2015,47,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.8,high_burden
KE-NRB-2018-02858,2018,32,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,59.0,high_burden
KE-NRB-2013-02859,2013,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,17.0,high_burden
KE-NRB-2018-02860,2018,45,45-54,Male,Oesophagus,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,23.7,high_burden
KE-NRB-2013-02861,2013,73,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,48.4,high_burden
KE-NRB-2012-02862,2012,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-02863,2018,44,35-44,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,43.8,high_burden
KE-NRB-2018-02864,2018,38,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-02865,2013,53,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,47.6,high_burden
KE-NRB-2011-02866,2011,48,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,22.8,high_burden
KE-NRB-2017-02867,2017,36,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,29.8,high_burden
KE-NRB-2018-02868,2018,41,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.1,high_burden
KE-NRB-2014-02869,2014,41,35-44,Male,Bladder,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.4,high_burden
KE-NRB-2016-02870,2016,88,75+,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.6,high_burden
KE-NRB-2017-02871,2017,64,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-02872,2011,45,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-02873,2018,67,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Rural,N/A,Dead,23.2,high_burden
KE-NRB-2014-02874,2014,55,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-02875,2013,19,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,41.3,high_burden
KE-NRB-2012-02876,2012,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.1,high_burden
KE-NRB-2016-02877,2016,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-02878,2009,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.1,high_burden
KE-NRB-2018-02879,2018,35,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,32.2,high_burden
KE-NRB-2012-02880,2012,46,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,43.9,high_burden
KE-NRB-2018-02881,2018,64,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,5.7,high_burden
KE-NRB-2016-02882,2016,54,45-54,Male,Kidney,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02883,2014,45,45-54,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.3,high_burden
KE-NRB-2012-02884,2012,73,65-74,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.0,high_burden
KE-NRB-2010-02885,2010,17,15-24,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,57.2,high_burden
KE-NRB-2014-02886,2014,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-02887,2016,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,0.6,high_burden
KE-NRB-2013-02888,2013,40,35-44,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2015-02889,2015,68,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02890,2014,60,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Peri-urban,N/A,Alive,4.1,high_burden
KE-NRB-2017-02891,2017,34,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,19.6,high_burden
KE-NRB-2017-02892,2017,50,45-54,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.0,high_burden
KE-NRB-2017-02893,2017,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.8,high_burden
KE-NRB-2016-02894,2016,50,45-54,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-02895,2013,64,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.3,high_burden
KE-NRB-2009-02896,2009,69,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-02897,2013,59,55-64,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,33.8,high_burden
KE-NRB-2009-02898,2009,55,55-64,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.3,high_burden
KE-NRB-2013-02899,2013,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,14.5,high_burden
KE-NRB-2013-02900,2013,28,25-34,Female,Ovary,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,17.3,high_burden
KE-NRB-2017-02901,2017,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.1,high_burden
KE-NRB-2010-02902,2010,48,45-54,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.8,high_burden
KE-NRB-2017-02903,2017,49,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,8.1,high_burden
KE-NRB-2011-02904,2011,69,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-02905,2010,30,25-34,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.9,high_burden
KE-NRB-2017-02906,2017,79,75+,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,13.2,high_burden
KE-NRB-2016-02907,2016,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.9,high_burden
KE-NRB-2018-02908,2018,26,25-34,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,40.7,high_burden
KE-NRB-2011-02909,2011,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.7,high_burden
KE-NRB-2013-02910,2013,64,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,28.0,high_burden
KE-NRB-2014-02911,2014,35,35-44,Male,Skin (melanoma),Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-02912,2011,61,55-64,Male,Pancreas,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.6,high_burden
KE-NRB-2012-02913,2012,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,35.5,high_burden
KE-NRB-2017-02914,2017,70,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.9,high_burden
KE-NRB-2015-02915,2015,60,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,19.5,high_burden
KE-NRB-2012-02916,2012,77,75+,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,25.0,high_burden
KE-NRB-2016-02917,2016,74,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,26.9,high_burden
KE-NRB-2012-02918,2012,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,12.2,high_burden
KE-NRB-2014-02919,2014,46,45-54,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Other,Malignant,Urban,Palliative care only,Dead,31.2,high_burden
KE-NRB-2016-02920,2016,20,15-24,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,58.6,high_burden
KE-NRB-2017-02921,2017,51,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,23.4,high_burden
KE-NRB-2017-02922,2017,39,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02923,2014,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,58.6,high_burden
KE-NRB-2018-02924,2018,42,35-44,Male,Stomach,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,18.2,high_burden
KE-NRB-2016-02925,2016,87,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.2,high_burden
KE-NRB-2016-02926,2016,80,75+,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,32.8,high_burden
KE-NRB-2010-02927,2010,52,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.9,high_burden
KE-NRB-2017-02928,2017,27,25-34,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,30.9,high_burden
KE-NRB-2010-02929,2010,56,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,22.1,high_burden
KE-NRB-2016-02930,2016,63,55-64,Male,Colorectum,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.8,high_burden
KE-NRB-2018-02931,2018,23,15-24,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2018-02932,2018,74,65-74,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,36.2,high_burden
KE-NRB-2015-02933,2015,64,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.7,high_burden
KE-NRB-2016-02934,2016,54,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-02935,2011,56,55-64,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,0.4,high_burden
KE-NRB-2013-02936,2013,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,22.0,high_burden
KE-NRB-2016-02937,2016,49,45-54,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,29.5,high_burden
KE-NRB-2017-02938,2017,33,25-34,Male,Prostate,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,23.1,high_burden
KE-NRB-2018-02939,2018,52,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,45.9,high_burden
KE-NRB-2016-02940,2016,68,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.3,high_burden
KE-NRB-2012-02941,2012,68,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,48.2,high_burden
KE-NRB-2009-02942,2009,31,25-34,Male,Kidney,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.3,high_burden
KE-NRB-2017-02943,2017,56,55-64,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-02944,2017,68,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.4,high_burden
KE-NRB-2017-02945,2017,48,45-54,Female,Breast,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-02946,2014,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.8,high_burden
KE-NRB-2018-02947,2018,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.2,high_burden
KE-NRB-2013-02948,2013,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,19.9,high_burden
KE-NRB-2014-02949,2014,48,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Peri-urban,N/A,Dead,20.7,high_burden
KE-NRB-2015-02950,2015,84,75+,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,34.5,high_burden
KE-NRB-2012-02951,2012,93,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,9.0,high_burden
KE-NRB-2009-02952,2009,48,45-54,Male,Lung,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.5,high_burden
KE-NRB-2017-02953,2017,47,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,28.7,high_burden
KE-NRB-2010-02954,2010,70,65-74,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.6,high_burden
KE-NRB-2012-02955,2012,36,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,36.9,high_burden
KE-NRB-2018-02956,2018,64,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.3,high_burden
KE-NRB-2015-02957,2015,66,65-74,Male,Bladder,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-02958,2016,55,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,23.3,high_burden
KE-NRB-2011-02959,2011,41,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,32.6,high_burden
KE-NRB-2010-02960,2010,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,3.9,high_burden
KE-NRB-2016-02961,2016,45,45-54,Male,Liver,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2016-02962,2016,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,21.6,high_burden
KE-NRB-2016-02963,2016,72,65-74,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.0,high_burden
KE-NRB-2013-02964,2013,62,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-02965,2017,30,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,23.1,high_burden
KE-NRB-2018-02966,2018,16,15-24,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.3,high_burden
KE-NRB-2012-02967,2012,78,75+,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-02968,2013,90,75+,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-02969,2013,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-02970,2009,55,55-64,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.7,high_burden
KE-NRB-2018-02971,2018,41,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,41.9,high_burden
KE-NRB-2013-02972,2013,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.7,high_burden
KE-NRB-2014-02973,2014,49,45-54,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Alive,19.8,high_burden
KE-NRB-2018-02974,2018,55,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.5,high_burden
KE-NRB-2010-02975,2010,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,55.0,high_burden
KE-NRB-2010-02976,2010,72,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,4.6,high_burden
KE-NRB-2010-02977,2010,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,9.2,high_burden
KE-NRB-2012-02978,2012,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2017-02979,2017,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-02980,2012,47,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,34.4,high_burden
KE-NRB-2013-02981,2013,67,65-74,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,2.6,high_burden
KE-NRB-2010-02982,2010,31,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,32.0,high_burden
KE-NRB-2018-02983,2018,60,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-02984,2013,59,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.0,high_burden
KE-NRB-2010-02985,2010,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Dead,43.7,high_burden
KE-NRB-2018-02986,2018,72,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,12.6,high_burden
KE-NRB-2011-02987,2011,41,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,55.2,high_burden
KE-NRB-2017-02988,2017,54,45-54,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,2.8,high_burden
KE-NRB-2015-02989,2015,30,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-02990,2018,46,45-54,Male,Stomach,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.1,high_burden
KE-NRB-2016-02991,2016,39,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.6,high_burden
KE-NRB-2011-02992,2011,17,15-24,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,58.1,high_burden
KE-NRB-2015-02993,2015,58,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,5.9,high_burden
KE-NRB-2016-02994,2016,78,75+,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-02995,2018,64,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,36.0,high_burden
KE-NRB-2012-02996,2012,68,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.1,high_burden
KE-NRB-2014-02997,2014,75,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,5.4,high_burden
KE-NRB-2018-02998,2018,74,65-74,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,4.1,high_burden
KE-NRB-2017-02999,2017,45,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,44.5,high_burden
KE-NRB-2012-03000,2012,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.0,high_burden
KE-NRB-2017-03001,2017,47,45-54,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.4,high_burden
KE-NRB-2011-03002,2011,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.0,high_burden
KE-NRB-2009-03003,2009,37,35-44,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.5,high_burden
KE-NRB-2016-03004,2016,60,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.5,high_burden
KE-NRB-2014-03005,2014,58,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.7,high_burden
KE-NRB-2016-03006,2016,50,45-54,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.5,high_burden
KE-NRB-2016-03007,2016,58,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.7,high_burden
KE-NRB-2018-03008,2018,62,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,11.3,high_burden
KE-NRB-2015-03009,2015,45,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,15.0,high_burden
KE-NRB-2017-03010,2017,28,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.5,high_burden
KE-NRB-2015-03011,2015,39,35-44,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Radiotherapy only,Lost to follow-up,15.9,high_burden
KE-NRB-2014-03012,2014,79,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,4.5,high_burden
KE-NRB-2017-03013,2017,66,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-03014,2014,38,35-44,Male,Pancreas,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,21.2,high_burden
KE-NRB-2018-03015,2018,72,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,23.5,high_burden
KE-NRB-2017-03016,2017,57,55-64,Female,Corpus uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,34.6,high_burden
KE-NRB-2016-03017,2016,91,75+,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,39.3,high_burden
KE-NRB-2009-03018,2009,68,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.9,high_burden
KE-NRB-2016-03019,2016,11,0-14,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,15.8,high_burden
KE-NRB-2017-03020,2017,61,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,44.5,high_burden
KE-NRB-2010-03021,2010,11,0-14,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.6,high_burden
KE-NRB-2014-03022,2014,53,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.6,high_burden
KE-NRB-2015-03023,2015,68,65-74,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,36.3,high_burden
KE-NRB-2012-03024,2012,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.9,high_burden
KE-NRB-2012-03025,2012,59,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,40.0,high_burden
KE-NRB-2009-03026,2009,38,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Alive,48.3,high_burden
KE-NRB-2017-03027,2017,72,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,12.8,high_burden
KE-NRB-2013-03028,2013,46,45-54,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,56.2,high_burden
KE-NRB-2014-03029,2014,69,65-74,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,46.2,high_burden
KE-NRB-2014-03030,2014,33,25-34,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,4.5,high_burden
KE-NRB-2013-03031,2013,57,55-64,Female,Thyroid,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,51.2,high_burden
KE-NRB-2016-03032,2016,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-03033,2018,55,55-64,Male,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,52.8,high_burden
KE-NRB-2017-03034,2017,57,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-03035,2015,31,25-34,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.6,high_burden
KE-NRB-2011-03036,2011,63,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,3.8,high_burden
KE-NRB-2018-03037,2018,37,35-44,Male,Stomach,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,13.2,high_burden
KE-NRB-2017-03038,2017,64,55-64,Male,Lung,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,19.3,high_burden
KE-NRB-2017-03039,2017,40,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,53.4,high_burden
KE-NRB-2015-03040,2015,48,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,46.1,high_burden
KE-NRB-2011-03041,2011,58,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.8,high_burden
KE-NRB-2017-03042,2017,48,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.7,high_burden
KE-NRB-2009-03043,2009,19,15-24,Male,Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,1.8,high_burden
KE-NRB-2017-03044,2017,37,35-44,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.3,high_burden
KE-NRB-2009-03045,2009,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,18.1,high_burden
KE-NRB-2013-03046,2013,83,75+,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,11.8,high_burden
KE-NRB-2016-03047,2016,48,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.2,high_burden
KE-NRB-2017-03048,2017,22,15-24,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,4.1,high_burden
KE-NRB-2009-03049,2009,14,0-14,Male,Kaposi sarcoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,8.5,high_burden
KE-NRB-2015-03050,2015,73,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.4,high_burden
KE-NRB-2016-03051,2016,11,0-14,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,58.0,high_burden
KE-NRB-2015-03052,2015,53,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,50.8,high_burden
KE-NRB-2017-03053,2017,60,55-64,Male,Lung,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.3,high_burden
KE-NRB-2017-03054,2017,57,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,58.5,high_burden
KE-NRB-2012-03055,2012,62,55-64,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.7,high_burden
KE-NRB-2018-03056,2018,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-03057,2018,70,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,15.2,high_burden
KE-NRB-2015-03058,2015,50,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.6,high_burden
KE-NRB-2016-03059,2016,72,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,2.1,high_burden
KE-NRB-2015-03060,2015,30,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2015-03061,2015,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.0,high_burden
KE-NRB-2012-03062,2012,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,33.7,high_burden
KE-NRB-2011-03063,2011,29,25-34,Female,Ovary,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-03064,2017,67,65-74,Male,Colorectum,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,58.3,high_burden
KE-NRB-2010-03065,2010,67,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-03066,2015,20,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,41.3,high_burden
KE-NRB-2016-03067,2016,44,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.9,high_burden
KE-NRB-2017-03068,2017,15,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-03069,2013,15,15-24,Male,Skin (melanoma),Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,18.3,high_burden
KE-NRB-2009-03070,2009,36,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,32.8,high_burden
KE-NRB-2015-03071,2015,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,20.9,high_burden
KE-NRB-2018-03072,2018,61,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,14.0,high_burden
KE-NRB-2013-03073,2013,65,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,38.9,high_burden
KE-NRB-2012-03074,2012,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-03075,2015,59,55-64,Male,Liver,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,11.3,high_burden
KE-NRB-2012-03076,2012,48,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,60.0,high_burden
KE-NRB-2013-03077,2013,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.4,high_burden
KE-NRB-2010-03078,2010,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,57.9,high_burden
KE-NRB-2017-03079,2017,46,45-54,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.6,high_burden
KE-NRB-2013-03080,2013,42,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-03081,2013,52,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.3,high_burden
KE-NRB-2017-03082,2017,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,28.3,high_burden
KE-NRB-2018-03083,2018,81,75+,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,12.5,high_burden
KE-NRB-2009-03084,2009,46,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,43.1,high_burden
KE-NRB-2012-03085,2012,49,45-54,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,high_burden
KE-NRB-2014-03086,2014,68,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,33.0,high_burden
KE-NRB-2018-03087,2018,72,65-74,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Other,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2009-03088,2009,27,25-34,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery only,Dead,34.0,high_burden
KE-NRB-2014-03089,2014,57,55-64,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,15.7,high_burden
KE-NRB-2016-03090,2016,30,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-03091,2011,66,65-74,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,7.5,high_burden
KE-NRB-2010-03092,2010,70,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03093,2017,48,45-54,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,41.7,high_burden
KE-NRB-2015-03094,2015,38,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-03095,2014,48,45-54,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2012-03096,2012,46,45-54,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-03097,2015,94,75+,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-03098,2011,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,35.2,high_burden
KE-NRB-2013-03099,2013,63,55-64,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,39.2,high_burden
KE-NRB-2010-03100,2010,65,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,37.2,high_burden
KE-NRB-2016-03101,2016,41,35-44,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.0,high_burden
KE-NRB-2010-03102,2010,78,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,17.0,high_burden
KE-NRB-2013-03103,2013,58,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,29.8,high_burden
KE-NRB-2010-03104,2010,9,0-14,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.7,high_burden
KE-NRB-2018-03105,2018,67,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-03106,2015,52,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.5,high_burden
KE-NRB-2013-03107,2013,66,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,46.6,high_burden
KE-NRB-2018-03108,2018,28,25-34,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,35.1,high_burden
KE-NRB-2011-03109,2011,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,15.8,high_burden
KE-NRB-2018-03110,2018,70,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-03111,2015,22,15-24,Female,Other,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,30.0,high_burden
KE-NRB-2010-03112,2010,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2015-03113,2015,71,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.4,high_burden
KE-NRB-2014-03114,2014,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,45.8,high_burden
KE-NRB-2009-03115,2009,51,45-54,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,37.2,high_burden
KE-NRB-2014-03116,2014,51,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Lost to follow-up,34.8,high_burden
KE-NRB-2017-03117,2017,44,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,22.3,high_burden
KE-NRB-2018-03118,2018,62,55-64,Male,Liver,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-03119,2015,66,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.2,high_burden
KE-NRB-2015-03120,2015,55,55-64,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.1,high_burden
KE-NRB-2018-03121,2018,49,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,52.1,high_burden
KE-NRB-2013-03122,2013,53,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.1,high_burden
KE-NRB-2011-03123,2011,47,45-54,Male,Lung,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,17.3,high_burden
KE-NRB-2011-03124,2011,38,35-44,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.3,high_burden
KE-NRB-2010-03125,2010,48,45-54,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,32.7,high_burden
KE-NRB-2017-03126,2017,53,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,5.7,high_burden
KE-NRB-2011-03127,2011,72,65-74,Male,Prostate,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,30.1,high_burden
KE-NRB-2011-03128,2011,67,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,45.9,high_burden
KE-NRB-2018-03129,2018,73,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,43.2,high_burden
KE-NRB-2016-03130,2016,28,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,0.6,high_burden
KE-NRB-2016-03131,2016,62,55-64,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-03132,2014,48,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,31.0,high_burden
KE-NRB-2011-03133,2011,38,35-44,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,1.5,high_burden
KE-NRB-2018-03134,2018,55,55-64,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,0.9,high_burden
KE-NRB-2010-03135,2010,60,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,46.0,high_burden
KE-NRB-2016-03136,2016,58,55-64,Male,Bladder,Squamous cell carcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,18.8,high_burden
KE-NRB-2016-03137,2016,51,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-03138,2017,54,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-03139,2012,74,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-03140,2014,73,65-74,Male,Bladder,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,47.3,high_burden
KE-NRB-2013-03141,2013,49,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,57.1,high_burden
KE-NRB-2012-03142,2012,65,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-03143,2013,83,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.9,high_burden
KE-NRB-2017-03144,2017,69,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,3.0,high_burden
KE-NRB-2011-03145,2011,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.2,high_burden
KE-NRB-2009-03146,2009,39,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03147,2017,39,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.6,high_burden
KE-NRB-2017-03148,2017,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03149,2017,63,55-64,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,53.1,high_burden
KE-NRB-2009-03150,2009,50,45-54,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,33.2,high_burden
KE-NRB-2015-03151,2015,93,75+,Male,Bladder,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,44.9,high_burden
KE-NRB-2011-03152,2011,86,75+,Female,Corpus uteri,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,11.0,high_burden
KE-NRB-2009-03153,2009,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-03154,2015,28,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,53.0,high_burden
KE-NRB-2013-03155,2013,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,33.9,high_burden
KE-NRB-2017-03156,2017,49,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,No treatment,Dead,3.2,high_burden
KE-NRB-2017-03157,2017,38,35-44,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,12.7,high_burden
KE-NRB-2016-03158,2016,67,65-74,Male,Bladder,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,2.8,high_burden
KE-NRB-2018-03159,2018,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.7,high_burden
KE-NRB-2012-03160,2012,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.4,high_burden
KE-NRB-2015-03161,2015,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,58.8,high_burden
KE-NRB-2017-03162,2017,45,45-54,Male,Prostate,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-03163,2014,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2017-03164,2017,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,3.6,high_burden
KE-NRB-2014-03165,2014,29,25-34,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-03166,2013,37,35-44,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.0,high_burden
KE-NRB-2011-03167,2011,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,11.0,high_burden
KE-NRB-2017-03168,2017,41,35-44,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,19.3,high_burden
KE-NRB-2011-03169,2011,62,55-64,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.4,high_burden
KE-NRB-2014-03170,2014,64,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03171,2017,52,45-54,Male,Leukemia,Other specified,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-03172,2016,43,35-44,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.9,high_burden
KE-NRB-2017-03173,2017,47,45-54,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.8,high_burden
KE-NRB-2011-03174,2011,75,75+,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-03175,2011,37,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,21.1,high_burden
KE-NRB-2018-03176,2018,57,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2018-03177,2018,45,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-03178,2016,43,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,3.8,high_burden
KE-NRB-2017-03179,2017,49,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-03180,2017,25,25-34,Female,Thyroid,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-03181,2010,40,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,42.0,high_burden
KE-NRB-2018-03182,2018,32,25-34,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.4,high_burden
KE-NRB-2015-03183,2015,35,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.1,high_burden
KE-NRB-2012-03184,2012,74,65-74,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,54.9,high_burden
KE-NRB-2009-03185,2009,63,55-64,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-03186,2016,73,65-74,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Rural,Palliative care only,Dead,42.6,high_burden
KE-NRB-2017-03187,2017,46,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,22.9,high_burden
KE-NRB-2013-03188,2013,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.4,high_burden
KE-NRB-2013-03189,2013,66,65-74,Male,Stomach,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,41.9,high_burden
KE-NRB-2012-03190,2012,72,65-74,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,3.5,high_burden
KE-NRB-2014-03191,2014,15,15-24,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.8,high_burden
KE-NRB-2012-03192,2012,51,45-54,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2017-03193,2017,62,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.6,high_burden
KE-NRB-2018-03194,2018,61,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.0,high_burden
KE-NRB-2013-03195,2013,32,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.4,high_burden
KE-NRB-2015-03196,2015,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,6.0,high_burden
KE-NRB-2017-03197,2017,51,45-54,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,46.4,high_burden
KE-NRB-2012-03198,2012,60,55-64,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,34.0,high_burden
KE-NRB-2012-03199,2012,29,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,48.7,high_burden
KE-NRB-2014-03200,2014,72,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.5,high_burden
KE-NRB-2016-03201,2016,63,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,2.6,high_burden
KE-NRB-2014-03202,2014,51,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,20.3,high_burden
KE-NRB-2013-03203,2013,64,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,41.0,high_burden
KE-NRB-2018-03204,2018,57,55-64,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.1,high_burden
KE-NRB-2017-03205,2017,91,75+,Male,Oesophagus,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,10.9,high_burden
KE-NRB-2009-03206,2009,46,45-54,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.3,high_burden
KE-NRB-2011-03207,2011,48,45-54,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-03208,2015,52,45-54,Male,Leukemia,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-03209,2015,71,65-74,Male,Oesophagus,Unspecified,Unknown,Death certificate only,Malignant,Urban,No treatment,Alive,12.7,high_burden
KE-NRB-2013-03210,2013,56,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.0,high_burden
KE-NRB-2016-03211,2016,45,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.3,high_burden
KE-NRB-2018-03212,2018,79,75+,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.9,high_burden
KE-NRB-2014-03213,2014,72,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,6.2,high_burden
KE-NRB-2010-03214,2010,71,65-74,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-03215,2015,62,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,45.5,high_burden
KE-NRB-2010-03216,2010,45,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,44.0,high_burden
KE-NRB-2012-03217,2012,42,35-44,Male,Kaposi sarcoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,24.0,high_burden
KE-NRB-2018-03218,2018,35,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,39.3,high_burden
KE-NRB-2016-03219,2016,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.4,high_burden
KE-NRB-2012-03220,2012,39,35-44,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Rural,Surgery + Radiotherapy,Dead,5.5,high_burden
KE-NRB-2010-03221,2010,85,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,58.8,high_burden
KE-NRB-2015-03222,2015,69,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,24.1,high_burden
KE-NRB-2017-03223,2017,63,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Dead,8.1,high_burden
KE-NRB-2011-03224,2011,63,55-64,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-03225,2012,48,45-54,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,44.2,high_burden
KE-NRB-2012-03226,2012,62,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-03227,2018,63,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,39.7,high_burden
KE-NRB-2015-03228,2015,62,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Dead,1.7,high_burden
KE-NRB-2015-03229,2015,62,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,4.1,high_burden
KE-NRB-2016-03230,2016,88,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-03231,2014,68,65-74,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery only,Dead,19.5,high_burden
KE-NRB-2014-03232,2014,38,35-44,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,18.4,high_burden
KE-NRB-2015-03233,2015,50,45-54,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,31.4,high_burden
KE-NRB-2013-03234,2013,72,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,47.5,high_burden
KE-NRB-2011-03235,2011,81,75+,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,27.4,high_burden
KE-NRB-2011-03236,2011,34,25-34,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,17.3,high_burden
KE-NRB-2017-03237,2017,92,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,3.9,high_burden
KE-NRB-2014-03238,2014,30,25-34,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2015-03239,2015,45,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-03240,2015,45,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-03241,2016,72,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,41.3,high_burden
KE-NRB-2014-03242,2014,11,0-14,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.8,high_burden
KE-NRB-2015-03243,2015,41,35-44,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-03244,2013,33,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-03245,2017,61,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2010-03246,2010,34,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.0,high_burden
KE-NRB-2010-03247,2010,56,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.3,high_burden
KE-NRB-2015-03248,2015,54,45-54,Female,Other,Sarcoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,6.3,high_burden
KE-NRB-2017-03249,2017,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,17.2,high_burden
KE-NRB-2015-03250,2015,64,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.1,high_burden
KE-NRB-2012-03251,2012,51,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.0,high_burden
KE-NRB-2009-03252,2009,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.2,high_burden
KE-NRB-2017-03253,2017,45,45-54,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,41.7,high_burden
KE-NRB-2014-03254,2014,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,54.5,high_burden
KE-NRB-2011-03255,2011,34,25-34,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,No treatment,Lost to follow-up,2.4,high_burden
KE-NRB-2017-03256,2017,56,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,8.0,high_burden
KE-NRB-2017-03257,2017,22,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.3,high_burden
KE-NRB-2013-03258,2013,50,45-54,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,19.2,high_burden
KE-NRB-2016-03259,2016,72,65-74,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,high_burden
KE-NRB-2011-03260,2011,70,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-03261,2017,49,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.1,high_burden
KE-NRB-2015-03262,2015,63,55-64,Male,Kidney,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,14.4,high_burden
KE-NRB-2011-03263,2011,3,0-14,Male,Lung,Unspecified,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,No treatment,Alive,3.8,high_burden
KE-NRB-2009-03264,2009,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,22.2,high_burden
KE-NRB-2009-03265,2009,23,15-24,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.3,high_burden
KE-NRB-2011-03266,2011,69,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,25.4,high_burden
KE-NRB-2011-03267,2011,27,25-34,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-03268,2016,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,5.0,high_burden
KE-NRB-2010-03269,2010,60,55-64,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,49.0,high_burden
KE-NRB-2013-03270,2013,71,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,13.3,high_burden
KE-NRB-2017-03271,2017,61,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,32.9,high_burden
KE-NRB-2018-03272,2018,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,10.4,high_burden
KE-NRB-2017-03273,2017,59,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-03274,2012,68,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,13.4,high_burden
KE-NRB-2009-03275,2009,51,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,45.4,high_burden
KE-NRB-2009-03276,2009,35,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.8,high_burden
KE-NRB-2015-03277,2015,63,55-64,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-03278,2010,41,35-44,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.3,high_burden
KE-NRB-2014-03279,2014,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2013-03280,2013,74,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,8.5,high_burden
KE-NRB-2017-03281,2017,41,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,12.7,high_burden
KE-NRB-2013-03282,2013,79,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03283,2017,59,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,29.1,high_burden
KE-NRB-2013-03284,2013,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,31.8,high_burden
KE-NRB-2012-03285,2012,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Lost to follow-up,9.6,high_burden
KE-NRB-2018-03286,2018,50,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.9,high_burden
KE-NRB-2012-03287,2012,58,55-64,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,3.3,high_burden
KE-NRB-2016-03288,2016,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,8.2,high_burden
KE-NRB-2017-03289,2017,57,55-64,Male,Prostate,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,2.0,high_burden
KE-NRB-2017-03290,2017,42,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-03291,2018,62,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.9,high_burden
KE-NRB-2009-03292,2009,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,10.5,high_burden
KE-NRB-2010-03293,2010,51,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.6,high_burden
KE-NRB-2015-03294,2015,47,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,54.2,high_burden
KE-NRB-2011-03295,2011,49,45-54,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,47.9,high_burden
KE-NRB-2010-03296,2010,60,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,10.2,high_burden
KE-NRB-2012-03297,2012,65,65-74,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.9,high_burden
KE-NRB-2016-03298,2016,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,13.3,high_burden
KE-NRB-2016-03299,2016,45,45-54,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,3.6,high_burden
KE-NRB-2017-03300,2017,88,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.0,high_burden
KE-NRB-2013-03301,2013,54,45-54,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,5.3,high_burden
KE-NRB-2017-03302,2017,18,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,16.9,high_burden
KE-NRB-2013-03303,2013,63,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,7.0,high_burden
KE-NRB-2009-03304,2009,83,75+,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.5,high_burden
KE-NRB-2015-03305,2015,91,75+,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,3.2,high_burden
KE-NRB-2016-03306,2016,61,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,7.3,high_burden
KE-NRB-2015-03307,2015,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,24.8,high_burden
KE-NRB-2010-03308,2010,63,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,29.9,high_burden
KE-NRB-2011-03309,2011,53,45-54,Male,Leukemia,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,23.4,high_burden
KE-NRB-2016-03310,2016,61,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,13.6,high_burden
KE-NRB-2014-03311,2014,67,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,7.9,high_burden
KE-NRB-2011-03312,2011,44,35-44,Female,Thyroid,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.9,high_burden
KE-NRB-2016-03313,2016,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,45.9,high_burden
KE-NRB-2012-03314,2012,28,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.8,high_burden
KE-NRB-2017-03315,2017,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,15.2,high_burden
KE-NRB-2015-03316,2015,59,55-64,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.2,high_burden
KE-NRB-2012-03317,2012,31,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,4.3,high_burden
KE-NRB-2018-03318,2018,59,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,38.9,high_burden
KE-NRB-2014-03319,2014,61,55-64,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.6,high_burden
KE-NRB-2010-03320,2010,38,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-03321,2009,88,75+,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.6,high_burden
KE-NRB-2015-03322,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.7,high_burden
KE-NRB-2010-03323,2010,49,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,44.6,high_burden
KE-NRB-2010-03324,2010,54,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2012-03325,2012,68,65-74,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,high_burden
KE-NRB-2016-03326,2016,31,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.4,high_burden
KE-NRB-2014-03327,2014,93,75+,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.4,high_burden
KE-NRB-2016-03328,2016,72,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.5,high_burden
KE-NRB-2017-03329,2017,94,75+,Female,Other,Leukemia,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,32.3,high_burden
KE-NRB-2012-03330,2012,87,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.0,high_burden
KE-NRB-2016-03331,2016,59,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,2.5,high_burden
KE-NRB-2009-03332,2009,42,35-44,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,43.0,high_burden
KE-NRB-2011-03333,2011,17,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,55.6,high_burden
KE-NRB-2016-03334,2016,70,65-74,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,49.3,high_burden
KE-NRB-2014-03335,2014,70,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,18.2,high_burden
KE-NRB-2018-03336,2018,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.8,high_burden
KE-NRB-2018-03337,2018,34,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,42.0,high_burden
KE-NRB-2010-03338,2010,54,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.8,high_burden
KE-NRB-2010-03339,2010,75,75+,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,17.2,high_burden
KE-NRB-2011-03340,2011,54,45-54,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,51.6,high_burden
KE-NRB-2012-03341,2012,84,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,27.4,high_burden
KE-NRB-2017-03342,2017,73,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Radiotherapy only,Dead,10.0,high_burden
KE-NRB-2010-03343,2010,71,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,22.8,high_burden
KE-NRB-2010-03344,2010,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,9.9,high_burden
KE-NRB-2013-03345,2013,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,9.6,high_burden
KE-NRB-2015-03346,2015,56,55-64,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.4,high_burden
KE-NRB-2011-03347,2011,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,5.7,high_burden
KE-NRB-2017-03348,2017,81,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-03349,2013,69,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,45.0,high_burden
KE-NRB-2014-03350,2014,46,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,30.9,high_burden
KE-NRB-2014-03351,2014,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.0,high_burden
KE-NRB-2013-03352,2013,74,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,9.4,high_burden
KE-NRB-2015-03353,2015,49,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,51.6,high_burden
KE-NRB-2009-03354,2009,81,75+,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery only,Alive,12.7,high_burden
KE-NRB-2011-03355,2011,22,15-24,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,24.7,high_burden
KE-NRB-2016-03356,2016,62,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2010-03357,2010,51,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,4.3,high_burden
KE-NRB-2018-03358,2018,39,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-03359,2017,65,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.9,high_burden
KE-NRB-2016-03360,2016,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-03361,2016,61,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-03362,2017,16,15-24,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2015-03363,2015,50,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.4,high_burden
KE-NRB-2017-03364,2017,82,75+,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,58.0,high_burden
KE-NRB-2013-03365,2013,28,25-34,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Rural,N/A,Alive,42.9,high_burden
KE-NRB-2018-03366,2018,44,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,31.8,high_burden
KE-NRB-2014-03367,2014,44,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.9,high_burden
KE-NRB-2016-03368,2016,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.6,high_burden
KE-NRB-2015-03369,2015,63,55-64,Male,Kaposi sarcoma,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-03370,2014,70,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-03371,2009,73,65-74,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-03372,2014,27,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,52.8,high_burden
KE-NRB-2009-03373,2009,58,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Radiotherapy only,Alive,50.2,high_burden
KE-NRB-2016-03374,2016,38,35-44,Male,Colorectum,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,0.4,high_burden
KE-NRB-2015-03375,2015,42,35-44,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2012-03376,2012,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.8,high_burden
KE-NRB-2011-03377,2011,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,34.5,high_burden
KE-NRB-2014-03378,2014,62,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.4,high_burden
KE-NRB-2017-03379,2017,66,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.9,high_burden
KE-NRB-2017-03380,2017,92,75+,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,19.8,high_burden
KE-NRB-2014-03381,2014,57,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,4.3,high_burden
KE-NRB-2014-03382,2014,59,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-03383,2010,46,45-54,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-03384,2009,67,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.7,high_burden
KE-NRB-2013-03385,2013,59,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,16.9,high_burden
KE-NRB-2010-03386,2010,36,35-44,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,56.9,high_burden
KE-NRB-2018-03387,2018,44,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.1,high_burden
KE-NRB-2015-03388,2015,54,45-54,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery only,Dead,12.9,high_burden
KE-NRB-2010-03389,2010,12,0-14,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.6,high_burden
KE-NRB-2015-03390,2015,56,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.1,high_burden
KE-NRB-2017-03391,2017,3,0-14,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2016-03392,2016,50,45-54,Male,Stomach,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,24.0,high_burden
KE-NRB-2014-03393,2014,70,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,10.2,high_burden
KE-NRB-2009-03394,2009,81,75+,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,34.2,high_burden
KE-NRB-2017-03395,2017,41,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Alive,20.2,high_burden
KE-NRB-2013-03396,2013,36,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.3,high_burden
KE-NRB-2012-03397,2012,26,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,10.1,high_burden
KE-NRB-2014-03398,2014,80,75+,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.0,high_burden
KE-NRB-2017-03399,2017,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,19.3,high_burden
KE-NRB-2012-03400,2012,71,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,57.0,high_burden
KE-NRB-2015-03401,2015,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,10.8,high_burden
KE-NRB-2018-03402,2018,54,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,18.1,high_burden
KE-NRB-2013-03403,2013,73,65-74,Female,Ovary,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2018-03404,2018,25,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Lost to follow-up,38.0,high_burden
KE-NRB-2015-03405,2015,48,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,49.8,high_burden
KE-NRB-2015-03406,2015,62,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,19.5,high_burden
KE-NRB-2011-03407,2011,76,75+,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.2,high_burden
KE-NRB-2013-03408,2013,39,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,29.4,high_burden
KE-NRB-2013-03409,2013,51,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,17.2,high_burden
KE-NRB-2016-03410,2016,45,45-54,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.1,high_burden
KE-NRB-2009-03411,2009,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,31.3,high_burden
KE-NRB-2015-03412,2015,56,55-64,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-03413,2015,65,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,16.5,high_burden
KE-NRB-2017-03414,2017,61,55-64,Male,Liver,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.3,high_burden
KE-NRB-2013-03415,2013,40,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.1,high_burden
KE-NRB-2012-03416,2012,73,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,32.0,high_burden
KE-NRB-2015-03417,2015,44,35-44,Male,Colorectum,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,3.0,high_burden
KE-NRB-2010-03418,2010,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.0,high_burden
KE-NRB-2012-03419,2012,39,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,12.1,high_burden
KE-NRB-2009-03420,2009,63,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.1,high_burden
KE-NRB-2011-03421,2011,65,65-74,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-03422,2017,95,75+,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.9,high_burden
KE-NRB-2010-03423,2010,58,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.7,high_burden
KE-NRB-2010-03424,2010,63,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,0.1,high_burden
KE-NRB-2012-03425,2012,52,45-54,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.3,high_burden
KE-NRB-2013-03426,2013,31,25-34,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,6.9,high_burden
KE-NRB-2015-03427,2015,55,55-64,Male,Colorectum,Squamous cell carcinoma,Unknown,Clinical only,Benign/uncertain,Urban,N/A,Dead,34.5,high_burden
KE-NRB-2018-03428,2018,69,65-74,Female,Thyroid,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,0.9,high_burden
KE-NRB-2014-03429,2014,35,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.5,high_burden
KE-NRB-2011-03430,2011,46,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,51.9,high_burden
KE-NRB-2018-03431,2018,55,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Radiotherapy only,Alive,25.9,high_burden
KE-NRB-2015-03432,2015,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,50.9,high_burden
KE-NRB-2017-03433,2017,63,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.3,high_burden
KE-NRB-2015-03434,2015,66,65-74,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,11.3,high_burden
KE-NRB-2011-03435,2011,85,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,22.0,high_burden
KE-NRB-2018-03436,2018,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03437,2017,39,35-44,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.5,high_burden
KE-NRB-2010-03438,2010,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,25.5,high_burden
KE-NRB-2016-03439,2016,60,55-64,Male,Liver,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,27.8,high_burden
KE-NRB-2014-03440,2014,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,35.6,high_burden
KE-NRB-2017-03441,2017,71,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-03442,2018,62,55-64,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,24.3,high_burden
KE-NRB-2018-03443,2018,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,57.1,high_burden
KE-NRB-2014-03444,2014,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.5,high_burden
KE-NRB-2010-03445,2010,49,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.2,high_burden
KE-NRB-2018-03446,2018,61,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Unknown,Death certificate only,Benign/uncertain,Urban,N/A,Dead,8.4,high_burden
KE-NRB-2018-03447,2018,66,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,5.0,high_burden
KE-NRB-2015-03448,2015,46,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.6,high_burden
KE-NRB-2013-03449,2013,65,65-74,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-03450,2011,69,65-74,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.1,high_burden
KE-NRB-2016-03451,2016,51,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.4,high_burden
KE-NRB-2011-03452,2011,50,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.0,high_burden
KE-NRB-2009-03453,2009,53,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,18.0,high_burden
KE-NRB-2018-03454,2018,50,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-03455,2009,61,55-64,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2017-03456,2017,70,65-74,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.6,high_burden
KE-NRB-2016-03457,2016,46,45-54,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-03458,2014,42,35-44,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.3,high_burden
KE-NRB-2012-03459,2012,40,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,16.7,high_burden
KE-NRB-2014-03460,2014,65,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,22.3,high_burden
KE-NRB-2009-03461,2009,69,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,46.9,high_burden
KE-NRB-2013-03462,2013,40,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,39.3,high_burden
KE-NRB-2012-03463,2012,86,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,6.2,high_burden
KE-NRB-2015-03464,2015,65,65-74,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.8,high_burden
KE-NRB-2016-03465,2016,60,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,29.6,high_burden
KE-NRB-2014-03466,2014,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,45.3,high_burden
KE-NRB-2017-03467,2017,53,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,1.1,high_burden
KE-NRB-2016-03468,2016,62,55-64,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,16.0,high_burden
KE-NRB-2017-03469,2017,25,25-34,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,3.2,high_burden
KE-NRB-2016-03470,2016,43,35-44,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,8.8,high_burden
KE-NRB-2018-03471,2018,37,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,44.9,high_burden
KE-NRB-2010-03472,2010,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.3,high_burden
KE-NRB-2013-03473,2013,57,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,54.6,high_burden
KE-NRB-2017-03474,2017,65,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,39.6,high_burden
KE-NRB-2013-03475,2013,45,45-54,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,42.0,high_burden
KE-NRB-2014-03476,2014,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.4,high_burden
KE-NRB-2015-03477,2015,57,55-64,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.4,high_burden
KE-NRB-2013-03478,2013,58,55-64,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,59.2,high_burden
KE-NRB-2014-03479,2014,72,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.0,high_burden
KE-NRB-2016-03480,2016,70,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,22.2,high_burden
KE-NRB-2012-03481,2012,59,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,20.0,high_burden
KE-NRB-2015-03482,2015,10,0-14,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-03483,2013,53,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,4.0,high_burden
KE-NRB-2013-03484,2013,31,25-34,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.8,high_burden
KE-NRB-2014-03485,2014,42,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.9,high_burden
KE-NRB-2012-03486,2012,53,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-03487,2015,48,45-54,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-03488,2014,61,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.3,high_burden
KE-NRB-2016-03489,2016,37,35-44,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-03490,2015,42,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,57.3,high_burden
KE-NRB-2012-03491,2012,70,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,52.6,high_burden
KE-NRB-2009-03492,2009,44,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,31.3,high_burden
KE-NRB-2013-03493,2013,87,75+,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.2,high_burden
KE-NRB-2018-03494,2018,68,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.3,high_burden
KE-NRB-2013-03495,2013,43,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2017-03496,2017,65,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,40.3,high_burden
KE-NRB-2012-03497,2012,36,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.3,high_burden
KE-NRB-2018-03498,2018,68,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2016-03499,2016,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.7,high_burden
KE-NRB-2012-03500,2012,38,35-44,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,45.6,high_burden
KE-NRB-2018-03501,2018,34,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-03502,2012,61,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-03503,2017,51,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,49.5,high_burden
KE-NRB-2017-03504,2017,52,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,30.4,high_burden
KE-NRB-2013-03505,2013,72,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.2,high_burden
KE-NRB-2014-03506,2014,42,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2016-03507,2016,75,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,4.2,high_burden
KE-NRB-2016-03508,2016,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,9.8,high_burden
KE-NRB-2012-03509,2012,71,65-74,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.1,high_burden
KE-NRB-2013-03510,2013,29,25-34,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,50.3,high_burden
KE-NRB-2016-03511,2016,76,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,9.6,high_burden
KE-NRB-2018-03512,2018,65,65-74,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-03513,2015,65,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,high_burden
KE-NRB-2018-03514,2018,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,10.5,high_burden
KE-NRB-2017-03515,2017,49,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,10.4,high_burden
KE-NRB-2018-03516,2018,39,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.8,high_burden
KE-NRB-2013-03517,2013,80,75+,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.8,high_burden
KE-NRB-2016-03518,2016,26,25-34,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,43.8,high_burden
KE-NRB-2016-03519,2016,53,45-54,Male,Multiple myeloma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-03520,2013,63,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-03521,2016,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,21.7,high_burden
KE-NRB-2017-03522,2017,36,35-44,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Dead,54.6,high_burden
KE-NRB-2014-03523,2014,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,15.9,high_burden
KE-NRB-2018-03524,2018,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,29.5,high_burden
KE-NRB-2009-03525,2009,40,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.0,high_burden
KE-NRB-2009-03526,2009,58,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-03527,2016,57,55-64,Female,Other,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-03528,2014,44,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,2.3,high_burden
KE-NRB-2013-03529,2013,45,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.6,high_burden
KE-NRB-2015-03530,2015,49,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2018-03531,2018,63,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,55.7,high_burden
KE-NRB-2016-03532,2016,63,55-64,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-03533,2017,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,57.5,high_burden
KE-NRB-2013-03534,2013,51,45-54,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-03535,2018,28,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.9,high_burden
KE-NRB-2011-03536,2011,63,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Lost to follow-up,1.6,high_burden
KE-NRB-2017-03537,2017,72,65-74,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03538,2017,29,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,1.0,high_burden
KE-NRB-2017-03539,2017,6,0-14,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.8,high_burden
KE-NRB-2015-03540,2015,41,35-44,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.5,high_burden
KE-NRB-2011-03541,2011,71,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,17.5,high_burden
KE-NRB-2017-03542,2017,71,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,36.0,high_burden
KE-NRB-2012-03543,2012,66,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,46.6,high_burden
KE-NRB-2013-03544,2013,69,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.0,high_burden
KE-NRB-2014-03545,2014,82,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,50.1,high_burden
KE-NRB-2010-03546,2010,73,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,42.8,high_burden
KE-NRB-2014-03547,2014,41,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,3.9,high_burden
KE-NRB-2009-03548,2009,45,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-03549,2013,32,25-34,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.4,high_burden
KE-NRB-2014-03550,2014,56,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,34.4,high_burden
KE-NRB-2013-03551,2013,41,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,33.1,high_burden
KE-NRB-2009-03552,2009,61,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,19.8,high_burden
KE-NRB-2014-03553,2014,37,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2009-03554,2009,76,75+,Male,Stomach,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,60.0,high_burden
KE-NRB-2015-03555,2015,91,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,22.6,high_burden
KE-NRB-2016-03556,2016,70,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.2,high_burden
KE-NRB-2011-03557,2011,83,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,11.1,high_burden
KE-NRB-2009-03558,2009,73,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.2,high_burden
KE-NRB-2012-03559,2012,7,0-14,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,3.8,high_burden
KE-NRB-2017-03560,2017,64,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,34.8,high_burden
KE-NRB-2009-03561,2009,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.3,high_burden
KE-NRB-2017-03562,2017,28,25-34,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,52.1,high_burden
KE-NRB-2011-03563,2011,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,33.0,high_burden
KE-NRB-2017-03564,2017,87,75+,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2018-03565,2018,40,35-44,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,6.2,high_burden
KE-NRB-2018-03566,2018,59,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,55.4,high_burden
KE-NRB-2017-03567,2017,38,35-44,Male,Skin (melanoma),Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,14.1,high_burden
KE-NRB-2015-03568,2015,58,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2010-03569,2010,25,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.0,high_burden
KE-NRB-2015-03570,2015,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.6,high_burden
KE-NRB-2012-03571,2012,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.6,high_burden
KE-NRB-2016-03572,2016,57,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,28.3,high_burden
KE-NRB-2015-03573,2015,67,65-74,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,2.7,high_burden
KE-NRB-2017-03574,2017,63,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.5,high_burden
KE-NRB-2014-03575,2014,70,65-74,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,41.0,high_burden
KE-NRB-2016-03576,2016,70,65-74,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Dead,59.4,high_burden
KE-NRB-2012-03577,2012,65,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.4,high_burden
KE-NRB-2014-03578,2014,62,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,16.0,high_burden
KE-NRB-2016-03579,2016,46,45-54,Male,Multiple myeloma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,5.5,high_burden
KE-NRB-2015-03580,2015,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,high_burden
KE-NRB-2009-03581,2009,69,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,15.4,high_burden
KE-NRB-2014-03582,2014,48,45-54,Female,Corpus uteri,Lymphoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Dead,22.5,high_burden
KE-NRB-2015-03583,2015,71,65-74,Male,Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-03584,2010,74,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,27.4,high_burden
KE-NRB-2017-03585,2017,34,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,45.4,high_burden
KE-NRB-2014-03586,2014,46,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.8,high_burden
KE-NRB-2017-03587,2017,45,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.2,high_burden
KE-NRB-2016-03588,2016,54,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,10.7,high_burden
KE-NRB-2017-03589,2017,49,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,6.3,high_burden
KE-NRB-2017-03590,2017,22,15-24,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,2.7,high_burden
KE-NRB-2018-03591,2018,66,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Dead,4.5,high_burden
KE-NRB-2013-03592,2013,42,35-44,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,30.7,high_burden
KE-NRB-2017-03593,2017,56,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,7.2,high_burden
KE-NRB-2012-03594,2012,51,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.1,high_burden
KE-NRB-2011-03595,2011,93,75+,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,31.0,high_burden
KE-NRB-2015-03596,2015,58,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-03597,2016,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-03598,2018,33,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.5,high_burden
KE-NRB-2014-03599,2014,67,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.3,high_burden
KE-NRB-2017-03600,2017,28,25-34,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-03601,2012,69,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.7,high_burden
KE-NRB-2016-03602,2016,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,32.9,high_burden
KE-NRB-2014-03603,2014,58,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.4,high_burden
KE-NRB-2014-03604,2014,59,55-64,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,43.0,high_burden
KE-NRB-2012-03605,2012,71,65-74,Male,Liver,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.9,high_burden
KE-NRB-2013-03606,2013,47,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,54.0,high_burden
KE-NRB-2013-03607,2013,69,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,5.3,high_burden
KE-NRB-2016-03608,2016,31,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,46.0,high_burden
KE-NRB-2009-03609,2009,47,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.8,high_burden
KE-NRB-2012-03610,2012,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,25.3,high_burden
KE-NRB-2013-03611,2013,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.2,high_burden
KE-NRB-2016-03612,2016,31,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Radiotherapy only,Alive,26.5,high_burden
KE-NRB-2018-03613,2018,36,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,28.6,high_burden
KE-NRB-2010-03614,2010,70,65-74,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.7,high_burden
KE-NRB-2016-03615,2016,57,55-64,Female,Breast,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,59.2,high_burden
KE-NRB-2015-03616,2015,61,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,26.7,high_burden
KE-NRB-2014-03617,2014,38,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-03618,2016,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.4,high_burden
KE-NRB-2012-03619,2012,40,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,20.5,high_burden
KE-NRB-2010-03620,2010,58,55-64,Male,Pancreas,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,28.0,high_burden
KE-NRB-2015-03621,2015,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-03622,2017,49,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.2,high_burden
KE-NRB-2010-03623,2010,38,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.2,high_burden
KE-NRB-2014-03624,2014,60,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.9,high_burden
KE-NRB-2016-03625,2016,57,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2014-03626,2014,41,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.7,high_burden
KE-NRB-2017-03627,2017,55,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,34.1,high_burden
KE-NRB-2015-03628,2015,27,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,12.5,high_burden
KE-NRB-2012-03629,2012,49,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.4,high_burden
KE-NRB-2017-03630,2017,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.3,high_burden
KE-NRB-2013-03631,2013,65,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2015-03632,2015,69,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,9.2,high_burden
KE-NRB-2016-03633,2016,35,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,33.8,high_burden
KE-NRB-2012-03634,2012,68,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,34.8,high_burden
KE-NRB-2010-03635,2010,51,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,51.4,high_burden
KE-NRB-2016-03636,2016,54,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.8,high_burden
KE-NRB-2014-03637,2014,24,15-24,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,9.5,high_burden
KE-NRB-2017-03638,2017,73,65-74,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,57.9,high_burden
KE-NRB-2010-03639,2010,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2014-03640,2014,64,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.1,high_burden
KE-NRB-2009-03641,2009,84,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.1,high_burden
KE-NRB-2016-03642,2016,64,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,10.7,high_burden
KE-NRB-2016-03643,2016,27,25-34,Male,Liver,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.0,high_burden
KE-NRB-2014-03644,2014,30,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,51.5,high_burden
KE-NRB-2009-03645,2009,48,45-54,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.8,high_burden
KE-NRB-2010-03646,2010,17,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,7.8,high_burden
KE-NRB-2017-03647,2017,57,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-03648,2017,46,45-54,Female,Corpus uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.6,high_burden
KE-NRB-2015-03649,2015,36,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,50.4,high_burden
KE-NRB-2013-03650,2013,23,15-24,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,10.3,high_burden
KE-NRB-2018-03651,2018,42,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.6,high_burden
KE-NRB-2013-03652,2013,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.5,high_burden
KE-NRB-2013-03653,2013,72,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,2.8,high_burden
KE-NRB-2015-03654,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,4.5,high_burden
KE-NRB-2012-03655,2012,26,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,17.9,high_burden
KE-NRB-2015-03656,2015,36,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-03657,2016,70,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Dead,14.5,high_burden
KE-NRB-2018-03658,2018,57,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-03659,2015,35,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,52.1,high_burden
KE-NRB-2015-03660,2015,24,15-24,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.0,high_burden
KE-NRB-2017-03661,2017,49,45-54,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.0,high_burden
KE-NRB-2011-03662,2011,39,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,30.0,high_burden
KE-NRB-2010-03663,2010,48,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.7,high_burden
KE-NRB-2012-03664,2012,17,15-24,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,23.8,high_burden
KE-NRB-2014-03665,2014,40,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-03666,2013,44,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,14.5,high_burden
KE-NRB-2016-03667,2016,50,45-54,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-03668,2011,51,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,5.9,high_burden
KE-NRB-2009-03669,2009,65,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-03670,2014,89,75+,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,53.4,high_burden
KE-NRB-2012-03671,2012,68,65-74,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.7,high_burden
KE-NRB-2013-03672,2013,27,25-34,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-03673,2014,55,55-64,Male,Lung,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.3,high_burden
KE-NRB-2017-03674,2017,50,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,42.3,high_burden
KE-NRB-2018-03675,2018,46,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2018-03676,2018,19,15-24,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,37.3,high_burden
KE-NRB-2014-03677,2014,57,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.1,high_burden
KE-NRB-2010-03678,2010,46,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,11.1,high_burden
KE-NRB-2013-03679,2013,39,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Dead,33.0,high_burden
KE-NRB-2011-03680,2011,46,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2016-03681,2016,75,75+,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,59.0,high_burden
KE-NRB-2012-03682,2012,35,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Palliative care only,Alive,15.2,high_burden
KE-NRB-2016-03683,2016,63,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.9,high_burden
KE-NRB-2016-03684,2016,65,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.7,high_burden
KE-NRB-2018-03685,2018,52,45-54,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,28.6,high_burden
KE-NRB-2016-03686,2016,40,35-44,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Radiotherapy only,Alive,51.1,high_burden
KE-NRB-2009-03687,2009,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,52.8,high_burden
KE-NRB-2010-03688,2010,38,35-44,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.7,high_burden
KE-NRB-2015-03689,2015,55,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,0.0,high_burden
KE-NRB-2017-03690,2017,19,15-24,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,28.0,high_burden
KE-NRB-2009-03691,2009,50,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-03692,2018,48,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.3,high_burden
KE-NRB-2013-03693,2013,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-03694,2013,47,45-54,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,45.3,high_burden
KE-NRB-2013-03695,2013,37,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,21.9,high_burden
KE-NRB-2013-03696,2013,56,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,60.0,high_burden
KE-NRB-2014-03697,2014,63,55-64,Female,Other,Unspecified,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-03698,2013,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,32.2,high_burden
KE-NRB-2016-03699,2016,82,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,13.4,high_burden
KE-NRB-2016-03700,2016,61,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,3.8,high_burden
KE-NRB-2016-03701,2016,53,45-54,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2018-03702,2018,58,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery only,Dead,16.6,high_burden
KE-NRB-2014-03703,2014,81,75+,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.1,high_burden
KE-NRB-2014-03704,2014,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-03705,2014,93,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-03706,2016,30,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,5.2,high_burden
KE-NRB-2018-03707,2018,53,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-03708,2017,49,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.3,high_burden
KE-NRB-2010-03709,2010,79,75+,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,20.1,high_burden
KE-NRB-2013-03710,2013,53,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.9,high_burden
KE-NRB-2014-03711,2014,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-03712,2010,39,35-44,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.4,high_burden
KE-NRB-2015-03713,2015,43,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,32.5,high_burden
KE-NRB-2018-03714,2018,38,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-03715,2016,29,25-34,Male,Brain and CNS,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,21.5,high_burden
KE-NRB-2015-03716,2015,70,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-03717,2018,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,38.4,high_burden
KE-NRB-2014-03718,2014,42,35-44,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-03719,2011,90,75+,Male,Stomach,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-03720,2017,45,45-54,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,53.7,high_burden
KE-NRB-2014-03721,2014,67,65-74,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.0,high_burden
KE-NRB-2018-03722,2018,52,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.1,high_burden
KE-NRB-2013-03723,2013,73,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,14.9,high_burden
KE-NRB-2013-03724,2013,16,15-24,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,7.1,high_burden
KE-NRB-2013-03725,2013,53,45-54,Male,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,44.5,high_burden
KE-NRB-2015-03726,2015,51,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Palliative care only,Alive,7.5,high_burden
KE-NRB-2015-03727,2015,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-03728,2017,41,35-44,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,1.3,high_burden
KE-NRB-2009-03729,2009,55,55-64,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2016-03730,2016,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,7.2,high_burden
KE-NRB-2015-03731,2015,66,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Alive,39.5,high_burden
KE-NRB-2010-03732,2010,11,0-14,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-03733,2018,61,55-64,Male,Brain and CNS,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.5,high_burden
KE-NRB-2011-03734,2011,43,35-44,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.2,high_burden
KE-NRB-2016-03735,2016,50,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.8,high_burden
KE-NRB-2013-03736,2013,45,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,44.6,high_burden
KE-NRB-2013-03737,2013,47,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,31.2,high_burden
KE-NRB-2014-03738,2014,40,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-03739,2011,53,45-54,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,28.2,high_burden
KE-NRB-2017-03740,2017,37,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,9.3,high_burden
KE-NRB-2012-03741,2012,41,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,17.4,high_burden
KE-NRB-2012-03742,2012,58,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,4.5,high_burden
KE-NRB-2012-03743,2012,44,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,4.7,high_burden
KE-NRB-2017-03744,2017,50,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.3,high_burden
KE-NRB-2012-03745,2012,70,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.7,high_burden
KE-NRB-2012-03746,2012,82,75+,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-03747,2017,54,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,33.6,high_burden
KE-NRB-2013-03748,2013,43,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-03749,2011,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,38.1,high_burden
KE-NRB-2016-03750,2016,83,75+,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-03751,2009,41,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.0,high_burden
KE-NRB-2014-03752,2014,31,25-34,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2013-03753,2013,69,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.7,high_burden
KE-NRB-2017-03754,2017,73,65-74,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.9,high_burden
KE-NRB-2017-03755,2017,68,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,20.8,high_burden
KE-NRB-2017-03756,2017,72,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,20.1,high_burden
KE-NRB-2016-03757,2016,22,15-24,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.6,high_burden
KE-NRB-2013-03758,2013,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,23.7,high_burden
KE-NRB-2018-03759,2018,51,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,19.8,high_burden
KE-NRB-2011-03760,2011,57,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,42.1,high_burden
KE-NRB-2018-03761,2018,55,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.4,high_burden
KE-NRB-2013-03762,2013,50,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,16.9,high_burden
KE-NRB-2018-03763,2018,64,55-64,Male,Stomach,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,46.4,high_burden
KE-NRB-2009-03764,2009,40,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.4,high_burden
KE-NRB-2009-03765,2009,66,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.8,high_burden
KE-NRB-2018-03766,2018,91,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.0,high_burden
KE-NRB-2013-03767,2013,74,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-03768,2011,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,26.0,high_burden
KE-NRB-2013-03769,2013,59,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,2.3,high_burden
KE-NRB-2016-03770,2016,69,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-03771,2016,75,75+,Female,Thyroid,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,6.6,high_burden
KE-NRB-2014-03772,2014,48,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-03773,2015,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2012-03774,2012,42,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-03775,2017,59,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.7,high_burden
KE-NRB-2010-03776,2010,44,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,1.8,high_burden
KE-NRB-2018-03777,2018,44,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.2,high_burden
KE-NRB-2018-03778,2018,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2016-03779,2016,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,26.4,high_burden
KE-NRB-2017-03780,2017,37,35-44,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.6,high_burden
KE-NRB-2017-03781,2017,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.5,high_burden
KE-NRB-2018-03782,2018,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-03783,2010,94,75+,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,39.8,high_burden
KE-NRB-2016-03784,2016,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.4,high_burden
KE-NRB-2017-03785,2017,36,35-44,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.6,high_burden
KE-NRB-2013-03786,2013,26,25-34,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.4,high_burden
KE-NRB-2017-03787,2017,71,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,21.5,high_burden
KE-NRB-2015-03788,2015,64,55-64,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,28.8,high_burden
KE-NRB-2011-03789,2011,43,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,8.0,high_burden
KE-NRB-2009-03790,2009,62,55-64,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,15.4,high_burden
KE-NRB-2009-03791,2009,77,75+,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,5.5,high_burden
KE-NRB-2014-03792,2014,38,35-44,Male,Colorectum,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.5,high_burden
KE-NRB-2015-03793,2015,25,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,23.7,high_burden
KE-NRB-2016-03794,2016,13,0-14,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-03795,2016,71,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,9.5,high_burden
KE-NRB-2011-03796,2011,56,55-64,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.4,high_burden
KE-NRB-2012-03797,2012,69,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,38.6,high_burden
KE-NRB-2016-03798,2016,79,75+,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,59.9,high_burden
KE-NRB-2018-03799,2018,64,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.0,high_burden
KE-NRB-2016-03800,2016,15,15-24,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.6,high_burden
KE-NRB-2013-03801,2013,92,75+,Male,Other,Lymphoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,0.4,high_burden
KE-NRB-2016-03802,2016,48,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,27.7,high_burden
KE-NRB-2011-03803,2011,51,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Dead,1.7,high_burden
KE-NRB-2009-03804,2009,51,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,45.7,high_burden
KE-NRB-2016-03805,2016,37,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2012-03806,2012,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.6,high_burden
KE-NRB-2012-03807,2012,33,25-34,Male,Colorectum,Leukemia,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,50.0,high_burden
KE-NRB-2009-03808,2009,45,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,16.8,high_burden
KE-NRB-2012-03809,2012,25,25-34,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,24.3,high_burden
KE-NRB-2017-03810,2017,40,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,18.4,high_burden
KE-NRB-2016-03811,2016,49,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-03812,2009,37,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,40.3,high_burden
KE-NRB-2010-03813,2010,36,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Lost to follow-up,15.5,high_burden
KE-NRB-2018-03814,2018,36,35-44,Male,Liver,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-03815,2009,59,55-64,Male,Pancreas,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,19.7,high_burden
KE-NRB-2014-03816,2014,92,75+,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-03817,2018,49,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,21.8,high_burden
KE-NRB-2013-03818,2013,45,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.8,high_burden
KE-NRB-2013-03819,2013,51,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,16.0,high_burden
KE-NRB-2011-03820,2011,71,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,39.8,high_burden
KE-NRB-2018-03821,2018,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,7.5,high_burden
KE-NRB-2016-03822,2016,68,65-74,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.2,high_burden
KE-NRB-2012-03823,2012,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,30.4,high_burden
KE-NRB-2014-03824,2014,41,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.9,high_burden
KE-NRB-2009-03825,2009,81,75+,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.4,high_burden
KE-NRB-2010-03826,2010,39,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,58.1,high_burden
KE-NRB-2011-03827,2011,78,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2018-03828,2018,63,55-64,Male,Multiple myeloma,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-03829,2012,39,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,21.7,high_burden
KE-NRB-2017-03830,2017,61,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2011-03831,2011,72,65-74,Male,Oesophagus,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-03832,2012,77,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,1.3,high_burden
KE-NRB-2018-03833,2018,81,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.6,high_burden
KE-NRB-2012-03834,2012,54,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-03835,2012,46,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,20.5,high_burden
KE-NRB-2018-03836,2018,43,35-44,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,8.9,high_burden
KE-NRB-2011-03837,2011,49,45-54,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,14.5,high_burden
KE-NRB-2013-03838,2013,73,65-74,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.8,high_burden
KE-NRB-2013-03839,2013,67,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,11.9,high_burden
KE-NRB-2017-03840,2017,52,45-54,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,58.2,high_burden
KE-NRB-2018-03841,2018,46,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.0,high_burden
KE-NRB-2009-03842,2009,6,0-14,Female,Breast,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,7.6,high_burden
KE-NRB-2012-03843,2012,66,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.8,high_burden
KE-NRB-2013-03844,2013,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,21.5,high_burden
KE-NRB-2013-03845,2013,41,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,42.9,high_burden
KE-NRB-2012-03846,2012,56,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-03847,2017,28,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,11.1,high_burden
KE-NRB-2010-03848,2010,68,65-74,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,23.7,high_burden
KE-NRB-2013-03849,2013,60,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,17.7,high_burden
KE-NRB-2018-03850,2018,74,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-03851,2014,25,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.7,high_burden
KE-NRB-2009-03852,2009,46,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.0,high_burden
KE-NRB-2016-03853,2016,94,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,7.3,high_burden
KE-NRB-2012-03854,2012,41,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.1,high_burden
KE-NRB-2012-03855,2012,59,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,7.6,high_burden
KE-NRB-2015-03856,2015,31,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.4,high_burden
KE-NRB-2016-03857,2016,26,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,45.5,high_burden
KE-NRB-2018-03858,2018,52,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,12.4,high_burden
KE-NRB-2016-03859,2016,58,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.4,high_burden
KE-NRB-2015-03860,2015,65,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.6,high_burden
KE-NRB-2013-03861,2013,7,0-14,Male,Liver,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-03862,2012,91,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,44.1,high_burden
KE-NRB-2012-03863,2012,45,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,22.7,high_burden
KE-NRB-2018-03864,2018,52,45-54,Male,Oesophagus,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,23.7,high_burden
KE-NRB-2010-03865,2010,81,75+,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2010-03866,2010,63,55-64,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,43.3,high_burden
KE-NRB-2014-03867,2014,61,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-03868,2013,71,65-74,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,10.7,high_burden
KE-NRB-2012-03869,2012,18,15-24,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,55.6,high_burden
KE-NRB-2016-03870,2016,25,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.2,high_burden
KE-NRB-2018-03871,2018,46,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.4,high_burden
KE-NRB-2018-03872,2018,84,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-03873,2018,37,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,15.5,high_burden
KE-NRB-2010-03874,2010,58,55-64,Male,Bladder,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,35.0,high_burden
KE-NRB-2009-03875,2009,53,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-03876,2017,35,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,28.5,high_burden
KE-NRB-2010-03877,2010,38,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.1,high_burden
KE-NRB-2013-03878,2013,62,55-64,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.1,high_burden
KE-NRB-2009-03879,2009,76,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.6,high_burden
KE-NRB-2015-03880,2015,61,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,29.7,high_burden
KE-NRB-2012-03881,2012,15,15-24,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-03882,2009,45,45-54,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Radiotherapy only,Alive,6.5,high_burden
KE-NRB-2017-03883,2017,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,60.0,high_burden
KE-NRB-2018-03884,2018,60,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.4,high_burden
KE-NRB-2017-03885,2017,60,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,10.0,high_burden
KE-NRB-2018-03886,2018,35,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,60.0,high_burden
KE-NRB-2018-03887,2018,3,0-14,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,5.4,high_burden
KE-NRB-2015-03888,2015,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,49.0,high_burden
KE-NRB-2015-03889,2015,22,15-24,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-03890,2010,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,6.7,high_burden
KE-NRB-2015-03891,2015,32,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-03892,2018,69,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,15.2,high_burden
KE-NRB-2012-03893,2012,79,75+,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,12.2,high_burden
KE-NRB-2017-03894,2017,48,45-54,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,24.5,high_burden
KE-NRB-2013-03895,2013,62,55-64,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-03896,2011,51,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,39.7,high_burden
KE-NRB-2015-03897,2015,55,55-64,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,12.3,high_burden
KE-NRB-2013-03898,2013,30,25-34,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,19.5,high_burden
KE-NRB-2014-03899,2014,71,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,17.7,high_burden
KE-NRB-2014-03900,2014,61,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.0,high_burden
KE-NRB-2012-03901,2012,51,45-54,Female,Breast,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,8.5,high_burden
KE-NRB-2018-03902,2018,63,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.3,high_burden
KE-NRB-2013-03903,2013,44,35-44,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,47.6,high_burden
KE-NRB-2015-03904,2015,74,65-74,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.3,high_burden
KE-NRB-2011-03905,2011,36,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,41.4,high_burden
KE-NRB-2017-03906,2017,36,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,25.1,high_burden
KE-NRB-2016-03907,2016,45,45-54,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.1,high_burden
KE-NRB-2016-03908,2016,67,65-74,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,17.6,high_burden
KE-NRB-2017-03909,2017,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.0,high_burden
KE-NRB-2016-03910,2016,55,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,20.5,high_burden
KE-NRB-2017-03911,2017,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-03912,2013,55,55-64,Female,Ovary,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,In situ,Rural,N/A,Dead,7.9,high_burden
KE-NRB-2018-03913,2018,56,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.1,high_burden
KE-NRB-2012-03914,2012,49,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.6,high_burden
KE-NRB-2015-03915,2015,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,5.4,high_burden
KE-NRB-2011-03916,2011,7,0-14,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-03917,2017,87,75+,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-03918,2015,61,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,4.8,high_burden
KE-NRB-2015-03919,2015,52,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.3,high_burden
KE-NRB-2014-03920,2014,26,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.9,high_burden
KE-NRB-2016-03921,2016,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,No treatment,Alive,38.4,high_burden
KE-NRB-2015-03922,2015,63,55-64,Female,Other,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Alive,51.4,high_burden
KE-NRB-2011-03923,2011,67,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,10.7,high_burden
KE-NRB-2014-03924,2014,56,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,35.3,high_burden
KE-NRB-2013-03925,2013,62,55-64,Male,Bladder,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.1,high_burden
KE-NRB-2011-03926,2011,19,15-24,Male,Liver,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,49.7,high_burden
KE-NRB-2010-03927,2010,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,52.2,high_burden
KE-NRB-2015-03928,2015,39,35-44,Male,Liver,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,57.5,high_burden
KE-NRB-2011-03929,2011,55,55-64,Male,Stomach,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Alive,2.2,high_burden
KE-NRB-2013-03930,2013,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,31.0,high_burden
KE-NRB-2018-03931,2018,10,0-14,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,33.5,high_burden
KE-NRB-2016-03932,2016,48,45-54,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Dead,7.1,high_burden
KE-NRB-2015-03933,2015,37,35-44,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,26.3,high_burden
KE-NRB-2018-03934,2018,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-03935,2009,65,65-74,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.7,high_burden
KE-NRB-2013-03936,2013,74,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,45.7,high_burden
KE-NRB-2011-03937,2011,47,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-03938,2015,66,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.3,high_burden
KE-NRB-2017-03939,2017,56,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,16.1,high_burden
KE-NRB-2017-03940,2017,47,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.9,high_burden
KE-NRB-2011-03941,2011,52,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,24.5,high_burden
KE-NRB-2017-03942,2017,43,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2014-03943,2014,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-03944,2016,52,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.7,high_burden
KE-NRB-2018-03945,2018,21,15-24,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-03946,2009,62,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2009-03947,2009,44,35-44,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,14.7,high_burden
KE-NRB-2018-03948,2018,19,15-24,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.7,high_burden
KE-NRB-2017-03949,2017,87,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2018-03950,2018,34,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.9,high_burden
KE-NRB-2017-03951,2017,48,45-54,Male,Oesophagus,Lymphoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Dead,14.0,high_burden
KE-NRB-2015-03952,2015,39,35-44,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,32.4,high_burden
KE-NRB-2018-03953,2018,72,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,26.8,high_burden
KE-NRB-2010-03954,2010,48,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.5,high_burden
KE-NRB-2013-03955,2013,51,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,26.6,high_burden
KE-NRB-2015-03956,2015,71,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-03957,2011,54,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,40.8,high_burden
KE-NRB-2014-03958,2014,67,65-74,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-03959,2011,35,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.1,high_burden
KE-NRB-2012-03960,2012,45,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,20.4,high_burden
KE-NRB-2017-03961,2017,68,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,5.6,high_burden
KE-NRB-2018-03962,2018,64,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,50.3,high_burden
KE-NRB-2014-03963,2014,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,38.4,high_burden
KE-NRB-2014-03964,2014,38,35-44,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.1,high_burden
KE-NRB-2018-03965,2018,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-03966,2014,62,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-03967,2014,48,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.8,high_burden
KE-NRB-2015-03968,2015,56,55-64,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,13.3,high_burden
KE-NRB-2016-03969,2016,36,35-44,Female,Other,Other specified,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,33.8,high_burden
KE-NRB-2015-03970,2015,41,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,2.9,high_burden
KE-NRB-2018-03971,2018,66,65-74,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-03972,2015,63,55-64,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,20.6,high_burden
KE-NRB-2016-03973,2016,74,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-03974,2011,58,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-03975,2018,50,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.4,high_burden
KE-NRB-2010-03976,2010,41,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.2,high_burden
KE-NRB-2017-03977,2017,36,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Rural,N/A,Alive,53.2,high_burden
KE-NRB-2014-03978,2014,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,1.7,high_burden
KE-NRB-2017-03979,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.9,high_burden
KE-NRB-2011-03980,2011,82,75+,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,43.5,high_burden
KE-NRB-2017-03981,2017,73,65-74,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.6,high_burden
KE-NRB-2011-03982,2011,40,35-44,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-03983,2014,60,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,33.0,high_burden
KE-NRB-2016-03984,2016,42,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,34.1,high_burden
KE-NRB-2015-03985,2015,56,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,high_burden
KE-NRB-2016-03986,2016,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.5,high_burden
KE-NRB-2009-03987,2009,93,75+,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,20.3,high_burden
KE-NRB-2010-03988,2010,59,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,36.1,high_burden
KE-NRB-2013-03989,2013,57,55-64,Male,Lung,Other specified,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,3.3,high_burden
KE-NRB-2011-03990,2011,73,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,18.3,high_burden
KE-NRB-2015-03991,2015,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-03992,2014,60,55-64,Female,Cervix uteri,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.9,high_burden
KE-NRB-2011-03993,2011,63,55-64,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,10.7,high_burden
KE-NRB-2016-03994,2016,62,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,15.5,high_burden
KE-NRB-2012-03995,2012,91,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.0,high_burden
KE-NRB-2018-03996,2018,54,45-54,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.4,high_burden
KE-NRB-2012-03997,2012,53,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,3.7,high_burden
KE-NRB-2018-03998,2018,90,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-03999,2010,61,55-64,Male,Skin (melanoma),Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.8,high_burden
KE-NRB-2013-04000,2013,72,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.0,high_burden
KE-NRB-2015-04001,2015,53,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.6,high_burden
KE-NRB-2014-04002,2014,52,45-54,Female,Other,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Rural,Chemotherapy only,Dead,1.2,high_burden
KE-NRB-2018-04003,2018,56,55-64,Male,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,13.1,high_burden
KE-NRB-2015-04004,2015,44,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,30.4,high_burden
KE-NRB-2009-04005,2009,29,25-34,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.0,high_burden
KE-NRB-2016-04006,2016,50,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,26.8,high_burden
KE-NRB-2017-04007,2017,93,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,19.0,high_burden
KE-NRB-2017-04008,2017,43,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,46.2,high_burden
KE-NRB-2013-04009,2013,82,75+,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-04010,2012,61,55-64,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.6,high_burden
KE-NRB-2018-04011,2018,85,75+,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,60.0,high_burden
KE-NRB-2012-04012,2012,63,55-64,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,58.4,high_burden
KE-NRB-2009-04013,2009,47,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,42.1,high_burden
KE-NRB-2015-04014,2015,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2014-04015,2014,44,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.3,high_burden
KE-NRB-2017-04016,2017,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,3.0,high_burden
KE-NRB-2017-04017,2017,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,12.1,high_burden
KE-NRB-2018-04018,2018,49,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.2,high_burden
KE-NRB-2009-04019,2009,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.5,high_burden
KE-NRB-2016-04020,2016,53,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2015-04021,2015,94,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-04022,2015,15,15-24,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,18.4,high_burden
KE-NRB-2018-04023,2018,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,45.5,high_burden
KE-NRB-2015-04024,2015,93,75+,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Dead,13.5,high_burden
KE-NRB-2009-04025,2009,63,55-64,Male,Oesophagus,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,22.5,high_burden
KE-NRB-2018-04026,2018,6,0-14,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,28.2,high_burden
KE-NRB-2014-04027,2014,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.4,high_burden
KE-NRB-2012-04028,2012,76,75+,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,54.7,high_burden
KE-NRB-2014-04029,2014,45,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,51.2,high_burden
KE-NRB-2011-04030,2011,57,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.1,high_burden
KE-NRB-2018-04031,2018,73,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,13.8,high_burden
KE-NRB-2018-04032,2018,70,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,55.9,high_burden
KE-NRB-2017-04033,2017,73,65-74,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,4.9,high_burden
KE-NRB-2010-04034,2010,26,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2009-04035,2009,69,65-74,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,11.3,high_burden
KE-NRB-2016-04036,2016,92,75+,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.3,high_burden
KE-NRB-2015-04037,2015,72,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,35.4,high_burden
KE-NRB-2017-04038,2017,74,65-74,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-04039,2011,70,65-74,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.5,high_burden
KE-NRB-2015-04040,2015,48,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,21.1,high_burden
KE-NRB-2010-04041,2010,32,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,8.4,high_burden
KE-NRB-2009-04042,2009,72,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,15.6,high_burden
KE-NRB-2017-04043,2017,30,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-04044,2010,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,5.3,high_burden
KE-NRB-2017-04045,2017,58,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,45.2,high_burden
KE-NRB-2016-04046,2016,37,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,4.3,high_burden
KE-NRB-2016-04047,2016,72,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,6.1,high_burden
KE-NRB-2015-04048,2015,35,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.0,high_burden
KE-NRB-2018-04049,2018,82,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,50.1,high_burden
KE-NRB-2015-04050,2015,24,15-24,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,57.1,high_burden
KE-NRB-2017-04051,2017,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.0,high_burden
KE-NRB-2014-04052,2014,51,45-54,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,9.2,high_burden
KE-NRB-2017-04053,2017,63,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-04054,2013,56,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,No treatment,Dead,50.6,high_burden
KE-NRB-2015-04055,2015,63,55-64,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,37.1,high_burden
KE-NRB-2015-04056,2015,56,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.5,high_burden
KE-NRB-2016-04057,2016,58,55-64,Male,Stomach,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,9.5,high_burden
KE-NRB-2017-04058,2017,35,35-44,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,0.2,high_burden
KE-NRB-2014-04059,2014,68,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,44.5,high_burden
KE-NRB-2017-04060,2017,74,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,44.0,high_burden
KE-NRB-2018-04061,2018,53,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,18.9,high_burden
KE-NRB-2010-04062,2010,85,75+,Female,Breast,Sarcoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Dead,22.0,high_burden
KE-NRB-2017-04063,2017,52,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.2,high_burden
KE-NRB-2014-04064,2014,78,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2017-04065,2017,32,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,17.1,high_burden
KE-NRB-2011-04066,2011,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,13.9,high_burden
KE-NRB-2013-04067,2013,94,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,52.4,high_burden
KE-NRB-2017-04068,2017,84,75+,Male,Leukemia,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-04069,2016,71,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,3.9,high_burden
KE-NRB-2012-04070,2012,71,65-74,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,24.4,high_burden
KE-NRB-2009-04071,2009,48,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,44.7,high_burden
KE-NRB-2017-04072,2017,45,45-54,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-04073,2012,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,high_burden
KE-NRB-2017-04074,2017,38,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,44.1,high_burden
KE-NRB-2015-04075,2015,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.2,high_burden
KE-NRB-2009-04076,2009,74,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-04077,2013,40,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,32.1,high_burden
KE-NRB-2014-04078,2014,73,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,49.7,high_burden
KE-NRB-2010-04079,2010,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,49.4,high_burden
KE-NRB-2011-04080,2011,46,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2012-04081,2012,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.6,high_burden
KE-NRB-2015-04082,2015,73,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-04083,2018,42,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,0.1,high_burden
KE-NRB-2012-04084,2012,51,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,2.6,high_burden
KE-NRB-2011-04085,2011,67,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.9,high_burden
KE-NRB-2016-04086,2016,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.5,high_burden
KE-NRB-2015-04087,2015,60,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.4,high_burden
KE-NRB-2010-04088,2010,52,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,37.8,high_burden
KE-NRB-2013-04089,2013,4,0-14,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.1,high_burden
KE-NRB-2017-04090,2017,61,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2013-04091,2013,48,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-04092,2013,80,75+,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,38.5,high_burden
KE-NRB-2015-04093,2015,71,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.6,high_burden
KE-NRB-2016-04094,2016,49,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,44.6,high_burden
KE-NRB-2016-04095,2016,61,55-64,Male,Non-Hodgkin lymphoma,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,21.9,high_burden
KE-NRB-2015-04096,2015,32,25-34,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.0,high_burden
KE-NRB-2014-04097,2014,75,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,2.9,high_burden
KE-NRB-2016-04098,2016,47,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,16.6,high_burden
KE-NRB-2018-04099,2018,45,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.3,high_burden
KE-NRB-2017-04100,2017,35,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-04101,2016,58,55-64,Male,Non-Hodgkin lymphoma,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.7,high_burden
KE-NRB-2015-04102,2015,44,35-44,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,44.1,high_burden
KE-NRB-2016-04103,2016,55,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,29.4,high_burden
KE-NRB-2010-04104,2010,41,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-04105,2017,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2016-04106,2016,55,55-64,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,8.7,high_burden
KE-NRB-2017-04107,2017,69,65-74,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.5,high_burden
KE-NRB-2011-04108,2011,19,15-24,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,29.3,high_burden
KE-NRB-2018-04109,2018,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.8,high_burden
KE-NRB-2015-04110,2015,58,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,37.2,high_burden
KE-NRB-2018-04111,2018,23,15-24,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2010-04112,2010,35,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.1,high_burden
KE-NRB-2017-04113,2017,52,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,18.0,high_burden
KE-NRB-2018-04114,2018,50,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,24.8,high_burden
KE-NRB-2015-04115,2015,48,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-04116,2015,52,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.7,high_burden
KE-NRB-2017-04117,2017,81,75+,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,35.5,high_burden
KE-NRB-2018-04118,2018,35,35-44,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-04119,2011,41,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,20.4,high_burden
KE-NRB-2011-04120,2011,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,26.7,high_burden
KE-NRB-2016-04121,2016,41,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-04122,2017,40,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,3.6,high_burden
KE-NRB-2017-04123,2017,51,45-54,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-04124,2017,66,65-74,Male,Colorectum,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,44.2,high_burden
KE-NRB-2010-04125,2010,26,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,7.0,high_burden
KE-NRB-2018-04126,2018,61,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.0,high_burden
KE-NRB-2012-04127,2012,95,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,5.5,high_burden
KE-NRB-2011-04128,2011,3,0-14,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,38.1,high_burden
KE-NRB-2018-04129,2018,28,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Rural,Chemo + Radiotherapy,Dead,49.5,high_burden
KE-NRB-2016-04130,2016,49,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-04131,2011,49,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.1,high_burden
KE-NRB-2016-04132,2016,70,65-74,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-04133,2010,55,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,28.4,high_burden
KE-NRB-2018-04134,2018,40,35-44,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,39.4,high_burden
KE-NRB-2017-04135,2017,68,65-74,Male,Lung,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-04136,2011,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2012-04137,2012,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,38.4,high_burden
KE-NRB-2018-04138,2018,89,75+,Male,Kidney,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,60.0,high_burden
KE-NRB-2011-04139,2011,42,35-44,Male,Oesophagus,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,11.2,high_burden
KE-NRB-2015-04140,2015,46,45-54,Female,Other,Leukemia,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,36.7,high_burden
KE-NRB-2015-04141,2015,35,35-44,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,30.2,high_burden
KE-NRB-2016-04142,2016,55,55-64,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-04143,2015,82,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,49.4,high_burden
KE-NRB-2017-04144,2017,58,55-64,Male,Kaposi sarcoma,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-04145,2010,32,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.5,high_burden
KE-NRB-2012-04146,2012,21,15-24,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,53.4,high_burden
KE-NRB-2010-04147,2010,36,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,No treatment,Dead,24.6,high_burden
KE-NRB-2011-04148,2011,71,65-74,Male,Liver,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-04149,2016,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,7.3,high_burden
KE-NRB-2018-04150,2018,28,25-34,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.5,high_burden
KE-NRB-2015-04151,2015,37,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-04152,2014,32,25-34,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,6.7,high_burden
KE-NRB-2017-04153,2017,50,45-54,Male,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,11.8,high_burden
KE-NRB-2016-04154,2016,37,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,33.4,high_burden
KE-NRB-2014-04155,2014,33,25-34,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.4,high_burden
KE-NRB-2011-04156,2011,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,5.0,high_burden
KE-NRB-2012-04157,2012,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,29.6,high_burden
KE-NRB-2012-04158,2012,69,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,40.4,high_burden
KE-NRB-2017-04159,2017,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,9.4,high_burden
KE-NRB-2013-04160,2013,31,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,31.3,high_burden
KE-NRB-2009-04161,2009,70,65-74,Female,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.8,high_burden
KE-NRB-2016-04162,2016,45,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,58.8,high_burden
KE-NRB-2016-04163,2016,91,75+,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.6,high_burden
KE-NRB-2014-04164,2014,42,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,28.8,high_burden
KE-NRB-2011-04165,2011,54,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.2,high_burden
KE-NRB-2017-04166,2017,73,65-74,Male,Stomach,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,0.7,high_burden
KE-NRB-2014-04167,2014,53,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,2.9,high_burden
KE-NRB-2013-04168,2013,66,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,47.6,high_burden
KE-NRB-2017-04169,2017,48,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,58.7,high_burden
KE-NRB-2014-04170,2014,68,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.3,high_burden
KE-NRB-2012-04171,2012,32,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,13.0,high_burden
KE-NRB-2017-04172,2017,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.6,high_burden
KE-NRB-2014-04173,2014,46,45-54,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2018-04174,2018,39,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,6.0,high_burden
KE-NRB-2015-04175,2015,51,45-54,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.2,high_burden
KE-NRB-2011-04176,2011,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,58.9,high_burden
KE-NRB-2017-04177,2017,51,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,15.5,high_burden
KE-NRB-2018-04178,2018,57,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,18.0,high_burden
KE-NRB-2017-04179,2017,76,75+,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-04180,2014,29,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,6.1,high_burden
KE-NRB-2016-04181,2016,37,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,6.2,high_burden
KE-NRB-2018-04182,2018,50,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,29.1,high_burden
KE-NRB-2016-04183,2016,39,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,1.1,high_burden
KE-NRB-2014-04184,2014,66,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,27.0,high_burden
KE-NRB-2018-04185,2018,63,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,11.8,high_burden
KE-NRB-2016-04186,2016,19,15-24,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,0.8,high_burden
KE-NRB-2013-04187,2013,47,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,58.4,high_burden
KE-NRB-2011-04188,2011,25,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-04189,2016,71,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,9.5,high_burden
KE-NRB-2017-04190,2017,34,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-04191,2013,48,45-54,Female,Ovary,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,26.5,high_burden
KE-NRB-2017-04192,2017,46,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,1.5,high_burden
KE-NRB-2011-04193,2011,52,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-04194,2017,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,48.7,high_burden
KE-NRB-2017-04195,2017,44,35-44,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,14.4,high_burden
KE-NRB-2009-04196,2009,47,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,34.6,high_burden
KE-NRB-2013-04197,2013,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-04198,2011,48,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.2,high_burden
KE-NRB-2018-04199,2018,76,75+,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,13.6,high_burden
KE-NRB-2013-04200,2013,37,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.4,high_burden
KE-NRB-2016-04201,2016,69,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,4.7,high_burden
KE-NRB-2013-04202,2013,54,45-54,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-04203,2017,37,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,56.1,high_burden
KE-NRB-2013-04204,2013,45,45-54,Male,Prostate,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,54.2,high_burden
KE-NRB-2014-04205,2014,62,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,In situ,Peri-urban,N/A,Dead,31.1,high_burden
KE-NRB-2018-04206,2018,35,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.6,high_burden
KE-NRB-2018-04207,2018,72,65-74,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,17.7,high_burden
KE-NRB-2011-04208,2011,71,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.6,high_burden
KE-NRB-2018-04209,2018,50,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.4,high_burden
KE-NRB-2017-04210,2017,61,55-64,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,1.8,high_burden
KE-NRB-2018-04211,2018,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-04212,2010,41,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-04213,2018,60,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,47.0,high_burden
KE-NRB-2014-04214,2014,66,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-04215,2016,52,45-54,Male,Colorectum,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,5.8,high_burden
KE-NRB-2016-04216,2016,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,9.8,high_burden
KE-NRB-2017-04217,2017,73,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.9,high_burden
KE-NRB-2014-04218,2014,64,55-64,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.2,high_burden
KE-NRB-2011-04219,2011,88,75+,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery only,Alive,35.9,high_burden
KE-NRB-2012-04220,2012,95,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,5.7,high_burden
KE-NRB-2015-04221,2015,71,65-74,Male,Lung,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-04222,2014,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,57.9,high_burden
KE-NRB-2010-04223,2010,90,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-04224,2016,57,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,9.1,high_burden
KE-NRB-2016-04225,2016,36,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,25.6,high_burden
KE-NRB-2009-04226,2009,39,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,28.6,high_burden
KE-NRB-2014-04227,2014,61,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,35.9,high_burden
KE-NRB-2014-04228,2014,56,55-64,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,0.4,high_burden
KE-NRB-2016-04229,2016,35,35-44,Male,Pancreas,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,33.0,high_burden
KE-NRB-2009-04230,2009,30,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04231,2015,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,42.0,high_burden
KE-NRB-2015-04232,2015,52,45-54,Male,Lung,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2011-04233,2011,62,55-64,Male,Oesophagus,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,21.4,high_burden
KE-NRB-2012-04234,2012,55,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.9,high_burden
KE-NRB-2015-04235,2015,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.1,high_burden
KE-NRB-2018-04236,2018,60,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,21.6,high_burden
KE-NRB-2017-04237,2017,25,25-34,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,28.2,high_burden
KE-NRB-2015-04238,2015,56,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.3,high_burden
KE-NRB-2014-04239,2014,67,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.8,high_burden
KE-NRB-2018-04240,2018,63,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-04241,2015,57,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,1.3,high_burden
KE-NRB-2017-04242,2017,66,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.8,high_burden
KE-NRB-2017-04243,2017,31,25-34,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.5,high_burden
KE-NRB-2015-04244,2015,29,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,18.7,high_burden
KE-NRB-2016-04245,2016,70,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,10.9,high_burden
KE-NRB-2016-04246,2016,42,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,10.4,high_burden
KE-NRB-2014-04247,2014,35,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.0,high_burden
KE-NRB-2015-04248,2015,68,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,24.1,high_burden
KE-NRB-2010-04249,2010,69,65-74,Male,Oesophagus,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,44.9,high_burden
KE-NRB-2015-04250,2015,48,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,24.0,high_burden
KE-NRB-2012-04251,2012,61,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.3,high_burden
KE-NRB-2014-04252,2014,51,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,23.5,high_burden
KE-NRB-2016-04253,2016,53,45-54,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,22.5,high_burden
KE-NRB-2018-04254,2018,32,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,20.4,high_burden
KE-NRB-2014-04255,2014,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,5.1,high_burden
KE-NRB-2016-04256,2016,34,25-34,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.3,high_burden
KE-NRB-2016-04257,2016,67,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-04258,2013,43,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.2,high_burden
KE-NRB-2016-04259,2016,73,65-74,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.0,high_burden
KE-NRB-2017-04260,2017,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.8,high_burden
KE-NRB-2015-04261,2015,50,45-54,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Radiotherapy only,Alive,30.5,high_burden
KE-NRB-2018-04262,2018,51,45-54,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,55.4,high_burden
KE-NRB-2009-04263,2009,31,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,1.9,high_burden
KE-NRB-2015-04264,2015,56,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-04265,2015,62,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Dead,27.3,high_burden
KE-NRB-2018-04266,2018,17,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.0,high_burden
KE-NRB-2009-04267,2009,41,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-04268,2013,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,31.5,high_burden
KE-NRB-2012-04269,2012,36,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,16.0,high_burden
KE-NRB-2015-04270,2015,80,75+,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.2,high_burden
KE-NRB-2018-04271,2018,80,75+,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.2,high_burden
KE-NRB-2014-04272,2014,27,25-34,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,53.0,high_burden
KE-NRB-2015-04273,2015,65,65-74,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.5,high_burden
KE-NRB-2014-04274,2014,62,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,23.8,high_burden
KE-NRB-2016-04275,2016,69,65-74,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,18.5,high_burden
KE-NRB-2017-04276,2017,13,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,0.2,high_burden
KE-NRB-2018-04277,2018,95,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-04278,2015,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,41.4,high_burden
KE-NRB-2015-04279,2015,27,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,41.7,high_burden
KE-NRB-2014-04280,2014,90,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,24.1,high_burden
KE-NRB-2011-04281,2011,36,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.5,high_burden
KE-NRB-2018-04282,2018,25,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,16.9,high_burden
KE-NRB-2014-04283,2014,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.2,high_burden
KE-NRB-2009-04284,2009,35,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,47.6,high_burden
KE-NRB-2017-04285,2017,34,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,16.8,high_burden
KE-NRB-2013-04286,2013,68,65-74,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,4.1,high_burden
KE-NRB-2015-04287,2015,45,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,15.5,high_burden
KE-NRB-2018-04288,2018,3,0-14,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.9,high_burden
KE-NRB-2017-04289,2017,64,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,49.5,high_burden
KE-NRB-2012-04290,2012,69,65-74,Male,Liver,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,5.4,high_burden
KE-NRB-2016-04291,2016,55,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.3,high_burden
KE-NRB-2017-04292,2017,12,0-14,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.4,high_burden
KE-NRB-2018-04293,2018,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.1,high_burden
KE-NRB-2014-04294,2014,61,55-64,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,42.4,high_burden
KE-NRB-2017-04295,2017,85,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,46.2,high_burden
KE-NRB-2012-04296,2012,72,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Dead,32.0,high_burden
KE-NRB-2014-04297,2014,27,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,24.5,high_burden
KE-NRB-2012-04298,2012,11,0-14,Male,Non-Hodgkin lymphoma,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Rural,N/A,Alive,60.0,high_burden
KE-NRB-2011-04299,2011,43,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.4,high_burden
KE-NRB-2015-04300,2015,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,24.5,high_burden
KE-NRB-2010-04301,2010,71,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-04302,2016,23,15-24,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.5,high_burden
KE-NRB-2017-04303,2017,71,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,51.3,high_burden
KE-NRB-2016-04304,2016,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.2,high_burden
KE-NRB-2016-04305,2016,45,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,29.2,high_burden
KE-NRB-2014-04306,2014,57,55-64,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2015-04307,2015,51,45-54,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,31.3,high_burden
KE-NRB-2016-04308,2016,52,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.3,high_burden
KE-NRB-2011-04309,2011,47,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,10.4,high_burden
KE-NRB-2014-04310,2014,54,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,22.1,high_burden
KE-NRB-2018-04311,2018,54,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,57.6,high_burden
KE-NRB-2017-04312,2017,67,65-74,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,49.2,high_burden
KE-NRB-2018-04313,2018,48,45-54,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,13.7,high_burden
KE-NRB-2015-04314,2015,26,25-34,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.5,high_burden
KE-NRB-2014-04315,2014,69,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,19.7,high_burden
KE-NRB-2018-04316,2018,33,25-34,Male,Brain and CNS,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,23.4,high_burden
KE-NRB-2009-04317,2009,76,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,16.6,high_burden
KE-NRB-2018-04318,2018,40,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,30.1,high_burden
KE-NRB-2015-04319,2015,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,10.2,high_burden
KE-NRB-2013-04320,2013,30,25-34,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.9,high_burden
KE-NRB-2012-04321,2012,73,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,9.9,high_burden
KE-NRB-2013-04322,2013,63,55-64,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-04323,2018,69,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,57.4,high_burden
KE-NRB-2014-04324,2014,91,75+,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.6,high_burden
KE-NRB-2015-04325,2015,52,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,19.8,high_burden
KE-NRB-2015-04326,2015,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,40.5,high_burden
KE-NRB-2015-04327,2015,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,39.4,high_burden
KE-NRB-2017-04328,2017,69,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-04329,2011,62,55-64,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-04330,2017,40,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.9,high_burden
KE-NRB-2017-04331,2017,57,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.7,high_burden
KE-NRB-2011-04332,2011,40,35-44,Male,Multiple myeloma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04333,2015,58,55-64,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,5.2,high_burden
KE-NRB-2017-04334,2017,59,55-64,Female,Ovary,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,35.2,high_burden
KE-NRB-2012-04335,2012,54,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.3,high_burden
KE-NRB-2012-04336,2012,65,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,47.5,high_burden
KE-NRB-2015-04337,2015,67,65-74,Male,Non-Hodgkin lymphoma,Unspecified,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Alive,11.7,high_burden
KE-NRB-2010-04338,2010,30,25-34,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.0,high_burden
KE-NRB-2010-04339,2010,45,45-54,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2016-04340,2016,61,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2012-04341,2012,61,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery only,Dead,16.1,high_burden
KE-NRB-2016-04342,2016,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,14.0,high_burden
KE-NRB-2010-04343,2010,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.5,high_burden
KE-NRB-2011-04344,2011,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,13.0,high_burden
KE-NRB-2016-04345,2016,73,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,43.2,high_burden
KE-NRB-2016-04346,2016,93,75+,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-04347,2015,32,25-34,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.1,high_burden
KE-NRB-2014-04348,2014,21,15-24,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,0.4,high_burden
KE-NRB-2018-04349,2018,70,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,13.7,high_burden
KE-NRB-2013-04350,2013,42,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,32.4,high_burden
KE-NRB-2011-04351,2011,50,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,16.3,high_burden
KE-NRB-2018-04352,2018,41,35-44,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,18.4,high_burden
KE-NRB-2012-04353,2012,62,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,4.9,high_burden
KE-NRB-2013-04354,2013,94,75+,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,59.4,high_burden
KE-NRB-2010-04355,2010,68,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,34.7,high_burden
KE-NRB-2014-04356,2014,54,45-54,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,16.9,high_burden
KE-NRB-2011-04357,2011,68,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04358,2015,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.6,high_burden
KE-NRB-2010-04359,2010,95,75+,Male,Lung,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.7,high_burden
KE-NRB-2018-04360,2018,57,55-64,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,No treatment,Alive,15.8,high_burden
KE-NRB-2018-04361,2018,86,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Dead,16.1,high_burden
KE-NRB-2011-04362,2011,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,22.7,high_burden
KE-NRB-2015-04363,2015,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.8,high_burden
KE-NRB-2011-04364,2011,59,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-04365,2015,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,1.6,high_burden
KE-NRB-2012-04366,2012,33,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,21.5,high_burden
KE-NRB-2014-04367,2014,40,35-44,Male,Kidney,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-04368,2013,38,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,52.2,high_burden
KE-NRB-2018-04369,2018,49,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.8,high_burden
KE-NRB-2013-04370,2013,61,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-04371,2013,64,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.9,high_burden
KE-NRB-2018-04372,2018,73,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.9,high_burden
KE-NRB-2015-04373,2015,55,55-64,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,12.1,high_burden
KE-NRB-2016-04374,2016,30,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-04375,2017,57,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.3,high_burden
KE-NRB-2014-04376,2014,50,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-04377,2017,38,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,44.5,high_burden
KE-NRB-2016-04378,2016,66,65-74,Male,Liver,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.9,high_burden
KE-NRB-2012-04379,2012,59,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2010-04380,2010,80,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,37.6,high_burden
KE-NRB-2016-04381,2016,59,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,9.1,high_burden
KE-NRB-2018-04382,2018,62,55-64,Male,Other,Other specified,Poorly differentiated (Grade III),Other,Malignant,Rural,Chemotherapy only,Dead,10.5,high_burden
KE-NRB-2017-04383,2017,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,51.2,high_burden
KE-NRB-2011-04384,2011,60,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.4,high_burden
KE-NRB-2017-04385,2017,56,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-04386,2012,67,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,34.7,high_burden
KE-NRB-2016-04387,2016,61,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,1.4,high_burden
KE-NRB-2015-04388,2015,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.3,high_burden
KE-NRB-2009-04389,2009,67,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-04390,2010,39,35-44,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.5,high_burden
KE-NRB-2016-04391,2016,83,75+,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,59.1,high_burden
KE-NRB-2010-04392,2010,68,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-04393,2010,17,15-24,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,21.1,high_burden
KE-NRB-2012-04394,2012,35,35-44,Male,Leukemia,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-04395,2012,71,65-74,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,19.7,high_burden
KE-NRB-2017-04396,2017,50,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.6,high_burden
KE-NRB-2017-04397,2017,53,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,46.7,high_burden
KE-NRB-2012-04398,2012,47,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,44.0,high_burden
KE-NRB-2017-04399,2017,59,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.8,high_burden
KE-NRB-2012-04400,2012,73,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.1,high_burden
KE-NRB-2015-04401,2015,40,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,54.5,high_burden
KE-NRB-2015-04402,2015,73,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,35.5,high_burden
KE-NRB-2009-04403,2009,39,35-44,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.0,high_burden
KE-NRB-2017-04404,2017,52,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2010-04405,2010,58,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2013-04406,2013,67,65-74,Male,Kidney,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,21.1,high_burden
KE-NRB-2011-04407,2011,65,65-74,Male,Stomach,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.0,high_burden
KE-NRB-2013-04408,2013,38,35-44,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,54.7,high_burden
KE-NRB-2013-04409,2013,62,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.7,high_burden
KE-NRB-2013-04410,2013,48,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,4.2,high_burden
KE-NRB-2013-04411,2013,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.2,high_burden
KE-NRB-2010-04412,2010,70,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,17.2,high_burden
KE-NRB-2018-04413,2018,67,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.8,high_burden
KE-NRB-2018-04414,2018,67,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-04415,2017,57,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,1.2,high_burden
KE-NRB-2016-04416,2016,50,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.3,high_burden
KE-NRB-2016-04417,2016,49,45-54,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-04418,2013,27,25-34,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,20.3,high_burden
KE-NRB-2017-04419,2017,26,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,59.2,high_burden
KE-NRB-2015-04420,2015,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.8,high_burden
KE-NRB-2013-04421,2013,71,65-74,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,37.3,high_burden
KE-NRB-2016-04422,2016,50,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,7.0,high_burden
KE-NRB-2015-04423,2015,47,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.9,high_burden
KE-NRB-2015-04424,2015,58,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-04425,2017,50,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,34.3,high_burden
KE-NRB-2011-04426,2011,44,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,26.0,high_burden
KE-NRB-2018-04427,2018,60,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,8.8,high_burden
KE-NRB-2012-04428,2012,36,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.6,high_burden
KE-NRB-2017-04429,2017,41,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,13.0,high_burden
KE-NRB-2018-04430,2018,37,35-44,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.7,high_burden
KE-NRB-2018-04431,2018,73,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-04432,2017,70,65-74,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.2,high_burden
KE-NRB-2017-04433,2017,69,65-74,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-04434,2017,59,55-64,Male,Colorectum,Other specified,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-04435,2017,42,35-44,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,59.5,high_burden
KE-NRB-2016-04436,2016,39,35-44,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-04437,2012,54,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,2.4,high_burden
KE-NRB-2017-04438,2017,45,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.7,high_burden
KE-NRB-2016-04439,2016,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,20.3,high_burden
KE-NRB-2012-04440,2012,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,48.6,high_burden
KE-NRB-2014-04441,2014,73,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.3,high_burden
KE-NRB-2013-04442,2013,70,65-74,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-04443,2011,74,65-74,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2017-04444,2017,56,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,34.1,high_burden
KE-NRB-2015-04445,2015,60,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.7,high_burden
KE-NRB-2015-04446,2015,87,75+,Male,Other,Unspecified,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.7,high_burden
KE-NRB-2014-04447,2014,9,0-14,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Alive,2.7,high_burden
KE-NRB-2009-04448,2009,36,35-44,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.7,high_burden
KE-NRB-2014-04449,2014,45,45-54,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,16.2,high_burden
KE-NRB-2018-04450,2018,48,45-54,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.3,high_burden
KE-NRB-2012-04451,2012,89,75+,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,Surgery only,Alive,11.3,high_burden
KE-NRB-2012-04452,2012,36,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,47.1,high_burden
KE-NRB-2012-04453,2012,31,25-34,Male,Stomach,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,34.2,high_burden
KE-NRB-2017-04454,2017,71,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,43.7,high_burden
KE-NRB-2009-04455,2009,23,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-04456,2012,40,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,1.7,high_burden
KE-NRB-2015-04457,2015,56,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Dead,53.5,high_burden
KE-NRB-2016-04458,2016,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-04459,2017,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,7.5,high_burden
KE-NRB-2010-04460,2010,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-04461,2018,72,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2009-04462,2009,15,15-24,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,9.8,high_burden
KE-NRB-2009-04463,2009,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,48.2,high_burden
KE-NRB-2013-04464,2013,37,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,22.9,high_burden
KE-NRB-2014-04465,2014,42,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,12.0,high_burden
KE-NRB-2012-04466,2012,65,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2009-04467,2009,75,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.2,high_burden
KE-NRB-2017-04468,2017,51,45-54,Male,Skin (melanoma),Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.8,high_burden
KE-NRB-2016-04469,2016,70,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,28.9,high_burden
KE-NRB-2018-04470,2018,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-04471,2018,36,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,25.7,high_burden
KE-NRB-2009-04472,2009,70,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,0.0,high_burden
KE-NRB-2009-04473,2009,54,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,24.1,high_burden
KE-NRB-2017-04474,2017,73,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,0.9,high_burden
KE-NRB-2015-04475,2015,47,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,32.1,high_burden
KE-NRB-2011-04476,2011,27,25-34,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,20.7,high_burden
KE-NRB-2016-04477,2016,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,47.2,high_burden
KE-NRB-2016-04478,2016,26,25-34,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,41.8,high_burden
KE-NRB-2012-04479,2012,40,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,3.1,high_burden
KE-NRB-2011-04480,2011,76,75+,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,29.2,high_burden
KE-NRB-2011-04481,2011,48,45-54,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-04482,2018,76,75+,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Lost to follow-up,11.0,high_burden
KE-NRB-2018-04483,2018,50,45-54,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,2.8,high_burden
KE-NRB-2012-04484,2012,65,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-04485,2009,86,75+,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,47.5,high_burden
KE-NRB-2016-04486,2016,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,14.7,high_burden
KE-NRB-2015-04487,2015,49,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.2,high_burden
KE-NRB-2014-04488,2014,37,35-44,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.9,high_burden
KE-NRB-2011-04489,2011,46,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.2,high_burden
KE-NRB-2017-04490,2017,73,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,11.7,high_burden
KE-NRB-2015-04491,2015,74,65-74,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-04492,2017,53,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.1,high_burden
KE-NRB-2014-04493,2014,41,35-44,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,18.7,high_burden
KE-NRB-2010-04494,2010,74,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,26.6,high_burden
KE-NRB-2011-04495,2011,56,55-64,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,55.2,high_burden
KE-NRB-2010-04496,2010,47,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,32.6,high_burden
KE-NRB-2012-04497,2012,75,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.7,high_burden
KE-NRB-2010-04498,2010,42,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,35.2,high_burden
KE-NRB-2011-04499,2011,9,0-14,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.1,high_burden
KE-NRB-2017-04500,2017,65,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.1,high_burden
KE-NRB-2016-04501,2016,72,65-74,Female,Ovary,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,46.4,high_burden
KE-NRB-2018-04502,2018,38,35-44,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.5,high_burden
KE-NRB-2014-04503,2014,39,35-44,Female,Other,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.3,high_burden
KE-NRB-2010-04504,2010,62,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-04505,2013,52,45-54,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,37.4,high_burden
KE-NRB-2014-04506,2014,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,17.0,high_burden
KE-NRB-2018-04507,2018,67,65-74,Male,Colorectum,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-04508,2017,32,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.9,high_burden
KE-NRB-2015-04509,2015,56,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,20.4,high_burden
KE-NRB-2017-04510,2017,62,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,28.5,high_burden
KE-NRB-2018-04511,2018,45,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.6,high_burden
KE-NRB-2016-04512,2016,50,45-54,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,53.1,high_burden
KE-NRB-2018-04513,2018,40,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.5,high_burden
KE-NRB-2014-04514,2014,61,55-64,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,31.2,high_burden
KE-NRB-2010-04515,2010,63,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,0.3,high_burden
KE-NRB-2015-04516,2015,15,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,32.6,high_burden
KE-NRB-2014-04517,2014,57,55-64,Male,Brain and CNS,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,7.2,high_burden
KE-NRB-2017-04518,2017,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,50.4,high_burden
KE-NRB-2015-04519,2015,29,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-04520,2015,33,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.1,high_burden
KE-NRB-2015-04521,2015,57,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2010-04522,2010,89,75+,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.5,high_burden
KE-NRB-2018-04523,2018,51,45-54,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,33.4,high_burden
KE-NRB-2013-04524,2013,88,75+,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,3.7,high_burden
KE-NRB-2010-04525,2010,3,0-14,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,16.3,high_burden
KE-NRB-2015-04526,2015,71,65-74,Male,Colorectum,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,42.9,high_burden
KE-NRB-2018-04527,2018,57,55-64,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-04528,2013,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,17.6,high_burden
KE-NRB-2015-04529,2015,69,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.1,high_burden
KE-NRB-2017-04530,2017,41,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,19.5,high_burden
KE-NRB-2017-04531,2017,42,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,10.4,high_burden
KE-NRB-2011-04532,2011,45,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-04533,2012,73,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,3.5,high_burden
KE-NRB-2009-04534,2009,34,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.5,high_burden
KE-NRB-2017-04535,2017,69,65-74,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,30.0,high_burden
KE-NRB-2009-04536,2009,55,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-04537,2018,63,55-64,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-04538,2011,57,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,44.1,high_burden
KE-NRB-2015-04539,2015,58,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,35.1,high_burden
KE-NRB-2013-04540,2013,94,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,24.7,high_burden
KE-NRB-2016-04541,2016,65,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,41.0,high_burden
KE-NRB-2018-04542,2018,46,45-54,Male,Kidney,Adenocarcinoma,Unknown,Clinical only,In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-04543,2009,45,45-54,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.5,high_burden
KE-NRB-2017-04544,2017,70,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-04545,2013,63,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-04546,2009,38,35-44,Male,Bladder,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,40.4,high_burden
KE-NRB-2010-04547,2010,74,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-04548,2012,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2015-04549,2015,37,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-04550,2018,30,25-34,Male,Lung,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.1,high_burden
KE-NRB-2018-04551,2018,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04552,2015,58,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,14.8,high_burden
KE-NRB-2014-04553,2014,70,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,32.2,high_burden
KE-NRB-2010-04554,2010,65,65-74,Male,Kaposi sarcoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.2,high_burden
KE-NRB-2011-04555,2011,68,65-74,Male,Stomach,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,22.0,high_burden
KE-NRB-2017-04556,2017,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,31.4,high_burden
KE-NRB-2017-04557,2017,66,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,60.0,high_burden
KE-NRB-2017-04558,2017,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,51.6,high_burden
KE-NRB-2010-04559,2010,74,65-74,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.8,high_burden
KE-NRB-2013-04560,2013,44,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.8,high_burden
KE-NRB-2013-04561,2013,49,45-54,Female,Breast,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,6.3,high_burden
KE-NRB-2014-04562,2014,64,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.3,high_burden
KE-NRB-2017-04563,2017,56,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-04564,2009,27,25-34,Female,Corpus uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,20.0,high_burden
KE-NRB-2011-04565,2011,44,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.9,high_burden
KE-NRB-2012-04566,2012,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.0,high_burden
KE-NRB-2014-04567,2014,70,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.1,high_burden
KE-NRB-2017-04568,2017,33,25-34,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,0.9,high_burden
KE-NRB-2014-04569,2014,69,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,25.3,high_burden
KE-NRB-2012-04570,2012,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-04571,2013,56,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.2,high_burden
KE-NRB-2016-04572,2016,70,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-04573,2016,51,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-04574,2018,42,35-44,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.3,high_burden
KE-NRB-2010-04575,2010,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,7.3,high_burden
KE-NRB-2010-04576,2010,16,15-24,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-04577,2010,57,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,16.6,high_burden
KE-NRB-2012-04578,2012,61,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,35.1,high_burden
KE-NRB-2015-04579,2015,90,75+,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,30.2,high_burden
KE-NRB-2018-04580,2018,60,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-04581,2014,38,35-44,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,11.9,high_burden
KE-NRB-2011-04582,2011,85,75+,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,10.7,high_burden
KE-NRB-2017-04583,2017,46,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,3.0,high_burden
KE-NRB-2014-04584,2014,42,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.7,high_burden
KE-NRB-2016-04585,2016,70,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-04586,2018,38,35-44,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery only,Lost to follow-up,4.8,high_burden
KE-NRB-2013-04587,2013,28,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2018-04588,2018,51,45-54,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,46.6,high_burden
KE-NRB-2018-04589,2018,66,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-04590,2018,16,15-24,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.0,high_burden
KE-NRB-2012-04591,2012,65,65-74,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,16.0,high_burden
KE-NRB-2017-04592,2017,75,75+,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,27.3,high_burden
KE-NRB-2011-04593,2011,50,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.4,high_burden
KE-NRB-2013-04594,2013,57,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,18.5,high_burden
KE-NRB-2017-04595,2017,71,65-74,Male,Kaposi sarcoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,40.6,high_burden
KE-NRB-2011-04596,2011,76,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-04597,2015,70,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,21.6,high_burden
KE-NRB-2018-04598,2018,70,65-74,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,45.8,high_burden
KE-NRB-2016-04599,2016,67,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,27.8,high_burden
KE-NRB-2014-04600,2014,58,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,22.8,high_burden
KE-NRB-2013-04601,2013,47,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,26.7,high_burden
KE-NRB-2016-04602,2016,51,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Radiotherapy only,Alive,44.3,high_burden
KE-NRB-2016-04603,2016,74,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,38.3,high_burden
KE-NRB-2016-04604,2016,43,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,16.0,high_burden
KE-NRB-2018-04605,2018,65,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,47.2,high_burden
KE-NRB-2017-04606,2017,82,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2018-04607,2018,58,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,36.7,high_burden
KE-NRB-2010-04608,2010,62,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,56.2,high_burden
KE-NRB-2018-04609,2018,42,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,42.4,high_burden
KE-NRB-2018-04610,2018,67,65-74,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.5,high_burden
KE-NRB-2009-04611,2009,69,65-74,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.8,high_burden
KE-NRB-2012-04612,2012,54,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Dead,1.1,high_burden
KE-NRB-2017-04613,2017,59,55-64,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.7,high_burden
KE-NRB-2012-04614,2012,27,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2013-04615,2013,62,55-64,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.0,high_burden
KE-NRB-2017-04616,2017,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,18.0,high_burden
KE-NRB-2012-04617,2012,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.4,high_burden
KE-NRB-2018-04618,2018,29,25-34,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,15.8,high_burden
KE-NRB-2012-04619,2012,61,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.3,high_burden
KE-NRB-2017-04620,2017,63,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.1,high_burden
KE-NRB-2017-04621,2017,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-04622,2018,63,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,27.2,high_burden
KE-NRB-2017-04623,2017,42,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,4.6,high_burden
KE-NRB-2015-04624,2015,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-04625,2011,44,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-04626,2017,36,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.0,high_burden
KE-NRB-2010-04627,2010,54,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,50.2,high_burden
KE-NRB-2018-04628,2018,57,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,27.1,high_burden
KE-NRB-2014-04629,2014,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2018-04630,2018,70,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,15.2,high_burden
KE-NRB-2017-04631,2017,28,25-34,Male,Oesophagus,Lymphoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,10.5,high_burden
KE-NRB-2018-04632,2018,49,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,36.7,high_burden
KE-NRB-2018-04633,2018,38,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.7,high_burden
KE-NRB-2011-04634,2011,16,15-24,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.7,high_burden
KE-NRB-2012-04635,2012,36,35-44,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,11.6,high_burden
KE-NRB-2015-04636,2015,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,1.1,high_burden
KE-NRB-2016-04637,2016,30,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,19.8,high_burden
KE-NRB-2014-04638,2014,62,55-64,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.5,high_burden
KE-NRB-2014-04639,2014,50,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,41.7,high_burden
KE-NRB-2018-04640,2018,32,25-34,Female,Thyroid,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,10.6,high_burden
KE-NRB-2017-04641,2017,32,25-34,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,24.6,high_burden
KE-NRB-2010-04642,2010,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-04643,2016,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,59.6,high_burden
KE-NRB-2010-04644,2010,82,75+,Male,Multiple myeloma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,26.4,high_burden
KE-NRB-2010-04645,2010,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,9.4,high_burden
KE-NRB-2012-04646,2012,18,15-24,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,8.6,high_burden
KE-NRB-2015-04647,2015,6,0-14,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,10.2,high_burden
KE-NRB-2016-04648,2016,95,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,24.7,high_burden
KE-NRB-2011-04649,2011,42,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.2,high_burden
KE-NRB-2017-04650,2017,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2017-04651,2017,5,0-14,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2016-04652,2016,3,0-14,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,28.1,high_burden
KE-NRB-2018-04653,2018,56,55-64,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-04654,2018,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,40.5,high_burden
KE-NRB-2010-04655,2010,46,45-54,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,3.8,high_burden
KE-NRB-2015-04656,2015,77,75+,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2015-04657,2015,69,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,38.2,high_burden
KE-NRB-2015-04658,2015,32,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,34.6,high_burden
KE-NRB-2014-04659,2014,42,35-44,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,49.6,high_burden
KE-NRB-2011-04660,2011,42,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,3.4,high_burden
KE-NRB-2016-04661,2016,45,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.7,high_burden
KE-NRB-2015-04662,2015,73,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,16.2,high_burden
KE-NRB-2018-04663,2018,40,35-44,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-04664,2016,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.4,high_burden
KE-NRB-2017-04665,2017,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,3.5,high_burden
KE-NRB-2009-04666,2009,89,75+,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.4,high_burden
KE-NRB-2012-04667,2012,80,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,27.6,high_burden
KE-NRB-2018-04668,2018,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,26.7,high_burden
KE-NRB-2016-04669,2016,52,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.0,high_burden
KE-NRB-2015-04670,2015,61,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.6,high_burden
KE-NRB-2017-04671,2017,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,9.1,high_burden
KE-NRB-2018-04672,2018,44,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,23.4,high_burden
KE-NRB-2016-04673,2016,73,65-74,Male,Other,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Alive,44.8,high_burden
KE-NRB-2011-04674,2011,55,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.2,high_burden
KE-NRB-2017-04675,2017,71,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,52.6,high_burden
KE-NRB-2015-04676,2015,36,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,38.9,high_burden
KE-NRB-2009-04677,2009,31,25-34,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-04678,2013,45,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,25.2,high_burden
KE-NRB-2014-04679,2014,2,0-14,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,11.7,high_burden
KE-NRB-2011-04680,2011,52,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,4.3,high_burden
KE-NRB-2010-04681,2010,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.1,high_burden
KE-NRB-2011-04682,2011,2,0-14,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,50.3,high_burden
KE-NRB-2018-04683,2018,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,39.6,high_burden
KE-NRB-2018-04684,2018,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-04685,2010,81,75+,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04686,2015,61,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,37.0,high_burden
KE-NRB-2016-04687,2016,49,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,25.5,high_burden
KE-NRB-2017-04688,2017,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2015-04689,2015,58,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.4,high_burden
KE-NRB-2010-04690,2010,43,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2017-04691,2017,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,6.6,high_burden
KE-NRB-2017-04692,2017,38,35-44,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,59.7,high_burden
KE-NRB-2015-04693,2015,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.6,high_burden
KE-NRB-2016-04694,2016,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Lost to follow-up,20.7,high_burden
KE-NRB-2009-04695,2009,53,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.7,high_burden
KE-NRB-2010-04696,2010,71,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-04697,2014,57,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,56.6,high_burden
KE-NRB-2017-04698,2017,32,25-34,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2014-04699,2014,45,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,33.1,high_burden
KE-NRB-2012-04700,2012,68,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,21.7,high_burden
KE-NRB-2015-04701,2015,44,35-44,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,47.8,high_burden
KE-NRB-2011-04702,2011,61,55-64,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,10.8,high_burden
KE-NRB-2014-04703,2014,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,12.2,high_burden
KE-NRB-2013-04704,2013,57,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Rural,N/A,Alive,19.0,high_burden
KE-NRB-2017-04705,2017,41,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-04706,2015,25,25-34,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,8.4,high_burden
KE-NRB-2009-04707,2009,60,55-64,Male,Liver,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,15.9,high_burden
KE-NRB-2017-04708,2017,46,45-54,Female,Other,Other specified,Unknown,Death certificate only,Malignant,Urban,Surgery only,Dead,1.8,high_burden
KE-NRB-2018-04709,2018,41,35-44,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2010-04710,2010,51,45-54,Male,Prostate,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,45.2,high_burden
KE-NRB-2013-04711,2013,63,55-64,Male,Pancreas,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,9.3,high_burden
KE-NRB-2009-04712,2009,54,45-54,Male,Colorectum,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,4.2,high_burden
KE-NRB-2014-04713,2014,47,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,60.0,high_burden
KE-NRB-2015-04714,2015,41,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,29.9,high_burden
KE-NRB-2015-04715,2015,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,6.1,high_burden
KE-NRB-2017-04716,2017,37,35-44,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.2,high_burden
KE-NRB-2018-04717,2018,41,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,In situ,Peri-urban,N/A,Dead,5.1,high_burden
KE-NRB-2014-04718,2014,78,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,21.7,high_burden
KE-NRB-2014-04719,2014,62,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.8,high_burden
KE-NRB-2009-04720,2009,38,35-44,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,37.2,high_burden
KE-NRB-2016-04721,2016,71,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.0,high_burden
KE-NRB-2018-04722,2018,49,45-54,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.8,high_burden
KE-NRB-2017-04723,2017,33,25-34,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.6,high_burden
KE-NRB-2013-04724,2013,40,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.0,high_burden
KE-NRB-2010-04725,2010,40,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2011-04726,2011,65,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.1,high_burden
KE-NRB-2014-04727,2014,40,35-44,Male,Kidney,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,26.4,high_burden
KE-NRB-2018-04728,2018,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Rural,N/A,Dead,9.1,high_burden
KE-NRB-2010-04729,2010,61,55-64,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.9,high_burden
KE-NRB-2018-04730,2018,46,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2014-04731,2014,31,25-34,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2010-04732,2010,61,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,28.7,high_burden
KE-NRB-2016-04733,2016,59,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2012-04734,2012,35,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-04735,2010,67,65-74,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,12.2,high_burden
KE-NRB-2018-04736,2018,74,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.0,high_burden
KE-NRB-2016-04737,2016,53,45-54,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,9.1,high_burden
KE-NRB-2016-04738,2016,80,75+,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.8,high_burden
KE-NRB-2016-04739,2016,54,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,12.6,high_burden
KE-NRB-2017-04740,2017,39,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,4.2,high_burden
KE-NRB-2016-04741,2016,41,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.3,high_burden
KE-NRB-2011-04742,2011,60,55-64,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,53.7,high_burden
KE-NRB-2015-04743,2015,86,75+,Male,Oesophagus,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,16.9,high_burden
KE-NRB-2018-04744,2018,16,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.1,high_burden
KE-NRB-2012-04745,2012,55,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,51.0,high_burden
KE-NRB-2018-04746,2018,50,45-54,Male,Bladder,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-04747,2016,38,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.0,high_burden
KE-NRB-2009-04748,2009,47,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Alive,47.7,high_burden
KE-NRB-2013-04749,2013,64,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04750,2015,42,35-44,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,21.0,high_burden
KE-NRB-2015-04751,2015,62,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-04752,2014,48,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,59.9,high_burden
KE-NRB-2012-04753,2012,53,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,21.4,high_burden
KE-NRB-2014-04754,2014,60,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Dead,2.3,high_burden
KE-NRB-2018-04755,2018,54,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,35.7,high_burden
KE-NRB-2012-04756,2012,51,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,6.9,high_burden
KE-NRB-2016-04757,2016,69,65-74,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.8,high_burden
KE-NRB-2012-04758,2012,63,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,17.9,high_burden
KE-NRB-2015-04759,2015,36,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-04760,2015,47,45-54,Male,Other,Unspecified,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,1.1,high_burden
KE-NRB-2012-04761,2012,32,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.5,high_burden
KE-NRB-2016-04762,2016,83,75+,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.8,high_burden
KE-NRB-2015-04763,2015,25,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-04764,2013,94,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,46.3,high_burden
KE-NRB-2015-04765,2015,27,25-34,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.5,high_burden
KE-NRB-2011-04766,2011,68,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,11.4,high_burden
KE-NRB-2017-04767,2017,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,35.3,high_burden
KE-NRB-2014-04768,2014,60,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.9,high_burden
KE-NRB-2013-04769,2013,26,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.8,high_burden
KE-NRB-2014-04770,2014,40,35-44,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Dead,3.9,high_burden
KE-NRB-2010-04771,2010,26,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,43.5,high_burden
KE-NRB-2011-04772,2011,23,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,7.1,high_burden
KE-NRB-2014-04773,2014,77,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,57.1,high_burden
KE-NRB-2018-04774,2018,50,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-04775,2018,58,55-64,Male,Liver,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.4,high_burden
KE-NRB-2016-04776,2016,81,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.7,high_burden
KE-NRB-2014-04777,2014,43,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,0.0,high_burden
KE-NRB-2015-04778,2015,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,0.7,high_burden
KE-NRB-2013-04779,2013,53,45-54,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.2,high_burden
KE-NRB-2015-04780,2015,69,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,30.9,high_burden
KE-NRB-2016-04781,2016,69,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2009-04782,2009,33,25-34,Male,Brain and CNS,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.2,high_burden
KE-NRB-2016-04783,2016,57,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.9,high_burden
KE-NRB-2011-04784,2011,64,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.9,high_burden
KE-NRB-2013-04785,2013,61,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,4.5,high_burden
KE-NRB-2017-04786,2017,68,65-74,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,8.2,high_burden
KE-NRB-2018-04787,2018,39,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.9,high_burden
KE-NRB-2017-04788,2017,48,45-54,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,5.0,high_burden
KE-NRB-2014-04789,2014,67,65-74,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,25.8,high_burden
KE-NRB-2010-04790,2010,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.6,high_burden
KE-NRB-2014-04791,2014,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,7.3,high_burden
KE-NRB-2017-04792,2017,79,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,39.3,high_burden
KE-NRB-2013-04793,2013,42,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2014-04794,2014,34,25-34,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.9,high_burden
KE-NRB-2011-04795,2011,60,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.1,high_burden
KE-NRB-2016-04796,2016,51,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.3,high_burden
KE-NRB-2012-04797,2012,83,75+,Male,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,6.0,high_burden
KE-NRB-2015-04798,2015,36,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,40.4,high_burden
KE-NRB-2015-04799,2015,26,25-34,Male,Skin (melanoma),Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,12.5,high_burden
KE-NRB-2016-04800,2016,71,65-74,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2011-04801,2011,45,45-54,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,20.0,high_burden
KE-NRB-2014-04802,2014,66,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-04803,2014,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-04804,2017,63,55-64,Male,Prostate,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,5.7,high_burden
KE-NRB-2017-04805,2017,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,6.9,high_burden
KE-NRB-2018-04806,2018,77,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.8,high_burden
KE-NRB-2016-04807,2016,46,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.6,high_burden
KE-NRB-2012-04808,2012,47,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,13.9,high_burden
KE-NRB-2009-04809,2009,45,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,37.4,high_burden
KE-NRB-2012-04810,2012,68,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.6,high_burden
KE-NRB-2011-04811,2011,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,26.2,high_burden
KE-NRB-2010-04812,2010,37,35-44,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Alive,25.2,high_burden
KE-NRB-2010-04813,2010,63,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,28.2,high_burden
KE-NRB-2009-04814,2009,51,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,5.1,high_burden
KE-NRB-2012-04815,2012,67,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-04816,2017,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,20.4,high_burden
KE-NRB-2013-04817,2013,61,55-64,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.4,high_burden
KE-NRB-2017-04818,2017,27,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,54.2,high_burden
KE-NRB-2014-04819,2014,51,45-54,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.7,high_burden
KE-NRB-2013-04820,2013,90,75+,Female,Thyroid,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Lost to follow-up,53.7,high_burden
KE-NRB-2010-04821,2010,69,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,31.3,high_burden
KE-NRB-2009-04822,2009,87,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-04823,2015,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2015-04824,2015,39,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.3,high_burden
KE-NRB-2012-04825,2012,55,55-64,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-04826,2013,50,45-54,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,12.6,high_burden
KE-NRB-2010-04827,2010,43,35-44,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,1.0,high_burden
KE-NRB-2018-04828,2018,73,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,55.9,high_burden
KE-NRB-2018-04829,2018,32,25-34,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-04830,2011,63,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,53.8,high_burden
KE-NRB-2014-04831,2014,54,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.3,high_burden
KE-NRB-2013-04832,2013,43,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,25.6,high_burden
KE-NRB-2017-04833,2017,70,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,21.0,high_burden
KE-NRB-2013-04834,2013,79,75+,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,59.3,high_burden
KE-NRB-2016-04835,2016,37,35-44,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,1.3,high_burden
KE-NRB-2015-04836,2015,45,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,1.1,high_burden
KE-NRB-2018-04837,2018,28,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,45.5,high_burden
KE-NRB-2014-04838,2014,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery only,Dead,17.5,high_burden
KE-NRB-2018-04839,2018,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2016-04840,2016,45,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-04841,2014,56,55-64,Male,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,33.6,high_burden
KE-NRB-2009-04842,2009,64,55-64,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.7,high_burden
KE-NRB-2014-04843,2014,55,55-64,Male,Kaposi sarcoma,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,21.3,high_burden
KE-NRB-2017-04844,2017,25,25-34,Male,Oesophagus,Adenocarcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,49.0,high_burden
KE-NRB-2009-04845,2009,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,32.6,high_burden
KE-NRB-2017-04846,2017,81,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-04847,2014,54,45-54,Male,Bladder,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,10.7,high_burden
KE-NRB-2018-04848,2018,37,35-44,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,9.5,high_burden
KE-NRB-2011-04849,2011,39,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.2,high_burden
KE-NRB-2016-04850,2016,56,55-64,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.3,high_burden
KE-NRB-2013-04851,2013,48,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,1.1,high_burden
KE-NRB-2011-04852,2011,32,25-34,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,42.9,high_burden
KE-NRB-2016-04853,2016,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,1.2,high_burden
KE-NRB-2015-04854,2015,52,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,10.0,high_burden
KE-NRB-2018-04855,2018,50,45-54,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,3.9,high_burden
KE-NRB-2012-04856,2012,50,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,60.0,high_burden
KE-NRB-2011-04857,2011,51,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,11.0,high_burden
KE-NRB-2017-04858,2017,63,55-64,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.5,high_burden
KE-NRB-2013-04859,2013,44,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,50.3,high_burden
KE-NRB-2016-04860,2016,60,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,11.5,high_burden
KE-NRB-2011-04861,2011,69,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.3,high_burden
KE-NRB-2011-04862,2011,64,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,23.0,high_burden
KE-NRB-2016-04863,2016,63,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,50.2,high_burden
KE-NRB-2013-04864,2013,52,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Peri-urban,N/A,Dead,55.7,high_burden
KE-NRB-2014-04865,2014,91,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.2,high_burden
KE-NRB-2009-04866,2009,23,15-24,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,11.9,high_burden
KE-NRB-2013-04867,2013,35,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-04868,2010,26,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,45.7,high_burden
KE-NRB-2013-04869,2013,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,30.4,high_burden
KE-NRB-2011-04870,2011,35,35-44,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,32.1,high_burden
KE-NRB-2009-04871,2009,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,27.5,high_burden
KE-NRB-2015-04872,2015,44,35-44,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-04873,2009,69,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,7.6,high_burden
KE-NRB-2015-04874,2015,59,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2016-04875,2016,57,55-64,Male,Colorectum,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,38.1,high_burden
KE-NRB-2018-04876,2018,31,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,1.2,high_burden
KE-NRB-2016-04877,2016,54,45-54,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,1.8,high_burden
KE-NRB-2015-04878,2015,61,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.4,high_burden
KE-NRB-2015-04879,2015,39,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,3.5,high_burden
KE-NRB-2012-04880,2012,34,25-34,Female,Ovary,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,5.0,high_burden
KE-NRB-2018-04881,2018,51,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,11.4,high_burden
KE-NRB-2017-04882,2017,62,55-64,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,4.9,high_burden
KE-NRB-2014-04883,2014,39,35-44,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2011-04884,2011,75,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,35.8,high_burden
KE-NRB-2011-04885,2011,94,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-04886,2012,49,45-54,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,16.7,high_burden
KE-NRB-2013-04887,2013,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,10.2,high_burden
KE-NRB-2018-04888,2018,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,29.6,high_burden
KE-NRB-2010-04889,2010,72,65-74,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,35.6,high_burden
KE-NRB-2009-04890,2009,64,55-64,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.2,high_burden
KE-NRB-2015-04891,2015,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.1,high_burden
KE-NRB-2017-04892,2017,61,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-04893,2012,67,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-04894,2018,59,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.5,high_burden
KE-NRB-2017-04895,2017,66,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2011-04896,2011,28,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,1.5,high_burden
KE-NRB-2009-04897,2009,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,3.1,high_burden
KE-NRB-2012-04898,2012,91,75+,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,4.8,high_burden
KE-NRB-2012-04899,2012,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,54.2,high_burden
KE-NRB-2017-04900,2017,40,35-44,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,22.4,high_burden
KE-NRB-2016-04901,2016,64,55-64,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,15.0,high_burden
KE-NRB-2009-04902,2009,69,65-74,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,13.1,high_burden
KE-NRB-2017-04903,2017,61,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,60.0,high_burden
KE-NRB-2015-04904,2015,48,45-54,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,7.8,high_burden
KE-NRB-2018-04905,2018,48,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.2,high_burden
KE-NRB-2015-04906,2015,46,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,58.3,high_burden
KE-NRB-2017-04907,2017,69,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-04908,2009,44,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,4.4,high_burden
KE-NRB-2018-04909,2018,44,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.2,high_burden
KE-NRB-2012-04910,2012,44,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,24.4,high_burden
KE-NRB-2017-04911,2017,50,45-54,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,9.8,high_burden
KE-NRB-2009-04912,2009,74,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,49.2,high_burden
KE-NRB-2017-04913,2017,29,25-34,Male,Kaposi sarcoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,6.7,high_burden
KE-NRB-2015-04914,2015,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,4.8,high_burden
KE-NRB-2017-04915,2017,48,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Lost to follow-up,27.4,high_burden
KE-NRB-2009-04916,2009,50,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,4.3,high_burden
KE-NRB-2010-04917,2010,46,45-54,Male,Liver,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.5,high_burden
KE-NRB-2014-04918,2014,86,75+,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,5.8,high_burden
KE-NRB-2017-04919,2017,67,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2016-04920,2016,39,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Radiotherapy only,Dead,9.1,high_burden
KE-NRB-2012-04921,2012,61,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.1,high_burden
KE-NRB-2013-04922,2013,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-04923,2011,29,25-34,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.0,high_burden
KE-NRB-2015-04924,2015,82,75+,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.7,high_burden
KE-NRB-2012-04925,2012,93,75+,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,32.1,high_burden
KE-NRB-2018-04926,2018,73,65-74,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Rural,N/A,Alive,37.3,high_burden
KE-NRB-2016-04927,2016,46,45-54,Female,Other,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,24.4,high_burden
KE-NRB-2012-04928,2012,32,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,41.0,high_burden
KE-NRB-2015-04929,2015,46,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,26.2,high_burden
KE-NRB-2015-04930,2015,74,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.9,high_burden
KE-NRB-2015-04931,2015,89,75+,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.9,high_burden
KE-NRB-2013-04932,2013,71,65-74,Male,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,17.2,high_burden
KE-NRB-2017-04933,2017,63,55-64,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,0.9,high_burden
KE-NRB-2015-04934,2015,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.4,high_burden
KE-NRB-2018-04935,2018,46,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-04936,2012,50,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-04937,2013,47,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,40.3,high_burden
KE-NRB-2015-04938,2015,56,55-64,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.9,high_burden
KE-NRB-2014-04939,2014,57,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,49.7,high_burden
KE-NRB-2012-04940,2012,95,75+,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,19.9,high_burden
KE-NRB-2012-04941,2012,30,25-34,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Radiotherapy only,Dead,3.4,high_burden
KE-NRB-2013-04942,2013,26,25-34,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,21.6,high_burden
KE-NRB-2017-04943,2017,51,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.4,high_burden
KE-NRB-2012-04944,2012,25,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,41.9,high_burden
KE-NRB-2017-04945,2017,47,45-54,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.3,high_burden
KE-NRB-2009-04946,2009,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,13.5,high_burden
KE-NRB-2018-04947,2018,47,45-54,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,17.6,high_burden
KE-NRB-2014-04948,2014,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,26.0,high_burden
KE-NRB-2011-04949,2011,55,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,2.4,high_burden
KE-NRB-2010-04950,2010,51,45-54,Male,Stomach,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-04951,2015,51,45-54,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,39.3,high_burden
KE-NRB-2017-04952,2017,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.3,high_burden
KE-NRB-2010-04953,2010,20,15-24,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,12.9,high_burden
KE-NRB-2016-04954,2016,71,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,40.6,high_burden
KE-NRB-2016-04955,2016,72,65-74,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,7.6,high_burden
KE-NRB-2014-04956,2014,28,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Lost to follow-up,21.5,high_burden
KE-NRB-2018-04957,2018,48,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,high_burden
KE-NRB-2014-04958,2014,41,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.0,high_burden
KE-NRB-2017-04959,2017,68,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,42.7,high_burden
KE-NRB-2017-04960,2017,47,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,53.2,high_burden
KE-NRB-2014-04961,2014,25,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,22.5,high_burden
KE-NRB-2018-04962,2018,33,25-34,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-04963,2016,50,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.4,high_burden
KE-NRB-2016-04964,2016,55,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,7.6,high_burden
KE-NRB-2014-04965,2014,46,45-54,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,46.1,high_burden
KE-NRB-2010-04966,2010,78,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,32.8,high_burden
KE-NRB-2017-04967,2017,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.1,high_burden
KE-NRB-2016-04968,2016,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,24.1,high_burden
KE-NRB-2017-04969,2017,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,9.7,high_burden
KE-NRB-2018-04970,2018,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.7,high_burden
KE-NRB-2017-04971,2017,47,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,35.1,high_burden
KE-NRB-2016-04972,2016,44,35-44,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.6,high_burden
KE-NRB-2013-04973,2013,44,35-44,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,53.4,high_burden
KE-NRB-2013-04974,2013,58,55-64,Male,Lung,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-04975,2010,58,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,24.2,high_burden
KE-NRB-2011-04976,2011,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,16.1,high_burden
KE-NRB-2018-04977,2018,57,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,49.4,high_burden
KE-NRB-2017-04978,2017,87,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,35.1,high_burden
KE-NRB-2009-04979,2009,63,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,29.2,high_burden
KE-NRB-2011-04980,2011,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,57.2,high_burden
KE-NRB-2013-04981,2013,42,35-44,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,1.4,high_burden
KE-NRB-2014-04982,2014,36,35-44,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,23.5,high_burden
KE-NRB-2013-04983,2013,39,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,18.8,high_burden
KE-NRB-2010-04984,2010,47,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.4,high_burden
KE-NRB-2009-04985,2009,61,55-64,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,23.7,high_burden
KE-NRB-2015-04986,2015,57,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,19.9,high_burden
KE-NRB-2011-04987,2011,74,65-74,Male,Leukemia,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,14.3,high_burden
KE-NRB-2016-04988,2016,62,55-64,Male,Colorectum,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,2.5,high_burden
KE-NRB-2016-04989,2016,69,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,6.7,high_burden
KE-NRB-2014-04990,2014,74,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-04991,2016,30,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,4.0,high_burden
KE-NRB-2018-04992,2018,56,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,8.5,high_burden
KE-NRB-2012-04993,2012,55,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,39.8,high_burden
KE-NRB-2011-04994,2011,73,65-74,Male,Kidney,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Urban,N/A,Dead,38.6,high_burden
KE-NRB-2018-04995,2018,39,35-44,Male,Brain and CNS,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-04996,2012,76,75+,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.4,high_burden
KE-NRB-2017-04997,2017,60,55-64,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Alive,15.8,high_burden
KE-NRB-2009-04998,2009,49,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.0,high_burden
KE-NRB-2018-04999,2018,55,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,46.7,high_burden
KE-NRB-2014-05000,2014,63,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.0,high_burden
KE-NRB-2011-05001,2011,4,0-14,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-05002,2017,28,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.6,high_burden
KE-NRB-2011-05003,2011,26,25-34,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.2,high_burden
KE-NRB-2016-05004,2016,54,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,7.2,high_burden
KE-NRB-2015-05005,2015,73,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,23.8,high_burden
KE-NRB-2017-05006,2017,62,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,29.1,high_burden
KE-NRB-2015-05007,2015,64,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,38.0,high_burden
KE-NRB-2012-05008,2012,68,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-05009,2010,39,35-44,Female,Breast,Unspecified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,2.3,high_burden
KE-NRB-2017-05010,2017,54,45-54,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,25.3,high_burden
KE-NRB-2011-05011,2011,81,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.4,high_burden
KE-NRB-2017-05012,2017,37,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.1,high_burden
KE-NRB-2014-05013,2014,66,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.0,high_burden
KE-NRB-2016-05014,2016,58,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,28.0,high_burden
KE-NRB-2017-05015,2017,34,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,55.8,high_burden
KE-NRB-2014-05016,2014,50,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,22.4,high_burden
KE-NRB-2013-05017,2013,70,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,high_burden
KE-NRB-2015-05018,2015,37,35-44,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.9,high_burden
KE-NRB-2018-05019,2018,51,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,2.4,high_burden
KE-NRB-2011-05020,2011,49,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2016-05021,2016,52,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-05022,2013,32,25-34,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.2,high_burden
KE-NRB-2009-05023,2009,4,0-14,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.2,high_burden
KE-NRB-2015-05024,2015,52,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-05025,2017,47,45-54,Male,Lung,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,42.6,high_burden
KE-NRB-2010-05026,2010,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-05027,2010,78,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.6,high_burden
KE-NRB-2013-05028,2013,47,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-05029,2016,63,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,22.6,high_burden
KE-NRB-2012-05030,2012,62,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,9.4,high_burden
KE-NRB-2013-05031,2013,74,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-05032,2013,28,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-05033,2014,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,23.6,high_burden
KE-NRB-2018-05034,2018,61,55-64,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,43.6,high_burden
KE-NRB-2015-05035,2015,50,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-05036,2011,36,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2010-05037,2010,30,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.9,high_burden
KE-NRB-2012-05038,2012,92,75+,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,43.3,high_burden
KE-NRB-2010-05039,2010,62,55-64,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2015-05040,2015,10,0-14,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,36.6,high_burden
KE-NRB-2017-05041,2017,61,55-64,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,24.2,high_burden
KE-NRB-2011-05042,2011,27,25-34,Female,Other,Leukemia,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,55.2,high_burden
KE-NRB-2018-05043,2018,38,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,54.1,high_burden
KE-NRB-2012-05044,2012,73,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,23.1,high_burden
KE-NRB-2014-05045,2014,66,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,40.9,high_burden
KE-NRB-2015-05046,2015,32,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-05047,2011,59,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-05048,2009,26,25-34,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.0,high_burden
KE-NRB-2013-05049,2013,31,25-34,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,16.4,high_burden
KE-NRB-2014-05050,2014,74,65-74,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Dead,15.4,high_burden
KE-NRB-2016-05051,2016,46,45-54,Male,Other,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,6.7,high_burden
KE-NRB-2013-05052,2013,63,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,31.1,high_burden
KE-NRB-2014-05053,2014,64,55-64,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,39.9,high_burden
KE-NRB-2014-05054,2014,55,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.2,high_burden
KE-NRB-2011-05055,2011,42,35-44,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.2,high_burden
KE-NRB-2016-05056,2016,63,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,8.3,high_burden
KE-NRB-2011-05057,2011,72,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,56.9,high_burden
KE-NRB-2015-05058,2015,20,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,7.4,high_burden
KE-NRB-2016-05059,2016,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,35.7,high_burden
KE-NRB-2009-05060,2009,51,45-54,Male,Prostate,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,53.2,high_burden
KE-NRB-2018-05061,2018,43,35-44,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,49.2,high_burden
KE-NRB-2014-05062,2014,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2009-05063,2009,30,25-34,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2016-05064,2016,0,0-14,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,37.2,high_burden
KE-NRB-2012-05065,2012,62,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-05066,2018,40,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,47.8,high_burden
KE-NRB-2014-05067,2014,58,55-64,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,2.3,high_burden
KE-NRB-2018-05068,2018,67,65-74,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,0.5,high_burden
KE-NRB-2015-05069,2015,70,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.5,high_burden
KE-NRB-2011-05070,2011,64,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-05071,2015,38,35-44,Female,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,19.2,high_burden
KE-NRB-2014-05072,2014,95,75+,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,10.7,high_burden
KE-NRB-2018-05073,2018,38,35-44,Male,Liver,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.8,high_burden
KE-NRB-2013-05074,2013,53,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-05075,2015,70,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,5.4,high_burden
KE-NRB-2013-05076,2013,74,65-74,Female,Thyroid,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-05077,2018,73,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-05078,2017,78,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,44.5,high_burden
KE-NRB-2016-05079,2016,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,59.7,high_burden
KE-NRB-2015-05080,2015,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,37.1,high_burden
KE-NRB-2012-05081,2012,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,0.7,high_burden
KE-NRB-2012-05082,2012,59,55-64,Male,Other,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,38.2,high_burden
KE-NRB-2015-05083,2015,43,35-44,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Dead,5.5,high_burden
KE-NRB-2012-05084,2012,62,55-64,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,5.3,high_burden
KE-NRB-2017-05085,2017,45,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,10.6,high_burden
KE-NRB-2015-05086,2015,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-05087,2015,88,75+,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,6.3,high_burden
KE-NRB-2011-05088,2011,78,75+,Male,Leukemia,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.0,high_burden
KE-NRB-2014-05089,2014,57,55-64,Female,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,17.2,high_burden
KE-NRB-2009-05090,2009,68,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,59.5,high_burden
KE-NRB-2017-05091,2017,83,75+,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-05092,2013,33,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,9.4,high_burden
KE-NRB-2018-05093,2018,27,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.3,high_burden
KE-NRB-2012-05094,2012,68,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,10.6,high_burden
KE-NRB-2017-05095,2017,52,45-54,Male,Other,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,53.5,high_burden
KE-NRB-2017-05096,2017,50,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.6,high_burden
KE-NRB-2011-05097,2011,68,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,4.6,high_burden
KE-NRB-2009-05098,2009,79,75+,Male,Kaposi sarcoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.8,high_burden
KE-NRB-2017-05099,2017,25,25-34,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,0.2,high_burden
KE-NRB-2018-05100,2018,88,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.5,high_burden
KE-NRB-2016-05101,2016,29,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-05102,2016,25,25-34,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.8,high_burden
KE-NRB-2009-05103,2009,50,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-05104,2014,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,5.9,high_burden
KE-NRB-2013-05105,2013,36,35-44,Male,Lung,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,No treatment,Alive,39.0,high_burden
KE-NRB-2016-05106,2016,45,45-54,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,30.2,high_burden
KE-NRB-2014-05107,2014,55,55-64,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,16.3,high_burden
KE-NRB-2014-05108,2014,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2011-05109,2011,67,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,51.6,high_burden
KE-NRB-2017-05110,2017,68,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,17.1,high_burden
KE-NRB-2010-05111,2010,93,75+,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,1.3,high_burden
KE-NRB-2018-05112,2018,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-05113,2017,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-05114,2015,45,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,56.7,high_burden
KE-NRB-2018-05115,2018,25,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.3,high_burden
KE-NRB-2018-05116,2018,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,22.3,high_burden
KE-NRB-2018-05117,2018,77,75+,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,45.3,high_burden
KE-NRB-2012-05118,2012,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.0,high_burden
KE-NRB-2016-05119,2016,62,55-64,Male,Bladder,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Dead,21.9,high_burden
KE-NRB-2016-05120,2016,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,31.0,high_burden
KE-NRB-2018-05121,2018,36,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.0,high_burden
KE-NRB-2014-05122,2014,38,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,6.0,high_burden
KE-NRB-2015-05123,2015,57,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,24.1,high_burden
KE-NRB-2017-05124,2017,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.5,high_burden
KE-NRB-2018-05125,2018,62,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,20.5,high_burden
KE-NRB-2018-05126,2018,47,45-54,Male,Oesophagus,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,5.8,high_burden
KE-NRB-2012-05127,2012,66,65-74,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,37.7,high_burden
KE-NRB-2017-05128,2017,37,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.1,high_burden
KE-NRB-2016-05129,2016,82,75+,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Death certificate only,In situ,Peri-urban,N/A,Alive,14.7,high_burden
KE-NRB-2017-05130,2017,85,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,37.0,high_burden
KE-NRB-2009-05131,2009,40,35-44,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2016-05132,2016,57,55-64,Male,Leukemia,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,9.1,high_burden
KE-NRB-2013-05133,2013,77,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,45.0,high_burden
KE-NRB-2016-05134,2016,37,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,44.4,high_burden
KE-NRB-2016-05135,2016,42,35-44,Male,Kaposi sarcoma,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2009-05136,2009,57,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.3,high_burden
KE-NRB-2012-05137,2012,26,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.7,high_burden
KE-NRB-2016-05138,2016,86,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.1,high_burden
KE-NRB-2011-05139,2011,67,65-74,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,38.5,high_burden
KE-NRB-2018-05140,2018,69,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-05141,2016,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-05142,2016,42,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,38.3,high_burden
KE-NRB-2013-05143,2013,34,25-34,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,23.4,high_burden
KE-NRB-2013-05144,2013,62,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,2.1,high_burden
KE-NRB-2016-05145,2016,32,25-34,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,6.1,high_burden
KE-NRB-2017-05146,2017,50,45-54,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,36.6,high_burden
KE-NRB-2015-05147,2015,43,35-44,Female,Thyroid,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.0,high_burden
KE-NRB-2012-05148,2012,61,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.5,high_burden
KE-NRB-2016-05149,2016,40,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,8.5,high_burden
KE-NRB-2015-05150,2015,38,35-44,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.2,high_burden
KE-NRB-2013-05151,2013,50,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.7,high_burden
KE-NRB-2016-05152,2016,56,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.0,high_burden
KE-NRB-2009-05153,2009,34,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-05154,2010,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.6,high_burden
KE-NRB-2016-05155,2016,31,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.9,high_burden
KE-NRB-2012-05156,2012,58,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.9,high_burden
KE-NRB-2017-05157,2017,60,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,31.6,high_burden
KE-NRB-2017-05158,2017,53,45-54,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,42.8,high_burden
KE-NRB-2012-05159,2012,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,6.9,high_burden
KE-NRB-2013-05160,2013,24,15-24,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.8,high_burden
KE-NRB-2015-05161,2015,14,0-14,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,9.4,high_burden
KE-NRB-2014-05162,2014,71,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.6,high_burden
KE-NRB-2018-05163,2018,22,15-24,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,11.7,high_burden
KE-NRB-2018-05164,2018,43,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.4,high_burden
KE-NRB-2015-05165,2015,68,65-74,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-05166,2018,26,25-34,Male,Prostate,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,23.7,high_burden
KE-NRB-2014-05167,2014,47,45-54,Male,Brain and CNS,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,37.4,high_burden
KE-NRB-2013-05168,2013,58,55-64,Male,Stomach,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,23.3,high_burden
KE-NRB-2016-05169,2016,31,25-34,Male,Oesophagus,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,25.7,high_burden
KE-NRB-2015-05170,2015,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,10.8,high_burden
KE-NRB-2009-05171,2009,66,65-74,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,44.7,high_burden
KE-NRB-2018-05172,2018,65,65-74,Male,Pancreas,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,20.3,high_burden
KE-NRB-2013-05173,2013,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,18.7,high_burden
KE-NRB-2014-05174,2014,69,65-74,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,15.2,high_burden
KE-NRB-2018-05175,2018,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.2,high_burden
KE-NRB-2018-05176,2018,56,55-64,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.4,high_burden
KE-NRB-2017-05177,2017,72,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.0,high_burden
KE-NRB-2009-05178,2009,51,45-54,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,1.3,high_burden
KE-NRB-2014-05179,2014,32,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2014-05180,2014,23,15-24,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,34.4,high_burden
KE-NRB-2018-05181,2018,41,35-44,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,20.3,high_burden
KE-NRB-2014-05182,2014,32,25-34,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,56.1,high_burden
KE-NRB-2018-05183,2018,55,55-64,Male,Lung,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Dead,3.2,high_burden
KE-NRB-2010-05184,2010,35,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2017-05185,2017,62,55-64,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,9.9,high_burden
KE-NRB-2014-05186,2014,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,4.9,high_burden
KE-NRB-2014-05187,2014,79,75+,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-05188,2016,57,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,26.5,high_burden
KE-NRB-2018-05189,2018,50,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,0.4,high_burden
KE-NRB-2012-05190,2012,91,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-05191,2013,64,55-64,Male,Skin (melanoma),Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-05192,2016,80,75+,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Dead,34.5,high_burden
KE-NRB-2018-05193,2018,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.4,high_burden
KE-NRB-2013-05194,2013,42,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.4,high_burden
KE-NRB-2017-05195,2017,56,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,33.1,high_burden
KE-NRB-2009-05196,2009,41,35-44,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,37.9,high_burden
KE-NRB-2017-05197,2017,46,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,17.9,high_burden
KE-NRB-2018-05198,2018,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.1,high_burden
KE-NRB-2018-05199,2018,40,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-05200,2017,36,35-44,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,40.2,high_burden
KE-NRB-2018-05201,2018,38,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,36.0,high_burden
KE-NRB-2014-05202,2014,30,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,10.9,high_burden
KE-NRB-2014-05203,2014,57,55-64,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.3,high_burden
KE-NRB-2016-05204,2016,47,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-05205,2016,35,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.4,high_burden
KE-NRB-2018-05206,2018,63,55-64,Male,Lung,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2010-05207,2010,68,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.0,high_burden
KE-NRB-2015-05208,2015,66,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.6,high_burden
KE-NRB-2013-05209,2013,56,55-64,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.5,high_burden
KE-NRB-2017-05210,2017,65,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Lost to follow-up,37.1,high_burden
KE-NRB-2013-05211,2013,27,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2014-05212,2014,70,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.8,high_burden
KE-NRB-2017-05213,2017,38,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Dead,10.3,high_burden
KE-NRB-2011-05214,2011,84,75+,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,6.3,high_burden
KE-NRB-2016-05215,2016,49,45-54,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-05216,2013,22,15-24,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,45.5,high_burden
KE-NRB-2017-05217,2017,26,25-34,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.6,high_burden
KE-NRB-2018-05218,2018,72,65-74,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-05219,2012,31,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,30.9,high_burden
KE-NRB-2017-05220,2017,55,55-64,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.4,high_burden
KE-NRB-2017-05221,2017,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,29.6,high_burden
KE-NRB-2012-05222,2012,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.6,high_burden
KE-NRB-2015-05223,2015,36,35-44,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.0,high_burden
KE-NRB-2017-05224,2017,58,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,1.8,high_burden
KE-NRB-2010-05225,2010,70,65-74,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.6,high_burden
KE-NRB-2016-05226,2016,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.3,high_burden
KE-NRB-2014-05227,2014,82,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.7,high_burden
KE-NRB-2014-05228,2014,74,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-05229,2017,63,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,3.6,high_burden
KE-NRB-2015-05230,2015,47,45-54,Male,Stomach,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,28.7,high_burden
KE-NRB-2018-05231,2018,62,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.9,high_burden
KE-NRB-2017-05232,2017,35,35-44,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.9,high_burden
KE-NRB-2012-05233,2012,90,75+,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,23.6,high_burden
KE-NRB-2011-05234,2011,36,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,1.7,high_burden
KE-NRB-2010-05235,2010,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.7,high_burden
KE-NRB-2012-05236,2012,60,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.4,high_burden
KE-NRB-2012-05237,2012,89,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,3.0,high_burden
KE-NRB-2012-05238,2012,50,45-54,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2009-05239,2009,79,75+,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2016-05240,2016,61,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.9,high_burden
KE-NRB-2016-05241,2016,54,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,11.7,high_burden
KE-NRB-2018-05242,2018,33,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2015-05243,2015,58,55-64,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.9,high_burden
KE-NRB-2016-05244,2016,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,36.5,high_burden
KE-NRB-2013-05245,2013,11,0-14,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.5,high_burden
KE-NRB-2012-05246,2012,60,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,48.7,high_burden
KE-NRB-2015-05247,2015,29,25-34,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,3.7,high_burden
KE-NRB-2014-05248,2014,67,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,26.6,high_burden
KE-NRB-2014-05249,2014,53,45-54,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-05250,2017,89,75+,Male,Kidney,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.6,high_burden
KE-NRB-2016-05251,2016,28,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2013-05252,2013,66,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,4.4,high_burden
KE-NRB-2018-05253,2018,37,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,7.1,high_burden
KE-NRB-2016-05254,2016,89,75+,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-05255,2011,44,35-44,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.6,high_burden
KE-NRB-2015-05256,2015,36,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,42.0,high_burden
KE-NRB-2017-05257,2017,42,35-44,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.2,high_burden
KE-NRB-2018-05258,2018,44,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-05259,2017,55,55-64,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,2.1,high_burden
KE-NRB-2017-05260,2017,35,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-05261,2014,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Dead,21.4,high_burden
KE-NRB-2009-05262,2009,57,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,24.4,high_burden
KE-NRB-2015-05263,2015,57,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,15.8,high_burden
KE-NRB-2017-05264,2017,52,45-54,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-05265,2011,62,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,11.0,high_burden
KE-NRB-2012-05266,2012,39,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-05267,2016,51,45-54,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Alive,6.6,high_burden
KE-NRB-2014-05268,2014,78,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,21.1,high_burden
KE-NRB-2011-05269,2011,58,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.1,high_burden
KE-NRB-2009-05270,2009,53,45-54,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,12.2,high_burden
KE-NRB-2018-05271,2018,25,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.8,high_burden
KE-NRB-2018-05272,2018,53,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.3,high_burden
KE-NRB-2013-05273,2013,42,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,17.8,high_burden
KE-NRB-2017-05274,2017,70,65-74,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2009-05275,2009,58,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-05276,2012,70,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,25.6,high_burden
KE-NRB-2014-05277,2014,79,75+,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,25.1,high_burden
KE-NRB-2009-05278,2009,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,28.5,high_burden
KE-NRB-2011-05279,2011,52,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,26.2,high_burden
KE-NRB-2017-05280,2017,74,65-74,Male,Liver,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.0,high_burden
KE-NRB-2010-05281,2010,25,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,15.1,high_burden
KE-NRB-2014-05282,2014,45,45-54,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,8.6,high_burden
KE-NRB-2016-05283,2016,43,35-44,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,15.8,high_burden
KE-NRB-2016-05284,2016,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,11.8,high_burden
KE-NRB-2018-05285,2018,4,0-14,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.7,high_burden
KE-NRB-2018-05286,2018,54,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.5,high_burden
KE-NRB-2018-05287,2018,25,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.1,high_burden
KE-NRB-2013-05288,2013,46,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.0,high_burden
KE-NRB-2017-05289,2017,37,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.9,high_burden
KE-NRB-2018-05290,2018,69,65-74,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.7,high_burden
KE-NRB-2010-05291,2010,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,59.0,high_burden
KE-NRB-2015-05292,2015,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,23.0,high_burden
KE-NRB-2015-05293,2015,70,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.2,high_burden
KE-NRB-2012-05294,2012,68,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.0,high_burden
KE-NRB-2010-05295,2010,71,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.8,high_burden
KE-NRB-2015-05296,2015,38,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,17.0,high_burden
KE-NRB-2012-05297,2012,69,65-74,Male,Brain and CNS,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,24.2,high_burden
KE-NRB-2018-05298,2018,32,25-34,Male,Lung,Adenocarcinoma,Unknown,Death certificate only,Malignant,Rural,Surgery only,Dead,14.4,high_burden
KE-NRB-2017-05299,2017,61,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,21.8,high_burden
KE-NRB-2014-05300,2014,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,26.0,high_burden
KE-NRB-2014-05301,2014,51,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-05302,2013,52,45-54,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,36.2,high_burden
KE-NRB-2013-05303,2013,74,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,12.9,high_burden
KE-NRB-2018-05304,2018,49,45-54,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.1,high_burden
KE-NRB-2014-05305,2014,48,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,44.9,high_burden
KE-NRB-2016-05306,2016,56,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.1,high_burden
KE-NRB-2010-05307,2010,73,65-74,Female,Breast,Leukemia,Well differentiated (Grade I),Death certificate only,Malignant,Urban,No treatment,Dead,48.9,high_burden
KE-NRB-2012-05308,2012,72,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,3.5,high_burden
KE-NRB-2015-05309,2015,49,45-54,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,18.5,high_burden
KE-NRB-2012-05310,2012,67,65-74,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,53.3,high_burden
KE-NRB-2010-05311,2010,58,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,40.5,high_burden
KE-NRB-2009-05312,2009,43,35-44,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,22.9,high_burden
KE-NRB-2017-05313,2017,83,75+,Male,Pancreas,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.8,high_burden
KE-NRB-2009-05314,2009,35,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,21.7,high_burden
KE-NRB-2014-05315,2014,69,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Clinical only,In situ,Peri-urban,N/A,Alive,6.3,high_burden
KE-NRB-2014-05316,2014,45,45-54,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,6.6,high_burden
KE-NRB-2011-05317,2011,63,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.4,high_burden
KE-NRB-2011-05318,2011,52,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-05319,2015,38,35-44,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,11.5,high_burden
KE-NRB-2018-05320,2018,56,55-64,Male,Colorectum,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.7,high_burden
KE-NRB-2013-05321,2013,44,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,2.0,high_burden
KE-NRB-2017-05322,2017,35,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,11.5,high_burden
KE-NRB-2015-05323,2015,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,8.5,high_burden
KE-NRB-2017-05324,2017,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.2,high_burden
KE-NRB-2017-05325,2017,46,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Alive,12.7,high_burden
KE-NRB-2010-05326,2010,71,65-74,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,10.5,high_burden
KE-NRB-2015-05327,2015,56,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,43.6,high_burden
KE-NRB-2017-05328,2017,29,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,22.6,high_burden
KE-NRB-2017-05329,2017,33,25-34,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.6,high_burden
KE-NRB-2013-05330,2013,59,55-64,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,10.1,high_burden
KE-NRB-2012-05331,2012,54,45-54,Male,Prostate,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,4.0,high_burden
KE-NRB-2018-05332,2018,42,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,21.9,high_burden
KE-NRB-2017-05333,2017,64,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,32.6,high_burden
KE-NRB-2013-05334,2013,27,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.9,high_burden
KE-NRB-2013-05335,2013,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,47.0,high_burden
KE-NRB-2016-05336,2016,43,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,46.9,high_burden
KE-NRB-2018-05337,2018,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,3.4,high_burden
KE-NRB-2013-05338,2013,32,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,42.1,high_burden
KE-NRB-2016-05339,2016,53,45-54,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.5,high_burden
KE-NRB-2014-05340,2014,35,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Chemotherapy only,Lost to follow-up,24.8,high_burden
KE-NRB-2015-05341,2015,32,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.1,high_burden
KE-NRB-2018-05342,2018,80,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,29.7,high_burden
KE-NRB-2014-05343,2014,40,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,34.1,high_burden
KE-NRB-2018-05344,2018,74,65-74,Male,Prostate,Unspecified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,32.4,high_burden
KE-NRB-2015-05345,2015,83,75+,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,25.0,high_burden
KE-NRB-2017-05346,2017,58,55-64,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.5,high_burden
KE-NRB-2014-05347,2014,61,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,16.0,high_burden
KE-NRB-2010-05348,2010,68,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.2,high_burden
KE-NRB-2018-05349,2018,63,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,5.4,high_burden
KE-NRB-2012-05350,2012,69,65-74,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.6,high_burden
KE-NRB-2011-05351,2011,40,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,60.0,high_burden
KE-NRB-2017-05352,2017,45,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,51.8,high_burden
KE-NRB-2016-05353,2016,27,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,6.9,high_burden
KE-NRB-2013-05354,2013,59,55-64,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,46.9,high_burden
KE-NRB-2011-05355,2011,49,45-54,Male,Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.5,high_burden
KE-NRB-2018-05356,2018,67,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,14.4,high_burden
KE-NRB-2016-05357,2016,48,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,23.0,high_burden
KE-NRB-2017-05358,2017,25,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,1.1,high_burden
KE-NRB-2015-05359,2015,87,75+,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,5.5,high_burden
KE-NRB-2013-05360,2013,46,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,4.5,high_burden
KE-NRB-2018-05361,2018,57,55-64,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,8.0,high_burden
KE-NRB-2015-05362,2015,61,55-64,Male,Lung,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,5.8,high_burden
KE-NRB-2013-05363,2013,93,75+,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,42.0,high_burden
KE-NRB-2013-05364,2013,46,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.9,high_burden
KE-NRB-2017-05365,2017,63,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,2.6,high_burden
KE-NRB-2009-05366,2009,43,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.1,high_burden
KE-NRB-2010-05367,2010,50,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,53.8,high_burden
KE-NRB-2013-05368,2013,72,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-05369,2015,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,52.4,high_burden
KE-NRB-2015-05370,2015,37,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,20.5,high_burden
KE-NRB-2016-05371,2016,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,4.1,high_burden
KE-NRB-2015-05372,2015,57,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.4,high_burden
KE-NRB-2010-05373,2010,29,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,50.8,high_burden
KE-NRB-2017-05374,2017,84,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,41.8,high_burden
KE-NRB-2014-05375,2014,93,75+,Female,Breast,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2013-05376,2013,67,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-05377,2018,92,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,12.9,high_burden
KE-NRB-2013-05378,2013,53,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.5,high_burden
KE-NRB-2015-05379,2015,51,45-54,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,29.5,high_burden
KE-NRB-2018-05380,2018,84,75+,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,56.0,high_burden
KE-NRB-2011-05381,2011,65,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,3.0,high_burden
KE-NRB-2016-05382,2016,64,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.0,high_burden
KE-NRB-2014-05383,2014,36,35-44,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2016-05384,2016,67,65-74,Male,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,7.8,high_burden
KE-NRB-2013-05385,2013,55,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,48.0,high_burden
KE-NRB-2017-05386,2017,48,45-54,Female,Ovary,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,17.7,high_burden
KE-NRB-2010-05387,2010,85,75+,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,17.9,high_burden
KE-NRB-2009-05388,2009,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.7,high_burden
KE-NRB-2011-05389,2011,56,55-64,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,37.8,high_burden
KE-NRB-2009-05390,2009,89,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,24.2,high_burden
KE-NRB-2013-05391,2013,3,0-14,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.4,high_burden
KE-NRB-2015-05392,2015,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.0,high_burden
KE-NRB-2014-05393,2014,75,75+,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-05394,2013,73,65-74,Male,Multiple myeloma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.2,high_burden
KE-NRB-2015-05395,2015,31,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,55.4,high_burden
KE-NRB-2015-05396,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2011-05397,2011,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,19.0,high_burden
KE-NRB-2016-05398,2016,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,11.5,high_burden
KE-NRB-2010-05399,2010,45,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,7.8,high_burden
KE-NRB-2016-05400,2016,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,0.3,high_burden
KE-NRB-2015-05401,2015,89,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Peri-urban,N/A,Dead,7.8,high_burden
KE-NRB-2013-05402,2013,34,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,2.6,high_burden
KE-NRB-2018-05403,2018,40,35-44,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,29.8,high_burden
KE-NRB-2016-05404,2016,40,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,37.5,high_burden
KE-NRB-2015-05405,2015,38,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-05406,2017,27,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,35.2,high_burden
KE-NRB-2013-05407,2013,87,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,19.7,high_burden
KE-NRB-2017-05408,2017,60,55-64,Male,Skin (melanoma),Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,22.7,high_burden
KE-NRB-2018-05409,2018,7,0-14,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.6,high_burden
KE-NRB-2015-05410,2015,35,35-44,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,3.3,high_burden
KE-NRB-2018-05411,2018,42,35-44,Male,Stomach,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-05412,2018,54,45-54,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,7.1,high_burden
KE-NRB-2010-05413,2010,37,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,8.5,high_burden
KE-NRB-2013-05414,2013,58,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,17.3,high_burden
KE-NRB-2013-05415,2013,57,55-64,Male,Stomach,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.4,high_burden
KE-NRB-2011-05416,2011,90,75+,Female,Breast,Leukemia,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-05417,2014,80,75+,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,55.1,high_burden
KE-NRB-2017-05418,2017,63,55-64,Male,Bladder,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-05419,2015,65,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,15.7,high_burden
KE-NRB-2017-05420,2017,53,45-54,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,30.9,high_burden
KE-NRB-2018-05421,2018,29,25-34,Male,Oesophagus,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.2,high_burden
KE-NRB-2017-05422,2017,37,35-44,Male,Stomach,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,59.0,high_burden
KE-NRB-2018-05423,2018,52,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.4,high_burden
KE-NRB-2015-05424,2015,59,55-64,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,44.3,high_burden
KE-NRB-2012-05425,2012,29,25-34,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,19.5,high_burden
KE-NRB-2017-05426,2017,54,45-54,Male,Bladder,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,54.5,high_burden
KE-NRB-2015-05427,2015,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2009-05428,2009,36,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,19.0,high_burden
KE-NRB-2016-05429,2016,26,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,45.8,high_burden
KE-NRB-2009-05430,2009,19,15-24,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.3,high_burden
KE-NRB-2010-05431,2010,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.4,high_burden
KE-NRB-2017-05432,2017,70,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.0,high_burden
KE-NRB-2012-05433,2012,50,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,10.3,high_burden
KE-NRB-2012-05434,2012,53,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,22.7,high_burden
KE-NRB-2015-05435,2015,63,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-05436,2013,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.4,high_burden
KE-NRB-2017-05437,2017,71,65-74,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.2,high_burden
KE-NRB-2011-05438,2011,48,45-54,Male,Bladder,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,44.8,high_burden
KE-NRB-2016-05439,2016,66,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,25.9,high_burden
KE-NRB-2014-05440,2014,43,35-44,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.6,high_burden
KE-NRB-2018-05441,2018,54,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Alive,14.2,high_burden
KE-NRB-2013-05442,2013,22,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,40.5,high_burden
KE-NRB-2013-05443,2013,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-05444,2016,64,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,59.3,high_burden
KE-NRB-2017-05445,2017,58,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,37.9,high_burden
KE-NRB-2012-05446,2012,87,75+,Male,Kaposi sarcoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.3,high_burden
KE-NRB-2015-05447,2015,68,65-74,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,17.7,high_burden
KE-NRB-2018-05448,2018,53,45-54,Male,Stomach,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,34.2,high_burden
KE-NRB-2013-05449,2013,87,75+,Female,Other,Adenocarcinoma,Unknown,Other,Benign/uncertain,Urban,N/A,Dead,2.4,high_burden
KE-NRB-2017-05450,2017,65,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,51.0,high_burden
KE-NRB-2009-05451,2009,22,15-24,Female,Ovary,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,40.7,high_burden
KE-NRB-2011-05452,2011,62,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,17.4,high_burden
KE-NRB-2009-05453,2009,46,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,17.5,high_burden
KE-NRB-2010-05454,2010,66,65-74,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,27.0,high_burden
KE-NRB-2015-05455,2015,67,65-74,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.4,high_burden
KE-NRB-2011-05456,2011,52,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,20.4,high_burden
KE-NRB-2011-05457,2011,46,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,21.1,high_burden
KE-NRB-2017-05458,2017,83,75+,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,21.8,high_burden
KE-NRB-2011-05459,2011,40,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,15.0,high_burden
KE-NRB-2017-05460,2017,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2011-05461,2011,35,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.9,high_burden
KE-NRB-2016-05462,2016,46,45-54,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2012-05463,2012,58,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.2,high_burden
KE-NRB-2016-05464,2016,37,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Urban,N/A,Dead,12.9,high_burden
KE-NRB-2012-05465,2012,71,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,13.2,high_burden
KE-NRB-2017-05466,2017,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.9,high_burden
KE-NRB-2016-05467,2016,49,45-54,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-05468,2015,47,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Palliative care only,Alive,12.3,high_burden
KE-NRB-2017-05469,2017,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,38.9,high_burden
KE-NRB-2010-05470,2010,42,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.8,high_burden
KE-NRB-2017-05471,2017,34,25-34,Male,Brain and CNS,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,36.3,high_burden
KE-NRB-2014-05472,2014,95,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.7,high_burden
KE-NRB-2010-05473,2010,64,55-64,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,24.4,high_burden
KE-NRB-2012-05474,2012,62,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,3.3,high_burden
KE-NRB-2016-05475,2016,69,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Dead,4.3,high_burden
KE-NRB-2011-05476,2011,35,35-44,Male,Pancreas,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,high_burden
KE-NRB-2017-05477,2017,54,45-54,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,high_burden
KE-NRB-2010-05478,2010,29,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,33.1,high_burden
KE-NRB-2016-05479,2016,43,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.0,high_burden
KE-NRB-2017-05480,2017,59,55-64,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.0,high_burden
KE-NRB-2017-05481,2017,65,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.9,high_burden
KE-NRB-2015-05482,2015,39,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,23.5,high_burden
KE-NRB-2017-05483,2017,73,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-05484,2018,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,34.9,high_burden
KE-NRB-2017-05485,2017,25,25-34,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,8.2,high_burden
KE-NRB-2014-05486,2014,44,35-44,Female,Cervix uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.6,high_burden
KE-NRB-2018-05487,2018,52,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,9.2,high_burden
KE-NRB-2013-05488,2013,29,25-34,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-05489,2015,52,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.9,high_burden
KE-NRB-2018-05490,2018,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,9.9,high_burden
KE-NRB-2017-05491,2017,45,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,26.5,high_burden
KE-NRB-2009-05492,2009,30,25-34,Female,Other,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,20.3,high_burden
KE-NRB-2018-05493,2018,25,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,47.7,high_burden
KE-NRB-2012-05494,2012,61,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,29.1,high_burden
KE-NRB-2018-05495,2018,31,25-34,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2015-05496,2015,37,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,39.4,high_burden
KE-NRB-2009-05497,2009,75,75+,Male,Lung,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,5.8,high_burden
KE-NRB-2017-05498,2017,71,65-74,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,20.9,high_burden
KE-NRB-2016-05499,2016,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,7.0,high_burden
KE-NRB-2018-05500,2018,38,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.9,high_burden
KE-NRB-2010-05501,2010,28,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,38.1,high_burden
KE-NRB-2018-05502,2018,51,45-54,Female,Thyroid,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-05503,2018,50,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.2,high_burden
KE-NRB-2013-05504,2013,59,55-64,Male,Leukemia,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,4.1,high_burden
KE-NRB-2011-05505,2011,52,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,9.5,high_burden
KE-NRB-2010-05506,2010,58,55-64,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Alive,39.7,high_burden
KE-NRB-2017-05507,2017,26,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.0,high_burden
KE-NRB-2016-05508,2016,46,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.6,high_burden
KE-NRB-2012-05509,2012,24,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,3.1,high_burden
KE-NRB-2011-05510,2011,56,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-05511,2013,36,35-44,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,28.3,high_burden
KE-NRB-2012-05512,2012,87,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,5.6,high_burden
KE-NRB-2018-05513,2018,66,65-74,Male,Pancreas,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.1,high_burden
KE-NRB-2014-05514,2014,59,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,1.5,high_burden
KE-NRB-2011-05515,2011,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2013-05516,2013,69,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2012-05517,2012,95,75+,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,0.1,high_burden
KE-NRB-2009-05518,2009,40,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,54.2,high_burden
KE-NRB-2011-05519,2011,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Palliative care only,Dead,3.1,high_burden
KE-NRB-2018-05520,2018,58,55-64,Male,Multiple myeloma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.9,high_burden
KE-NRB-2010-05521,2010,27,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.6,high_burden
KE-NRB-2010-05522,2010,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,28.5,high_burden
KE-NRB-2017-05523,2017,72,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,17.5,high_burden
KE-NRB-2017-05524,2017,46,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,55.4,high_burden
KE-NRB-2011-05525,2011,38,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2011-05526,2011,65,65-74,Male,Prostate,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,33.7,high_burden
KE-NRB-2015-05527,2015,25,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,7.0,high_burden
KE-NRB-2014-05528,2014,48,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,7.0,high_burden
KE-NRB-2017-05529,2017,32,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Dead,6.5,high_burden
KE-NRB-2016-05530,2016,44,35-44,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.5,high_burden
KE-NRB-2016-05531,2016,47,45-54,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,9.9,high_burden
KE-NRB-2015-05532,2015,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,11.7,high_burden
KE-NRB-2015-05533,2015,32,25-34,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.4,high_burden
KE-NRB-2014-05534,2014,65,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,24.6,high_burden
KE-NRB-2014-05535,2014,72,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,23.0,high_burden
KE-NRB-2011-05536,2011,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.0,high_burden
KE-NRB-2017-05537,2017,30,25-34,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,1.0,high_burden
KE-NRB-2015-05538,2015,35,35-44,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,20.0,high_burden
KE-NRB-2017-05539,2017,77,75+,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.3,high_burden
KE-NRB-2017-05540,2017,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.2,high_burden
KE-NRB-2012-05541,2012,29,25-34,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.2,high_burden
KE-NRB-2015-05542,2015,31,25-34,Male,Brain and CNS,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-05543,2017,39,35-44,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,60.0,high_burden
KE-NRB-2010-05544,2010,73,65-74,Male,Stomach,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,45.8,high_burden
KE-NRB-2017-05545,2017,44,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.8,high_burden
KE-NRB-2013-05546,2013,63,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,37.3,high_burden
KE-NRB-2015-05547,2015,44,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.5,high_burden
KE-NRB-2018-05548,2018,34,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,12.9,high_burden
KE-NRB-2015-05549,2015,28,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.5,high_burden
KE-NRB-2017-05550,2017,62,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,13.5,high_burden
KE-NRB-2012-05551,2012,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.7,high_burden
KE-NRB-2018-05552,2018,31,25-34,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,28.4,high_burden
KE-NRB-2017-05553,2017,52,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2017-05554,2017,59,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,40.8,high_burden
KE-NRB-2009-05555,2009,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2016-05556,2016,64,55-64,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.6,high_burden
KE-NRB-2018-05557,2018,48,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2011-05558,2011,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,16.7,high_burden
KE-NRB-2018-05559,2018,36,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,60.0,high_burden
KE-NRB-2016-05560,2016,40,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-05561,2014,60,55-64,Male,Kaposi sarcoma,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.0,high_burden
KE-NRB-2017-05562,2017,25,25-34,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,45.4,high_burden
KE-NRB-2014-05563,2014,35,35-44,Male,Brain and CNS,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,55.7,high_burden
KE-NRB-2017-05564,2017,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,30.0,high_burden
KE-NRB-2013-05565,2013,51,45-54,Male,Multiple myeloma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-05566,2016,26,25-34,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,3.3,high_burden
KE-NRB-2018-05567,2018,72,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-05568,2018,53,45-54,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.9,high_burden
KE-NRB-2010-05569,2010,45,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Dead,10.2,high_burden
KE-NRB-2017-05570,2017,41,35-44,Male,Prostate,Leukemia,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-05571,2018,45,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,9.0,high_burden
KE-NRB-2013-05572,2013,65,65-74,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,3.3,high_burden
KE-NRB-2016-05573,2016,41,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.9,high_burden
KE-NRB-2014-05574,2014,48,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2010-05575,2010,27,25-34,Female,Corpus uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.2,high_burden
KE-NRB-2014-05576,2014,74,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.3,high_burden
KE-NRB-2017-05577,2017,70,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.5,high_burden
KE-NRB-2014-05578,2014,12,0-14,Male,Colorectum,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2013-05579,2013,2,0-14,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.9,high_burden
KE-NRB-2012-05580,2012,61,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.3,high_burden
KE-NRB-2009-05581,2009,46,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.7,high_burden
KE-NRB-2015-05582,2015,68,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2015-05583,2015,54,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,39.1,high_burden
KE-NRB-2011-05584,2011,53,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-05585,2011,47,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,14.6,high_burden
KE-NRB-2017-05586,2017,27,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,60.0,high_burden
KE-NRB-2018-05587,2018,67,65-74,Male,Lung,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,0.4,high_burden
KE-NRB-2009-05588,2009,39,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,0.6,high_burden
KE-NRB-2011-05589,2011,63,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-05590,2010,42,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,42.0,high_burden
KE-NRB-2011-05591,2011,39,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.9,high_burden
KE-NRB-2016-05592,2016,35,35-44,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,6.2,high_burden
KE-NRB-2013-05593,2013,73,65-74,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,4.1,high_burden
KE-NRB-2016-05594,2016,62,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,23.0,high_burden
KE-NRB-2009-05595,2009,49,45-54,Male,Colorectum,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,22.9,high_burden
KE-NRB-2015-05596,2015,65,65-74,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,16.7,high_burden
KE-NRB-2012-05597,2012,47,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,33.4,high_burden
KE-NRB-2015-05598,2015,69,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.0,high_burden
KE-NRB-2017-05599,2017,55,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.1,high_burden
KE-NRB-2013-05600,2013,42,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.4,high_burden
KE-NRB-2018-05601,2018,22,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Dead,10.9,high_burden
KE-NRB-2017-05602,2017,37,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.0,high_burden
KE-NRB-2015-05603,2015,28,25-34,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,6.0,high_burden
KE-NRB-2011-05604,2011,49,45-54,Male,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,44.1,high_burden
KE-NRB-2014-05605,2014,68,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2016-05606,2016,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,50.1,high_burden
KE-NRB-2018-05607,2018,49,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2013-05608,2013,37,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,high_burden
KE-NRB-2010-05609,2010,86,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-05610,2012,47,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,51.8,high_burden
KE-NRB-2014-05611,2014,27,25-34,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,24.6,high_burden
KE-NRB-2011-05612,2011,40,35-44,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2016-05613,2016,26,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.4,high_burden
KE-NRB-2009-05614,2009,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-05615,2017,26,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,50.5,high_burden
KE-NRB-2017-05616,2017,35,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,14.7,high_burden
KE-NRB-2012-05617,2012,77,75+,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.6,high_burden
KE-NRB-2014-05618,2014,65,65-74,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-05619,2017,15,15-24,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,8.9,high_burden
KE-NRB-2015-05620,2015,12,0-14,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,9.3,high_burden
KE-NRB-2018-05621,2018,83,75+,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.8,high_burden
KE-NRB-2014-05622,2014,46,45-54,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,10.7,high_burden
KE-NRB-2018-05623,2018,18,15-24,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,3.6,high_burden
KE-NRB-2014-05624,2014,49,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-05625,2015,27,25-34,Female,Breast,Leukemia,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,32.8,high_burden
KE-NRB-2015-05626,2015,51,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,11.3,high_burden
KE-NRB-2013-05627,2013,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,17.2,high_burden
KE-NRB-2016-05628,2016,72,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,36.9,high_burden
KE-NRB-2017-05629,2017,53,45-54,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.9,high_burden
KE-NRB-2017-05630,2017,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.1,high_burden
KE-NRB-2014-05631,2014,48,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.1,high_burden
KE-NRB-2012-05632,2012,54,45-54,Male,Leukemia,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.6,high_burden
KE-NRB-2017-05633,2017,25,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,35.9,high_burden
KE-NRB-2015-05634,2015,45,45-54,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,35.2,high_burden
KE-NRB-2016-05635,2016,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.8,high_burden
KE-NRB-2013-05636,2013,50,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.7,high_burden
KE-NRB-2016-05637,2016,66,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.4,high_burden
KE-NRB-2011-05638,2011,65,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,16.3,high_burden
KE-NRB-2011-05639,2011,1,0-14,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.1,high_burden
KE-NRB-2012-05640,2012,26,25-34,Male,Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2011-05641,2011,39,35-44,Female,Ovary,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,4.8,high_burden
KE-NRB-2015-05642,2015,58,55-64,Male,Colorectum,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.8,high_burden
KE-NRB-2014-05643,2014,62,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.1,high_burden
KE-NRB-2013-05644,2013,49,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2017-05645,2017,47,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.2,high_burden
KE-NRB-2016-05646,2016,62,55-64,Male,Colorectum,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,29.0,high_burden
KE-NRB-2009-05647,2009,78,75+,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-05648,2014,73,65-74,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,33.7,high_burden
KE-NRB-2012-05649,2012,67,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,38.6,high_burden
KE-NRB-2015-05650,2015,65,65-74,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,No treatment,Dead,2.4,high_burden
KE-NRB-2018-05651,2018,31,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,14.9,high_burden
KE-NRB-2016-05652,2016,71,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,46.1,high_burden
KE-NRB-2018-05653,2018,29,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,47.2,high_burden
KE-NRB-2013-05654,2013,93,75+,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-05655,2017,62,55-64,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Lost to follow-up,15.5,high_burden
KE-NRB-2015-05656,2015,49,45-54,Female,Corpus uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,34.6,high_burden
KE-NRB-2017-05657,2017,57,55-64,Male,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,27.3,high_burden
KE-NRB-2015-05658,2015,72,65-74,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2014-05659,2014,63,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-05660,2012,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,55.6,high_burden
KE-NRB-2018-05661,2018,65,65-74,Male,Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-05662,2018,86,75+,Female,Breast,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,3.4,high_burden
KE-NRB-2016-05663,2016,20,15-24,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,0.2,high_burden
KE-NRB-2015-05664,2015,35,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,24.9,high_burden
KE-NRB-2015-05665,2015,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,28.6,high_burden
KE-NRB-2014-05666,2014,52,45-54,Male,Leukemia,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,30.4,high_burden
KE-NRB-2018-05667,2018,67,65-74,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,15.8,high_burden
KE-NRB-2017-05668,2017,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-05669,2014,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Lost to follow-up,31.0,high_burden
KE-NRB-2015-05670,2015,67,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.4,high_burden
KE-NRB-2012-05671,2012,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,0.0,high_burden
KE-NRB-2018-05672,2018,25,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.4,high_burden
KE-NRB-2018-05673,2018,65,65-74,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,15.7,high_burden
KE-NRB-2018-05674,2018,57,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,24.2,high_burden
KE-NRB-2017-05675,2017,67,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,0.6,high_burden
KE-NRB-2013-05676,2013,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,34.0,high_burden
KE-NRB-2016-05677,2016,65,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.3,high_burden
KE-NRB-2013-05678,2013,25,25-34,Male,Oesophagus,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,12.8,high_burden
KE-NRB-2018-05679,2018,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,11.0,high_burden
KE-NRB-2013-05680,2013,55,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2014-05681,2014,71,65-74,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,29.5,high_burden
KE-NRB-2018-05682,2018,88,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,0.7,high_burden
KE-NRB-2017-05683,2017,69,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-05684,2014,52,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Alive,18.5,high_burden
KE-NRB-2017-05685,2017,35,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,22.3,high_burden
KE-NRB-2015-05686,2015,57,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,0.5,high_burden
KE-NRB-2018-05687,2018,33,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,56.0,high_burden
KE-NRB-2010-05688,2010,57,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Alive,25.8,high_burden
KE-NRB-2017-05689,2017,73,65-74,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.4,high_burden
KE-NRB-2016-05690,2016,32,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.0,high_burden
KE-NRB-2012-05691,2012,2,0-14,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-05692,2012,46,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-05693,2014,79,75+,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.7,high_burden
KE-NRB-2014-05694,2014,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-05695,2016,71,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,19.3,high_burden
KE-NRB-2018-05696,2018,22,15-24,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,23.3,high_burden
KE-NRB-2013-05697,2013,66,65-74,Male,Bladder,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,31.7,high_burden
KE-NRB-2014-05698,2014,52,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2014-05699,2014,38,35-44,Male,Lung,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,high_burden
KE-NRB-2012-05700,2012,4,0-14,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,33.4,high_burden
KE-NRB-2013-05701,2013,71,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,5.8,high_burden
KE-NRB-2014-05702,2014,43,35-44,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,2.4,high_burden
KE-NRB-2010-05703,2010,27,25-34,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,21.7,high_burden
KE-NRB-2016-05704,2016,31,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-05705,2013,50,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.4,high_burden
KE-NRB-2017-05706,2017,52,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.5,high_burden
KE-NRB-2013-05707,2013,59,55-64,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,20.3,high_burden
KE-NRB-2016-05708,2016,30,25-34,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.8,high_burden
KE-NRB-2014-05709,2014,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,45.5,high_burden
KE-NRB-2018-05710,2018,53,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-05711,2010,40,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,52.0,high_burden
KE-NRB-2017-05712,2017,47,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.6,high_burden
KE-NRB-2010-05713,2010,70,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.9,high_burden
KE-NRB-2012-05714,2012,67,65-74,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,11.5,high_burden
KE-NRB-2012-05715,2012,40,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.9,high_burden
KE-NRB-2018-05716,2018,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,20.2,high_burden
KE-NRB-2018-05717,2018,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2010-05718,2010,61,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.4,high_burden
KE-NRB-2016-05719,2016,41,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,10.0,high_burden
KE-NRB-2018-05720,2018,90,75+,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,21.1,high_burden
KE-NRB-2018-05721,2018,61,55-64,Male,Bladder,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,15.5,high_burden
KE-NRB-2017-05722,2017,43,35-44,Male,Prostate,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.1,high_burden
KE-NRB-2018-05723,2018,66,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.8,high_burden
KE-NRB-2011-05724,2011,57,55-64,Male,Bladder,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.4,high_burden
KE-NRB-2013-05725,2013,92,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,5.4,high_burden
KE-NRB-2013-05726,2013,52,45-54,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-05727,2018,32,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-05728,2014,71,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.3,high_burden
KE-NRB-2017-05729,2017,58,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2009-05730,2009,60,55-64,Male,Oesophagus,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,17.7,high_burden
KE-NRB-2016-05731,2016,43,35-44,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,12.2,high_burden
KE-NRB-2010-05732,2010,61,55-64,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2010-05733,2010,91,75+,Male,Bladder,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.0,high_burden
KE-NRB-2012-05734,2012,73,65-74,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,12.6,high_burden
KE-NRB-2017-05735,2017,72,65-74,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,27.3,high_burden
KE-NRB-2013-05736,2013,86,75+,Female,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,52.9,high_burden
KE-NRB-2017-05737,2017,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,54.0,high_burden
KE-NRB-2009-05738,2009,41,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.1,high_burden
KE-NRB-2012-05739,2012,62,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,44.9,high_burden
KE-NRB-2013-05740,2013,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2013-05741,2013,35,35-44,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,2.7,high_burden
KE-NRB-2018-05742,2018,62,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.1,high_burden
KE-NRB-2018-05743,2018,58,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,8.7,high_burden
KE-NRB-2011-05744,2011,56,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,2.0,high_burden
KE-NRB-2014-05745,2014,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,10.6,high_burden
KE-NRB-2009-05746,2009,36,35-44,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,10.4,high_burden
KE-NRB-2014-05747,2014,44,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,19.1,high_burden
KE-NRB-2011-05748,2011,66,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,10.9,high_burden
KE-NRB-2010-05749,2010,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,20.2,high_burden
KE-NRB-2010-05750,2010,68,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2012-05751,2012,55,55-64,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,4.5,high_burden
KE-NRB-2014-05752,2014,55,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.8,high_burden
KE-NRB-2018-05753,2018,45,45-54,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2018-05754,2018,69,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2012-05755,2012,59,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,32.8,high_burden
KE-NRB-2016-05756,2016,46,45-54,Female,Cervix uteri,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,9.8,high_burden
KE-NRB-2014-05757,2014,65,65-74,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,27.9,high_burden
KE-NRB-2015-05758,2015,53,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.4,high_burden
KE-NRB-2012-05759,2012,57,55-64,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.3,high_burden
KE-NRB-2014-05760,2014,73,65-74,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,high_burden
KE-NRB-2015-05761,2015,10,0-14,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,48.3,high_burden
KE-NRB-2011-05762,2011,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.6,high_burden
KE-NRB-2018-05763,2018,90,75+,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,33.4,high_burden
KE-NRB-2014-05764,2014,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2018-05765,2018,45,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,11.1,high_burden
KE-NRB-2018-05766,2018,73,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.1,high_burden
KE-NRB-2012-05767,2012,13,0-14,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,44.2,high_burden
KE-NRB-2017-05768,2017,58,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.6,high_burden
KE-NRB-2015-05769,2015,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.5,high_burden
KE-NRB-2017-05770,2017,46,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,38.5,high_burden
KE-NRB-2013-05771,2013,76,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,7.2,high_burden
KE-NRB-2016-05772,2016,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,23.0,high_burden
KE-NRB-2013-05773,2013,52,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,33.4,high_burden
KE-NRB-2016-05774,2016,42,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,50.2,high_burden
KE-NRB-2017-05775,2017,52,45-54,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,40.1,high_burden
KE-NRB-2016-05776,2016,19,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,0.7,high_burden
KE-NRB-2010-05777,2010,62,55-64,Male,Colorectum,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,38.1,high_burden
KE-NRB-2016-05778,2016,60,55-64,Male,Multiple myeloma,Squamous cell carcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,5.1,high_burden
KE-NRB-2012-05779,2012,42,35-44,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.3,high_burden
KE-NRB-2011-05780,2011,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-05781,2011,81,75+,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,19.2,high_burden
KE-NRB-2012-05782,2012,48,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.9,high_burden
KE-NRB-2014-05783,2014,39,35-44,Female,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,48.9,high_burden
KE-NRB-2016-05784,2016,48,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,7.4,high_burden
KE-NRB-2015-05785,2015,56,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,8.7,high_burden
KE-NRB-2010-05786,2010,69,65-74,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,45.7,high_burden
KE-NRB-2017-05787,2017,53,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,high_burden
KE-NRB-2018-05788,2018,58,55-64,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-05789,2016,47,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,15.2,high_burden
KE-NRB-2016-05790,2016,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2013-05791,2013,34,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemotherapy only,Dead,2.2,high_burden
KE-NRB-2009-05792,2009,50,45-54,Female,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,11.9,high_burden
KE-NRB-2016-05793,2016,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,4.2,high_burden
KE-NRB-2014-05794,2014,57,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,25.7,high_burden
KE-NRB-2017-05795,2017,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,10.9,high_burden
KE-NRB-2016-05796,2016,62,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.4,high_burden
KE-NRB-2011-05797,2011,22,15-24,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.1,high_burden
KE-NRB-2017-05798,2017,72,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,22.5,high_burden
KE-NRB-2012-05799,2012,46,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,52.7,high_burden
KE-NRB-2014-05800,2014,20,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,13.6,high_burden
KE-NRB-2017-05801,2017,35,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,50.6,high_burden
KE-NRB-2014-05802,2014,73,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.4,high_burden
KE-NRB-2010-05803,2010,58,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-05804,2013,67,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,60.0,high_burden
KE-NRB-2010-05805,2010,67,65-74,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.2,high_burden
KE-NRB-2014-05806,2014,49,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2012-05807,2012,63,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.2,high_burden
KE-NRB-2013-05808,2013,21,15-24,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,12.1,high_burden
KE-NRB-2012-05809,2012,63,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2013-05810,2013,82,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-05811,2011,74,65-74,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.6,high_burden
KE-NRB-2012-05812,2012,61,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2017-05813,2017,35,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2017-05814,2017,73,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,32.4,high_burden
KE-NRB-2017-05815,2017,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,34.2,high_burden
KE-NRB-2018-05816,2018,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Other,Malignant,Urban,Surgery only,Dead,20.1,high_burden
KE-NRB-2018-05817,2018,29,25-34,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,26.6,high_burden
KE-NRB-2009-05818,2009,72,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,31.8,high_burden
KE-NRB-2016-05819,2016,76,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,No treatment,Alive,22.8,high_burden
KE-NRB-2013-05820,2013,42,35-44,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Radiotherapy only,Dead,32.9,high_burden
KE-NRB-2018-05821,2018,31,25-34,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2016-05822,2016,65,65-74,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2014-05823,2014,71,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.1,high_burden
KE-NRB-2017-05824,2017,28,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,23.4,high_burden
KE-NRB-2017-05825,2017,52,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.5,high_burden
KE-NRB-2010-05826,2010,66,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,32.6,high_burden
KE-NRB-2015-05827,2015,55,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,52.0,high_burden
KE-NRB-2016-05828,2016,65,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,1.8,high_burden
KE-NRB-2015-05829,2015,48,45-54,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,41.6,high_burden
KE-NRB-2013-05830,2013,40,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-05831,2016,37,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,37.9,high_burden
KE-NRB-2013-05832,2013,35,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Palliative care only,Dead,5.6,high_burden
KE-NRB-2017-05833,2017,25,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,high_burden
KE-NRB-2017-05834,2017,55,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,58.3,high_burden
KE-NRB-2017-05835,2017,64,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.0,high_burden
KE-NRB-2017-05836,2017,51,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,40.6,high_burden
KE-NRB-2017-05837,2017,59,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-05838,2014,57,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2017-05839,2017,46,45-54,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.4,high_burden
KE-NRB-2010-05840,2010,93,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2014-05841,2014,93,75+,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.1,high_burden
KE-NRB-2016-05842,2016,70,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,5.4,high_burden
KE-NRB-2013-05843,2013,24,15-24,Female,Breast,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,58.4,high_burden
KE-NRB-2014-05844,2014,44,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,20.2,high_burden
KE-NRB-2012-05845,2012,52,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,0.3,high_burden
KE-NRB-2016-05846,2016,47,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.4,high_burden
KE-NRB-2017-05847,2017,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,18.1,high_burden
KE-NRB-2017-05848,2017,53,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Lost to follow-up,8.5,high_burden
KE-NRB-2012-05849,2012,56,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,11.3,high_burden
KE-NRB-2017-05850,2017,39,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.9,high_burden
KE-NRB-2017-05851,2017,20,15-24,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,7.6,high_burden
KE-NRB-2018-05852,2018,37,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,6.0,high_burden
KE-NRB-2010-05853,2010,75,75+,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,35.1,high_burden
KE-NRB-2010-05854,2010,58,55-64,Male,Brain and CNS,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2014-05855,2014,57,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,19.4,high_burden
KE-NRB-2012-05856,2012,66,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,46.9,high_burden
KE-NRB-2011-05857,2011,68,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.8,high_burden
KE-NRB-2017-05858,2017,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Lost to follow-up,0.6,high_burden
KE-NRB-2017-05859,2017,64,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,40.9,high_burden
KE-NRB-2010-05860,2010,54,45-54,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-05861,2013,65,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,10.5,high_burden
KE-NRB-2015-05862,2015,70,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,17.1,high_burden
KE-NRB-2016-05863,2016,40,35-44,Female,Other,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,17.4,high_burden
KE-NRB-2015-05864,2015,82,75+,Male,Bladder,Unspecified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,22.2,high_burden
KE-NRB-2009-05865,2009,74,65-74,Male,Leukemia,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,25.4,high_burden
KE-NRB-2010-05866,2010,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,6.1,high_burden
KE-NRB-2011-05867,2011,44,35-44,Female,Thyroid,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.0,high_burden
KE-NRB-2018-05868,2018,61,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Radiotherapy only,Dead,16.8,high_burden
KE-NRB-2013-05869,2013,26,25-34,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,30.8,high_burden
KE-NRB-2018-05870,2018,54,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,4.6,high_burden
KE-NRB-2011-05871,2011,57,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,3.1,high_burden
KE-NRB-2010-05872,2010,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,11.9,high_burden
KE-NRB-2016-05873,2016,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,53.0,high_burden
KE-NRB-2012-05874,2012,25,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-05875,2018,34,25-34,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.6,high_burden
KE-NRB-2011-05876,2011,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.5,high_burden
KE-NRB-2014-05877,2014,6,0-14,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,10.9,high_burden
KE-NRB-2015-05878,2015,52,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,6.7,high_burden
KE-NRB-2016-05879,2016,94,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.1,high_burden
KE-NRB-2014-05880,2014,29,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,39.6,high_burden
KE-NRB-2015-05881,2015,79,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,high_burden
KE-NRB-2016-05882,2016,26,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.2,high_burden
KE-NRB-2015-05883,2015,49,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,48.8,high_burden
KE-NRB-2011-05884,2011,53,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,24.6,high_burden
KE-NRB-2012-05885,2012,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,43.9,high_burden
KE-NRB-2013-05886,2013,38,35-44,Female,Breast,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,37.2,high_burden
KE-NRB-2009-05887,2009,30,25-34,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.8,high_burden
KE-NRB-2017-05888,2017,25,25-34,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,14.1,high_burden
KE-NRB-2016-05889,2016,62,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.6,high_burden
KE-NRB-2018-05890,2018,45,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,6.6,high_burden
KE-NRB-2018-05891,2018,47,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,52.9,high_burden
KE-NRB-2013-05892,2013,25,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,5.3,high_burden
KE-NRB-2018-05893,2018,3,0-14,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.1,high_burden
KE-NRB-2016-05894,2016,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.7,high_burden
KE-NRB-2015-05895,2015,56,55-64,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,4.1,high_burden
KE-NRB-2018-05896,2018,32,25-34,Male,Multiple myeloma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,47.7,high_burden
KE-NRB-2014-05897,2014,14,0-14,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.5,high_burden
KE-NRB-2013-05898,2013,58,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,35.1,high_burden
KE-NRB-2015-05899,2015,95,75+,Male,Bladder,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.1,high_burden
KE-NRB-2014-05900,2014,37,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2011-05901,2011,61,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,No treatment,Alive,4.2,high_burden
KE-NRB-2018-05902,2018,73,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.9,high_burden
KE-NRB-2016-05903,2016,72,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,28.2,high_burden
KE-NRB-2018-05904,2018,50,45-54,Male,Kaposi sarcoma,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.4,high_burden
KE-NRB-2015-05905,2015,51,45-54,Male,Prostate,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2014-05906,2014,29,25-34,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,19.6,high_burden
KE-NRB-2009-05907,2009,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.7,high_burden
KE-NRB-2013-05908,2013,66,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,27.6,high_burden
KE-NRB-2010-05909,2010,22,15-24,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,29.6,high_burden
KE-NRB-2011-05910,2011,47,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.1,high_burden
KE-NRB-2013-05911,2013,50,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-05912,2018,73,65-74,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.8,high_burden
KE-NRB-2012-05913,2012,64,55-64,Male,Pancreas,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.0,high_burden
KE-NRB-2013-05914,2013,44,35-44,Male,Prostate,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,8.3,high_burden
KE-NRB-2015-05915,2015,91,75+,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,60.0,high_burden
KE-NRB-2016-05916,2016,76,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.2,high_burden
KE-NRB-2016-05917,2016,41,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,24.9,high_burden
KE-NRB-2012-05918,2012,29,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,15.7,high_burden
KE-NRB-2014-05919,2014,72,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,52.2,high_burden
KE-NRB-2016-05920,2016,66,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,12.9,high_burden
KE-NRB-2012-05921,2012,36,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,14.7,high_burden
KE-NRB-2012-05922,2012,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,60.0,high_burden
KE-NRB-2017-05923,2017,64,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,34.3,high_burden
KE-NRB-2013-05924,2013,34,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.9,high_burden
KE-NRB-2014-05925,2014,72,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,6.9,high_burden
KE-NRB-2012-05926,2012,68,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,12.7,high_burden
KE-NRB-2017-05927,2017,45,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,12.5,high_burden
KE-NRB-2017-05928,2017,86,75+,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,8.1,high_burden
KE-NRB-2012-05929,2012,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,7.5,high_burden
KE-NRB-2010-05930,2010,35,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.3,high_burden
KE-NRB-2011-05931,2011,43,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,15.5,high_burden
KE-NRB-2018-05932,2018,55,55-64,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,high_burden
KE-NRB-2018-05933,2018,48,45-54,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,40.3,high_burden
KE-NRB-2010-05934,2010,43,35-44,Male,Multiple myeloma,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,16.2,high_burden
KE-NRB-2015-05935,2015,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,46.6,high_burden
KE-NRB-2011-05936,2011,61,55-64,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,10.5,high_burden
KE-NRB-2014-05937,2014,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,15.2,high_burden
KE-NRB-2017-05938,2017,66,65-74,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2011-05939,2011,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,high_burden
KE-NRB-2016-05940,2016,50,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.8,high_burden
KE-NRB-2017-05941,2017,46,45-54,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.3,high_burden
KE-NRB-2016-05942,2016,42,35-44,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,6.9,high_burden
KE-NRB-2012-05943,2012,69,65-74,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,4.7,high_burden
KE-NRB-2014-05944,2014,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,2.0,high_burden
KE-NRB-2015-05945,2015,33,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,8.2,high_burden
KE-NRB-2017-05946,2017,41,35-44,Male,Prostate,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,7.4,high_burden
KE-NRB-2015-05947,2015,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-05948,2018,59,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.1,high_burden
KE-NRB-2017-05949,2017,59,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Alive,16.0,high_burden
KE-NRB-2017-05950,2017,25,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,6.5,high_burden
KE-NRB-2014-05951,2014,50,45-54,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,12.3,high_burden
KE-NRB-2018-05952,2018,25,25-34,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,43.6,high_burden
KE-NRB-2017-05953,2017,60,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Alive,10.5,high_burden
KE-NRB-2012-05954,2012,29,25-34,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2009-05955,2009,71,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,16.8,high_burden
KE-NRB-2018-05956,2018,66,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.3,high_burden
KE-NRB-2014-05957,2014,52,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,25.0,high_burden
KE-NRB-2013-05958,2013,64,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,13.8,high_burden
KE-NRB-2016-05959,2016,62,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2017-05960,2017,51,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,7.9,high_burden
KE-NRB-2014-05961,2014,53,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,11.1,high_burden
KE-NRB-2012-05962,2012,49,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Urban,N/A,Alive,3.3,high_burden
KE-NRB-2017-05963,2017,70,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.1,high_burden
KE-NRB-2018-05964,2018,53,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,33.5,high_burden
KE-NRB-2014-05965,2014,51,45-54,Female,Other,Squamous cell carcinoma,Unknown,Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2015-05966,2015,60,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,42.8,high_burden
KE-NRB-2017-05967,2017,67,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2016-05968,2016,72,65-74,Male,Oesophagus,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,48.5,high_burden
KE-NRB-2012-05969,2012,86,75+,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.6,high_burden
KE-NRB-2010-05970,2010,47,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.5,high_burden
KE-NRB-2010-05971,2010,31,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,9.2,high_burden
KE-NRB-2017-05972,2017,68,65-74,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2016-05973,2016,39,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,14.6,high_burden
KE-NRB-2010-05974,2010,59,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,11.0,high_burden
KE-NRB-2013-05975,2013,95,75+,Male,Pancreas,Adenocarcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,3.1,high_burden
KE-NRB-2018-05976,2018,5,0-14,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.4,high_burden
KE-NRB-2014-05977,2014,53,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,1.5,high_burden
KE-NRB-2011-05978,2011,56,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,29.8,high_burden
KE-NRB-2009-05979,2009,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,58.6,high_burden
KE-NRB-2014-05980,2014,85,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Surgery + Chemotherapy,Dead,30.8,high_burden
KE-NRB-2017-05981,2017,48,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2015-05982,2015,68,65-74,Male,Lung,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.3,high_burden
KE-NRB-2016-05983,2016,7,0-14,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2013-05984,2013,95,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,15.9,high_burden
KE-NRB-2013-05985,2013,62,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,high_burden
KE-NRB-2018-05986,2018,54,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,33.6,high_burden
KE-NRB-2010-05987,2010,33,25-34,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.6,high_burden
KE-NRB-2012-05988,2012,60,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,23.6,high_burden
KE-NRB-2016-05989,2016,44,35-44,Female,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,high_burden
KE-NRB-2011-05990,2011,25,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,27.2,high_burden
KE-NRB-2015-05991,2015,44,35-44,Female,Other,Unspecified,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Alive,60.0,high_burden
KE-NRB-2018-05992,2018,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.3,high_burden
KE-NRB-2016-05993,2016,49,45-54,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,51.5,high_burden
KE-NRB-2010-05994,2010,74,65-74,Male,Kidney,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2011-05995,2011,66,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,high_burden
KE-NRB-2013-05996,2013,46,45-54,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.3,high_burden
KE-NRB-2012-05997,2012,32,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,high_burden
KE-NRB-2016-05998,2016,48,45-54,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,high_burden
KE-NRB-2018-05999,2018,23,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.5,high_burden
KE-NRB-2014-06000,2014,62,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.9,high_burden